PCIDB

KNApSAcK Metabolite C00003491

Metabolite

KNApSAcK Entry

id C00003491
Name 12-Tetradecanoylphorbol 13-acetate
CAS RN 16561-29-8
Standard InChI InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3/t24-,27+,28-,30-,32-,34-,35-,36-/m1/s1
Standard InChI (Main Layer) InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3

Cluster

Phytochemical cluster No. 41
KCF-S cluster No. 1817

Link

ChEMBL

By standard InChI CHEMBL279115
By standard InChI Main Layer CHEMBL291793 CHEMBL279115 CHEMBL1328542 CHEMBL1441758 CHEMBL1443384 CHEMBL1446902 CHEMBL1515083

KEGG

By LinkDB C05151

CTD

By CAS RN D013755

Species

Summary

Plant class

class name count
rosids 1

Family

family name count
Euphorbiaceae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Croton tiglium 497687 Euphorbiaceae rosids Viridiplantae

Human Protein / Gene in interaction

57 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P10635 Cytochrome P450 2D6 Cytochrome P450 2D6 CHEMBL1441758 CHEMBL1741321 (1)
1 / 0
P42345 Serine/threonine-protein kinase mTOR Enzyme CHEMBL1328542 CHEMBL1614316 (1) CHEMBL1613805 (1)
CHEMBL1614009 (1) CHEMBL1614293 (1)
0 / 0
P04637 Cellular tumor antigen p53 Transcription Factor CHEMBL1441758 CHEMBL1443384 CHEMBL1613992 (2) CHEMBL1613995 (1)
7 / 44
Q16637 Survival motor neuron protein Unclassified protein CHEMBL1443384 CHEMBL1613842 (1)
4 / 2
Q99700 Ataxin-2 Unclassified protein CHEMBL1328542 CHEMBL1794367 (1)
1 / 1
P49798 Regulator of G-protein signaling 4 Unclassified protein CHEMBL1328542 CHEMBL1794499 (1)
2 / 0
P21728 D(1A) dopamine receptor Dopamine receptor CHEMBL1328542 CHEMBL2114744 (1)
0 / 0
Q12809 Potassium voltage-gated channel subfamily H member 2 KCNH, Kv10-12.x (Ether-a-go-go) CHEMBL1446902 CHEMBL1794573 (1)
2 / 2
P17252 Protein kinase C alpha type Alpha CHEMBL279115 CHEMBL767783 (1) CHEMBL823698 (1)
CHEMBL1780758 (1) CHEMBL1780891 (1)
CHEMBL1780892 (1) CHEMBL1780893 (1)
CHEMBL1780894 (1) CHEMBL1780919 (1)
CHEMBL1780920 (1) CHEMBL1780921 (1)
CHEMBL1821186 (1)
0 / 0
Q05655 Protein kinase C delta type Delta CHEMBL279115 CHEMBL767783 (1) CHEMBL822181 (1)
CHEMBL1072759 (1)
0 / 0
Q04759 Protein kinase C theta type Delta CHEMBL279115 CHEMBL767783 (1) CHEMBL1072761 (1)
0 / 1
O75604 Ubiquitin carboxyl-terminal hydrolase 2 Enzyme CHEMBL1441758 CHEMBL1443384 CHEMBL1614331 (2)
0 / 0
P02545 Prelamin-A/C Unclassified protein CHEMBL1446902 CHEMBL1614310 (1) CHEMBL1614544 (1)
11 / 10
P16473 Thyrotropin receptor Glycohormone receptor CHEMBL1441758 CHEMBL1614281 (1) CHEMBL1614361 (1)
3 / 2
Q02156 Protein kinase C epsilon type Eta CHEMBL279115 CHEMBL767783 (1) CHEMBL819877 (1)
CHEMBL1072760 (1) CHEMBL2034157 (1)
0 / 0
P11712 Cytochrome P450 2C9 Cytochrome P450 2C9 CHEMBL1441758 CHEMBL1614027 (1) CHEMBL1741325 (1)
0 / 1
P54132 Bloom syndrome protein Enzyme CHEMBL1446902 CHEMBL1614522 (1) CHEMBL1614067 (1)
1 / 2
P00352 Retinal dehydrogenase 1 Enzyme CHEMBL1443384 CHEMBL1614458 (1)
0 / 0
Q16665 Hypoxia-inducible factor 1-alpha Transcription Factor CHEMBL1441758 CHEMBL1614456 (1) CHEMBL1613803 (1)
0 / 0
O75496 Geminin Unclassified protein CHEMBL1446902 CHEMBL1613941 (1)
0 / 0
P51151 Ras-related protein Rab-9A Unclassified protein CHEMBL1328542 CHEMBL1613838 (1)
0 / 0
Q9Y253 DNA polymerase eta Enzyme CHEMBL1446902 CHEMBL1794569 (1)
1 / 1
P83916 Chromobox protein homolog 1 Unclassified protein CHEMBL1328542 CHEMBL1738610 (1)
0 / 0
P11021 78 kDa glucose-regulated protein Unclassified protein CHEMBL279115 CHEMBL1328542 CHEMBL1963893 (2)
0 / 0
O94782 Ubiquitin carboxyl-terminal hydrolase 1 Enzyme CHEMBL1328542 CHEMBL1443384 CHEMBL1794467 (2)
0 / 0
P05129 Protein kinase C gamma type Alpha CHEMBL279115 CHEMBL767783 (1) CHEMBL874096 (1)
1 / 1
P05177 Cytochrome P450 1A2 Cytochrome P450 1A2 CHEMBL1441758 CHEMBL1741322 (1)
0 / 0
Q99714 3-hydroxyacyl-CoA dehydrogenase type-2 Enzyme CHEMBL1441758 CHEMBL1614227 (1)
3 / 3
O15118 Niemann-Pick C1 protein Unclassified protein CHEMBL1328542 CHEMBL1614342 (1)
1 / 1
Q01453 Peripheral myelin protein 22 Unclassified protein CHEMBL1446902 CHEMBL1614171 (1)
5 / 2
Q96QE3 ATPase family AAA domain-containing protein 5 Unclassified protein CHEMBL1328542 CHEMBL1515083 CHEMBL1738675 (1) CHEMBL1737868 (1)
CHEMBL2114827 (1) CHEMBL2114907 (1)
CHEMBL2114929 (1)
0 / 0
P19838 Nuclear factor NF-kappa-B p105 subunit Transcription Factor CHEMBL1441758 CHEMBL1614274 (1) CHEMBL1613823 (1)
0 / 0
P05771 Protein kinase C beta type Alpha CHEMBL279115 CHEMBL767783 (1) CHEMBL823901 (1)
0 / 0
P33261 Cytochrome P450 2C19 Cytochrome P450 2C19 CHEMBL1441758 CHEMBL1741323 (1)
1 / 1
P08684 Cytochrome P450 3A4 Cytochrome P450 3A4 CHEMBL1441758 CHEMBL1614108 (1) CHEMBL1613886 (1)
CHEMBL1741324 (1)
0 / 1
Q8IV61 Ras guanyl-releasing protein 3 Other cytosolic protein CHEMBL279115 CHEMBL2034158 (1)
0 / 0
Q9UNA4 DNA polymerase iota Enzyme CHEMBL1446902 CHEMBL1794483 (1)
0 / 0
Q6W5P4 Neuropeptide S receptor Neuropeptide receptor CHEMBL1446902 CHEMBL1614052 (1)
1 / 0
P27695 DNA-(apurinic or apyrimidinic site) lyase Enzyme CHEMBL279115 CHEMBL1446902 CHEMBL1614283 (1) CHEMBL1614211 (2)
0 / 0
P10636 Microtubule-associated protein tau Unclassified protein CHEMBL279115 CHEMBL1515083 CHEMBL1614421 (2)
4 / 3
Q99549 M-phase phosphoprotein 8 Unclassified protein CHEMBL1446902 CHEMBL1738402 (1)
0 / 0
Q9UBT6 DNA polymerase kappa Enzyme CHEMBL279115 CHEMBL1328542 CHEMBL1515083 CHEMBL1794536 (3)
0 / 0
B2RXH2 Lysine-specific demethylase 4E Enzyme CHEMBL1443384 CHEMBL1613914 (1)
0 / 0
P40225 Thrombopoietin Unclassified protein CHEMBL1441758 CHEMBL1614086 (1) CHEMBL1614034 (1)
1 / 1
O00167 Eyes absent homolog 2 Enzyme CHEMBL1328542 CHEMBL1614315 (1)
0 / 0
Q96KQ7 Histone-lysine N-methyltransferase EHMT2 Enzyme CHEMBL1328542 CHEMBL1446902 CHEMBL1738442 (2)
0 / 0
O95267 RAS guanyl-releasing protein 1 Unclassified protein CHEMBL279115 CHEMBL919053 (1)
1 / 0
Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 Enzyme CHEMBL279115 CHEMBL1614364 (1)
1 / 1
O00255 Menin Unclassified protein CHEMBL1446902 CHEMBL1614257 (1)
2 / 5
Q03164 Histone-lysine N-methyltransferase 2A Enzyme CHEMBL1446902 CHEMBL1614257 (1)
1 / 3
Q13951 Core-binding factor subunit beta Unclassified protein CHEMBL279115 CHEMBL1613933 (1)
0 / 1
Q01196 Runt-related transcription factor 1 Unclassified protein CHEMBL279115 CHEMBL1613933 (1)
1 / 6
Q05513 Protein kinase C zeta type Iota CHEMBL279115 CHEMBL767783 (1)
0 / 0
O94806 Serine/threonine-protein kinase D3 Pkd CHEMBL279115 CHEMBL767783 (1)
0 / 0
P24723 Protein kinase C eta type Eta CHEMBL279115 CHEMBL767783 (1)
1 / 0
P41743 Protein kinase C iota type Iota CHEMBL279115 CHEMBL767783 (1)
0 / 0
Q15139 Serine/threonine-protein kinase D1 Pkd CHEMBL279115 CHEMBL767783 (1)
0 / 0

CTD interaction (2004)

compound gene gene name gene description interaction interaction type form reference
pmid
D013755 5244 ABCB4
ABC21
GBD1
ICP3
MDR2
MDR2/3
MDR3
PFIC-3
PGY3
ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44) bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of ABCB4 mRNA] decreases expression
/ decreases reaction
mRNA 11331069
D013755 5244 ABCB4
ABC21
GBD1
ICP3
MDR2
MDR2/3
MDR3
PFIC-3
PGY3
ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44) calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of ABCB4 mRNA] decreases expression
/ decreases reaction
mRNA 11331069
D013755 5244 ABCB4
ABC21
GBD1
ICP3
MDR2
MDR2/3
MDR3
PFIC-3
PGY3
ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44) Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of ABCB4 mRNA] decreases expression
/ decreases reaction
mRNA 11331069
D013755 5244 ABCB4
ABC21
GBD1
ICP3
MDR2
MDR2/3
MDR3
PFIC-3
PGY3
ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44) Tetradecanoylphorbol Acetate results in decreased expression of ABCB4 mRNA decreases expression
mRNA 11331069
D013755 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 Tetradecanoylphorbol Acetate results in decreased expression of ABCC1 protein decreases expression
protein 15517594
D013755 10257 ABCC4
EST170205
MOAT-B
MOATB
MRP4
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 Tetradecanoylphorbol Acetate results in decreased expression of ABCC4 mRNA decreases expression
mRNA 19142964
D013755 1636 ACE
ACE1
CD143
DCP
DCP1
ICH
MVCD3
angiotensin I converting enzyme (EC:3.4.15.1) carvedilol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ACE mRNA] decreases reaction
/ increases expression
mRNA 15071347
D013755 1636 ACE
ACE1
CD143
DCP
DCP1
ICH
MVCD3
angiotensin I converting enzyme (EC:3.4.15.1) Tetradecanoylphorbol Acetate inhibits the reaction [VEGFA protein results in increased expression of ACE protein] decreases reaction
/ increases expression
protein 11158990
D013755 1636 ACE
ACE1
CD143
DCP
DCP1
ICH
MVCD3
angiotensin I converting enzyme (EC:3.4.15.1) Tetradecanoylphorbol Acetate results in increased expression of ACE mRNA increases expression
mRNA 15071347
D013755 60 ACTB
BRWS1
PS1TP5BP1
actin, beta [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 60 ACTB
BRWS1
PS1TP5BP1
actin, beta [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 8038 ADAM12
MCMP
MCMPMltna
MLTN
MLTNA
ADAM metallopeptidase domain 12 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ADAM12 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 101 ADAM8
CD156
MS2
ADAM metallopeptidase domain 8 (EC:3.4.24.-) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ADAM8 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 154 ADRB2
ADRB2R
ADRBR
B2AR
BAR
BETA2AR
adrenoceptor beta 2, surface Tetradecanoylphorbol Acetate results in increased phosphorylation of ADRB2 protein increases phosphorylation
protein 14722251
D013755 196 AHR
bHLHe76
aryl hydrocarbon receptor Tetradecanoylphorbol Acetate affects the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein] affects reaction
/ increases activity
/ increases localization
protein 8396892
D013755 196 AHR
bHLHe76
aryl hydrocarbon receptor [Tetradecanoylphorbol Acetate co-treated with Tetrachlorodibenzodioxin] results in increased expression of AHR mRNA affects cotreatment
/ increases expression
mRNA 9706865
D013755 196 AHR
bHLHe76
aryl hydrocarbon receptor Tetradecanoylphorbol Acetate results in increased expression of AHR mRNA increases expression
mRNA 9706865
D013755 196 AHR
bHLHe76
aryl hydrocarbon receptor Tetradecanoylphorbol Acetate results in increased expression of AHR protein increases expression
protein 9706865
D013755 37815 Tetradecanoylphorbol Acetate results in decreased expression of ALAS mRNA decreases expression
mRNA 15797241
D013755 11199 ANXA10
ANX14
annexin A10 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ANXA10 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 306 ANXA3
ANX3
annexin A3 (EC:3.1.4.43) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ANXA3 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 317 APAF1
APAF-1
CED4
apoptotic peptidase activating factor 1 Tetradecanoylphorbol Acetate affects the expression of APAF1 protein affects expression
protein 11139146
D013755 27301 APEX2
APE2
APEXL2
XTH2
APEX nuclease (apurinic/apyrimidinic endonuclease) 2 (EC:4.2.99.18) Tetradecanoylphorbol Acetate results in increased expression of APEX2 mRNA increases expression
mRNA 19031421
D013755 334 APLP2
APLP-2
APPH
APPL2
CDEBP
amyloid beta (A4) precursor-like protein 2 N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of APLP2 protein] decreases reaction
/ increases secretion
protein 16279945
D013755 334 APLP2
APLP-2
APPH
APPL2
CDEBP
amyloid beta (A4) precursor-like protein 2 Tetradecanoylphorbol Acetate results in increased secretion of APLP2 protein increases secretion
protein 16279945
D013755 374 AREG
AR
CRDGF
SDGF
amphiregulin bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of AREG mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 22643241
D013755 374 AREG
AR
CRDGF
SDGF
amphiregulin Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of AREG mRNA] increases expression
/ increases reaction
mRNA 22643241
D013755 375 ARF1
ADP-ribosylation factor 1 Tetradecanoylphorbol Acetate affects the localization of ARF1 protein affects localization
protein 10931844
D013755 382 ARF6
ADP-ribosylation factor 6 Tetradecanoylphorbol Acetate affects the localization of ARF6 protein affects localization
protein 10931844
16280360
D013755 23229 ARHGEF9
COLLYBISTIN
EIEE8
HPEM-2
PEM-2
PEM2
Cdc42 guanine nucleotide exchange factor (GEF) 9 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ARHGEF9 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 10123 ARL4C
ARL7
LAK
ADP-ribosylation factor-like 4C [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ARL4C mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 10550 ARL6IP5
DERP11
GTRAP3-18
JWA
PRAF3
addicsin
hp22
jmx
ADP-ribosylation-like factor 6 interacting protein 5 Tetradecanoylphorbol Acetate inhibits the reaction [Tretinoin results in increased expression of ARL6IP5 mRNA] decreases reaction
/ increases expression
mRNA 16468075
D013755 10550 ARL6IP5
DERP11
GTRAP3-18
JWA
PRAF3
addicsin
hp22
jmx
ADP-ribosylation-like factor 6 interacting protein 5 Tetradecanoylphorbol Acetate results in increased expression of ARL6IP5 protein increases expression
protein 16430862
D013755 10109 ARPC2
ARC34
PNAS-139
p34-Arc
actin related protein 2/3 complex, subunit 2, 34kDa pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 10109 ARPC2
ARC34
PNAS-139
p34-Arc
actin related protein 2/3 complex, subunit 2, 34kDa [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 445 ASS1
ASS
CTLN1
argininosuccinate synthase 1 (EC:6.3.4.5) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ASS1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 468 ATF4
CREB-2
CREB2
TAXREB67
TXREB
activating transcription factor 4 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ATF4 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 468 ATF4
CREB-2
CREB2
TAXREB67
TXREB
activating transcription factor 4 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ATF4 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 22809 ATF5
ATFX
HMFN0395
activating transcription factor 5 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ATF5 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 538 ATP7A
DSMAX
MK
MNK
SMAX3
ATPase, Cu++ transporting, alpha polypeptide (EC:3.6.3.54) ATP7A protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FLT1 mRNA] increases expression
/ increases reaction
protein 19205902
D013755 538 ATP7A
DSMAX
MK
MNK
SMAX3
ATPase, Cu++ transporting, alpha polypeptide (EC:3.6.3.54) Tetradecanoylphorbol Acetate results in increased expression of ATP7A protein increases expression
protein 19205902
D013755 538 ATP7A
DSMAX
MK
MNK
SMAX3
ATPase, Cu++ transporting, alpha polypeptide (EC:3.6.3.54) [Tetradecanoylphorbol Acetate results in increased expression of ATP7A protein] which results in increased export of Copper increases export
/ increases expression
protein 19205902
D013755 540 ATP7B
PWD
WC1
WD
WND
ATPase, Cu++ transporting, beta polypeptide (EC:3.6.3.54) [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKD1 protein] which results in increased expression of ATP7B protein increases expression
/ increases phosphorylation
protein 21189263
D013755 6790 AURKA
AIK
ARK1
AURA
AURORA2
BTAK
PPP1R47
STK15
STK6
STK7
aurora kinase A (EC:2.7.11.1) Tetradecanoylphorbol Acetate results in increased expression of AURKA mRNA increases expression
mRNA 19031421
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of DUSP1 mRNA] decreases reaction
/ increases expression
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA] decreases reaction
/ increases expression
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of RELA protein] increases activity
/ increases degradation
/ increases localization
/ increases reaction
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA] increases expression
/ increases reaction
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 mRNA] increases expression
/ increases reaction
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 mRNA] increases expression
/ increases reaction
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 mRNA] increases expression
/ increases reaction
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] increases expression
/ increases reaction
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] increases degradation
/ increases phosphorylation
/ increases reaction
protein 20858459
D013755 573 BAG1
BAG-1
HAP
RAP46
BCL2-associated athanogene BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of NFKB1 protein] increases activity
/ increases degradation
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 20858459
D013755 578 BAK1
BAK
BAK-LIKE
BCL2L7
CDN1
BCL2-antagonist/killer 1 Tetradecanoylphorbol Acetate results in increased expression of BAK1 protein increases expression
protein 11139146
D013755 581 BAX
BCL2L4
BCL2-associated X protein Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BAX protein] decreases expression
/ decreases reaction
protein 15748703
D013755 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 edelfosine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein] decreases reaction
/ increases expression
protein 9295281
D013755 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BCL2 protein] decreases expression
/ decreases reaction
protein 15748703
D013755 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 Tetradecanoylphorbol Acetate inhibits the reaction [Trichlorfon results in decreased expression of BCL2 protein] decreases expression
/ decreases reaction
protein 19631781
D013755 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 Tetradecanoylphorbol Acetate results in decreased expression of BCL2 protein decreases expression
protein 11139146
D013755 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein increases expression
protein 9295281
D013755 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 597 BCL2A1
ACC-1
ACC-2
BCL2L5
BFL1
GRS
HBPA1
BCL2-related protein A1 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 597 BCL2A1
ACC-1
ACC-2
BCL2L5
BFL1
GRS
HBPA1
BCL2-related protein A1 bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA]] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 597 BCL2A1
ACC-1
ACC-2
BCL2L5
BFL1
GRS
HBPA1
BCL2-related protein A1 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 597 BCL2A1
ACC-1
ACC-2
BCL2L5
BFL1
GRS
HBPA1
BCL2-related protein A1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 597 BCL2A1
ACC-1
ACC-2
BCL2L5
BFL1
GRS
HBPA1
BCL2-related protein A1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2A1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2L1 mRNA affects cotreatment
/ increases expression
mRNA 18958680
D013755 598 BCL2L1
BCL-XL/S
BCL2L
BCLX
BCLXL
BCLXS
Bcl-X
PPP1R52
bcl-xL
bcl-xS
BCL2-like 1 Tetradecanoylphorbol Acetate results in increased expression of BCL2L1 protein increases expression
protein 11139146
D013755 329 BIRC2
API1
HIAP2
Hiap-2
MIHB
RNF48
c-IAP1
cIAP1
baculoviral IAP repeat containing 2 Tetradecanoylphorbol Acetate affects the localization of BIRC2 protein affects localization
protein 15187025
D013755 330 BIRC3
AIP1
API2
CIAP2
HAIP1
HIAP1
MALT2
MIHC
RNF49
c-IAP2
baculoviral IAP repeat containing 3 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] decreases reaction
/ increases expression
mRNA 14527959
D013755 330 BIRC3
AIP1
API2
CIAP2
HAIP1
HIAP1
MALT2
MIHC
RNF49
c-IAP2
baculoviral IAP repeat containing 3 Gliotoxin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] decreases reaction
/ increases expression
mRNA 14527959
D013755 330 BIRC3
AIP1
API2
CIAP2
HAIP1
HIAP1
MALT2
MIHC
RNF49
c-IAP2
baculoviral IAP repeat containing 3 pyrrolidine dithiocarbamic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] decreases reaction
/ increases expression
mRNA 14527959
D013755 330 BIRC3
AIP1
API2
CIAP2
HAIP1
HIAP1
MALT2
MIHC
RNF49
c-IAP2
baculoviral IAP repeat containing 3 rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA] decreases reaction
/ increases expression
mRNA 14527959
D013755 330 BIRC3
AIP1
API2
CIAP2
HAIP1
HIAP1
MALT2
MIHC
RNF49
c-IAP2
baculoviral IAP repeat containing 3 Tetradecanoylphorbol Acetate results in increased expression of BIRC3 mRNA increases expression
mRNA 14527959
D013755 332 BIRC5
API4
EPR-1
baculoviral IAP repeat containing 5 Tetradecanoylphorbol Acetate results in increased expression of BIRC5 mRNA increases expression
mRNA 19031421
D013755 650 BMP2
BDA2
BMP2A
bone morphogenetic protein 2 Tetradecanoylphorbol Acetate results in increased expression of BMP2 mRNA increases expression
mRNA 10910055
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA] decreases reaction
/ increases expression
mRNA 18647594
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein] decreases reaction
/ increases expression
protein 18647594
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]] decreases reaction
/ increases expression
protein 16860414
17055343
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]] decreases reaction
/ increases expression
protein 17055343
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA] decreases reaction
/ increases expression
mRNA 16860414
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein] decreases reaction
/ increases expression
protein 16860414
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA] decreases reaction
/ increases expression
mRNA 16860414
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein] decreases reaction
/ increases expression
protein 16860414
17055343
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG] decreases reaction
/ increases expression
18647594
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein] decreases reaction
/ increases expression
protein 17055343
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA] decreases reaction
/ increases expression
mRNA 18647594
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein] decreases reaction
/ increases expression
protein 18647594
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA increases expression
mRNA 16860414
18647594
D013755 682 BSG
5F7
CD147
EMMPRIN
M6
OK
TCSF
basigin Tetradecanoylphorbol Acetate results in increased expression of BSG protein increases expression
protein 16860414
17055343
18647594
D013755 7832 BTG2
PC3
TIS21
BTG family, member 2 [Tetradecanoylphorbol Acetate co-treated with Go 6976] results in increased expression of BTG2 mRNA affects cotreatment
/ increases expression
mRNA 15302583
D013755 701 BUB1B
BUB1beta
BUBR1
Bub1A
MAD3L
MVA1
SSK1
hBUBR1
BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) Tetradecanoylphorbol Acetate results in increased expression of BUB1B mRNA increases expression
mRNA 19031421
D013755 23632 CA14
CAXiV
carbonic anhydrase XIV (EC:4.2.1.1) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CA14 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 811 CALR
CRT
RO
SSA
cC1qR
calreticulin Tetradecanoylphorbol Acetate results in decreased expression of CALR mRNA decreases expression
mRNA 19031421
D013755 8536 CAMK1
CAMKI
calcium/calmodulin-dependent protein kinase I (EC:2.7.11.17) 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of CAMK1 protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 8536 CAMK1
CAMKI
calcium/calmodulin-dependent protein kinase I (EC:2.7.11.17) CAMK1 mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
mutant form 20590612
D013755 8536 CAMK1
CAMKI
calcium/calmodulin-dependent protein kinase I (EC:2.7.11.17) Tetradecanoylphorbol Acetate results in increased phosphorylation of CAMK1 protein increases phosphorylation
protein 20590612
D013755 8536 CAMK1
CAMKI
calcium/calmodulin-dependent protein kinase I (EC:2.7.11.17) W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of CAMK1 protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 11131 CAPN11
calpain11
calpain 11 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CAPN11 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 10753 CAPN9
GC36
nCL-4
calpain 9 (EC:3.4.22.-) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CAPN9 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 834 CASP1
ICE
IL1BC
P45
caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein affects cotreatment
/ increases activity
protein 21515303
D013755 834 CASP1
ICE
IL1BC
P45
caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 21515303
D013755 834 CASP1
ICE
IL1BC
P45
caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased cleavage of CASP1 protein affects cotreatment
/ increases cleavage
protein 22322153
D013755 100506742 CASP12
CASP-12
CASP12P1
caspase 12 (gene/pseudogene) Tetradecanoylphorbol Acetate inhibits the reaction [Trichlorfon results in increased cleavage of and results in increased activity of CASP12 protein] decreases reaction
/ increases activity
/ increases cleavage
protein 19631781
D013755 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP3 protein affects cotreatment
/ increases activity
protein 17309078
D013755 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP3 protein affects cotreatment
/ increases activity
protein 12165276
D013755 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) Tetradecanoylphorbol Acetate inhibits the reaction [arsenic trioxide results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 14610070
D013755 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) Tetradecanoylphorbol Acetate inhibits the reaction [Trichlorfon results in increased cleavage of and results in increased activity of CASP3 protein] decreases reaction
/ increases activity
/ increases cleavage
protein 19631781
D013755 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) Tetradecanoylphorbol Acetate promotes the reaction [arsenic trioxide results in increased activity of CASP3 protein] increases activity
/ increases reaction
protein 14610070
D013755 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) Tetradecanoylphorbol Acetate results in increased cleavage of and results in increased activity of CASP3 protein increases activity
/ increases cleavage
protein 11139146
D013755 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA]] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CASP8 mRNA affects cotreatment
/ increases expression
mRNA 18958680
D013755 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP8 protein affects cotreatment
/ increases activity
protein 12165276
D013755 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein affects cotreatment
/ increases activity
protein 17309078
D013755 847 CAT
catalase (EC:1.11.1.6) CAT protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Reactive Oxygen Species] decreases reaction
/ increases abundance
protein 16091123
D013755 847 CAT
catalase (EC:1.11.1.6) CAT protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] decreases reaction
/ increases activity
protein 2126186
D013755 847 CAT
catalase (EC:1.11.1.6) CAT protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased oxidation of 1,2-diaminobenzene] decreases reaction
/ increases oxidation
protein 3030588
D013755 847 CAT
catalase (EC:1.11.1.6) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CAT mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 6346 CCL1
I-309
P500
SCYA1
SISe
TCA3
chemokine (C-C motif) ligand 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CCL1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL11 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL11 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 6356 CCL11
SCYA11
chemokine (C-C motif) ligand 11 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL11 protein affects cotreatment
/ increases expression
protein 17572062
D013755 6362 CCL18
AMAC-1
AMAC1
CKb7
DC-CK1
DCCK1
MIP-4
PARC
SCYA18
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CCL18 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL2 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA] decreases reaction
/ increases expression
mRNA 16376386
D013755 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein] decreases reaction
/ increases secretion
protein 16376386
D013755 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL2 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL2 protein affects cotreatment
/ increases expression
protein 17572062
D013755 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 Tetradecanoylphorbol Acetate results in increased expression of CCL2 mRNA increases expression
mRNA 16376386
D013755 6347 CCL2
GDCF-2
HC11
HSMCR30
MCAF
MCP-1
MCP1
SCYA2
SMC-CF
chemokine (C-C motif) ligand 2 Tetradecanoylphorbol Acetate results in increased secretion of CCL2 protein increases secretion
protein 16376386
D013755 6348 CCL3
G0S19-1
LD78ALPHA
MIP-1-alpha
MIP1A
SCYA3
chemokine (C-C motif) ligand 3 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL3 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 6348 CCL3
G0S19-1
LD78ALPHA
MIP-1-alpha
MIP1A
SCYA3
chemokine (C-C motif) ligand 3 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL3 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 6348 CCL3
G0S19-1
LD78ALPHA
MIP-1-alpha
MIP1A
SCYA3
chemokine (C-C motif) ligand 3 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL3 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 6348 CCL3
G0S19-1
LD78ALPHA
MIP-1-alpha
MIP1A
SCYA3
chemokine (C-C motif) ligand 3 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL3 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 6348 CCL3
G0S19-1
LD78ALPHA
MIP-1-alpha
MIP1A
SCYA3
chemokine (C-C motif) ligand 3 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL3 protein affects cotreatment
/ increases expression
protein 17572062
D013755 6349 CCL3L1
464.2
D17S1718
G0S19-2
LD78
LD78BETA
MIP1AP
SCYA3L
SCYA3L1
chemokine (C-C motif) ligand 3-like 1 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL3L1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 6349 CCL3L1
464.2
D17S1718
G0S19-2
LD78
LD78BETA
MIP1AP
SCYA3L
SCYA3L1
chemokine (C-C motif) ligand 3-like 1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL3L1 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 6351 CCL4
ACT2
AT744.1
G-26
HC21
LAG-1
LAG1
MIP-1-beta
MIP1B
MIP1B1
SCYA2
SCYA4
chemokine (C-C motif) ligand 4 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CCL4 mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 6351 CCL4
ACT2
AT744.1
G-26
HC21
LAG-1
LAG1
MIP-1-beta
MIP1B
MIP1B1
SCYA2
SCYA4
chemokine (C-C motif) ligand 4 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL4 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 6351 CCL4
ACT2
AT744.1
G-26
HC21
LAG-1
LAG1
MIP-1-beta
MIP1B
MIP1B1
SCYA2
SCYA4
chemokine (C-C motif) ligand 4 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL4 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 6351 CCL4
ACT2
AT744.1
G-26
HC21
LAG-1
LAG1
MIP-1-beta
MIP1B
MIP1B1
SCYA2
SCYA4
chemokine (C-C motif) ligand 4 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL4 protein affects cotreatment
/ increases expression
protein 17572062
D013755 9560 CCL4L1
AT744.2
CCL4L
LAG-1
LAG1
SCYA4L
chemokine (C-C motif) ligand 4-like 1 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL4L1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 9560 CCL4L1
AT744.2
CCL4L
LAG-1
LAG1
SCYA4L
chemokine (C-C motif) ligand 4-like 1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL4L1 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 6352 CCL5
D17S136E
RANTES
SCYA5
SIS-delta
SISd
TCP228
eoCP
chemokine (C-C motif) ligand 5 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL5 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 6352 CCL5
D17S136E
RANTES
SCYA5
SIS-delta
SISd
TCP228
eoCP
chemokine (C-C motif) ligand 5 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CCL5 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 6352 CCL5
D17S136E
RANTES
SCYA5
SIS-delta
SISd
TCP228
eoCP
chemokine (C-C motif) ligand 5 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL5 protein affects cotreatment
/ increases expression
protein 17572062
D013755 890 CCNA2
CCN1
CCNA
cyclin A2 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNA2 protein] increases expression
/ increases reaction
protein 12421932
D013755 890 CCNA2
CCN1
CCNA
cyclin A2 IL2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNA2 protein] increases expression
/ increases reaction
protein 12421932
D013755 890 CCNA2
CCN1
CCNA
cyclin A2 Tetradecanoylphorbol Acetate results in decreased expression of CCNA2 protein decreases expression
protein 15949478
D013755 890 CCNA2
CCN1
CCNA
cyclin A2 Tetradecanoylphorbol Acetate results in increased expression of CCNA2 mRNA increases expression
mRNA 19031421
D013755 890 CCNA2
CCN1
CCNA
cyclin A2 Tetradecanoylphorbol Acetate results in increased expression of CCNA2 protein increases expression
protein 12421932
D013755 890 CCNA2
CCN1
CCNA
cyclin A2 Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNA2 protein] increases expression
/ increases reaction
protein 12421932
D013755 9133 CCNB2
HsT17299
cyclin B2 Tetradecanoylphorbol Acetate results in increased expression of CCNB2 mRNA increases expression
mRNA 19031421
D013755 9133 CCNB2
HsT17299
cyclin B2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CCNB2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 [arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CCND1 mRNA affects cotreatment
/ increases expression
mRNA 18922899
D013755 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 Tetradecanoylphorbol Acetate results in decreased expression of CCND1 protein decreases expression
protein 15949478
D013755 595 CCND1
BCL1
D11S287E
PRAD1
U21B31
cyclin D1 Tetradecanoylphorbol Acetate results in increased expression of CCND1 protein increases expression
protein 21375462
D013755 896 CCND3
cyclin D3 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCND3 protein] increases expression
/ increases reaction
protein 12421932
D013755 896 CCND3
cyclin D3 Tetradecanoylphorbol Acetate results in increased expression of CCND3 protein increases expression
protein 12421932
D013755 896 CCND3
cyclin D3 Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCND3 protein] increases expression
/ increases reaction
protein 12421932
D013755 898 CCNE1
CCNE
cyclin E1 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNE1 protein] increases expression
/ increases reaction
protein 12421932
D013755 898 CCNE1
CCNE
cyclin E1 IL2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNE1 protein] increases expression
/ increases reaction
protein 12421932
D013755 898 CCNE1
CCNE
cyclin E1 Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNE1 protein]] decreases reaction
/ increases expression
/ increases reaction
protein 12421932
D013755 898 CCNE1
CCNE
cyclin E1 Tetradecanoylphorbol Acetate results in increased expression of CCNE1 protein increases expression
protein 12421932
D013755 898 CCNE1
CCNE
cyclin E1 Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNE1 protein] increases expression
/ increases reaction
protein 12421932
D013755 900 CCNG1
CCNG
cyclin G1 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CCNG1 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 900 CCNG1
CCNG
cyclin G1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CCNG1 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 22948 CCT5
CCT-epsilon
CCTE
TCP-1-epsilon
chaperonin containing TCP1, subunit 5 (epsilon) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCT5 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 22948 CCT5
CCT-epsilon
CCTE
TCP-1-epsilon
chaperonin containing TCP1, subunit 5 (epsilon) bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCT5 mRNA]] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 22948 CCT5
CCT-epsilon
CCTE
TCP-1-epsilon
chaperonin containing TCP1, subunit 5 (epsilon) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCT5 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 22948 CCT5
CCT-epsilon
CCTE
TCP-1-epsilon
chaperonin containing TCP1, subunit 5 (epsilon) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCT5 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 100136148 [salvin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD11B protein affects cotreatment
/ increases expression
protein 11504768
D013755 929 CD14
CD14 molecule N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD14 protein] increases expression
/ increases reaction
protein 20089671
D013755 929 CD14
CD14 molecule Tetradecanoylphorbol Acetate results in increased expression of CD14 protein increases expression
protein 16430862
19135038
20089671
D013755 4345 CD200
MOX1
MOX2
MRC
OX-2
CD200 molecule [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD200 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 4345 CD200
MOX1
MOX2
MRC
OX-2
CD200 molecule pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD200 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 4345 CD200
MOX1
MOX2
MRC
OX-2
CD200 molecule [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD200 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 940 CD28
Tp44
CD28 molecule Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD28 protein] decreases reaction
/ increases expression
protein 11465111
D013755 940 CD28
Tp44
CD28 molecule Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD28 protein] decreases reaction
/ increases expression
protein 11465111
D013755 940 CD28
Tp44
CD28 molecule Tetradecanoylphorbol Acetate results in increased expression of CD28 protein increases expression
protein 11465111
D013755 947 CD34
CD34 molecule [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of CD34 mRNA affects cotreatment
/ increases expression
mRNA 18922899
D013755 947 CD34
CD34 molecule [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of CD34 protein affects cotreatment
/ increases expression
protein 18922899
D013755 947 CD34
CD34 molecule Tetradecanoylphorbol Acetate results in increased expression of CD34 protein increases expression
protein 18922899
D013755 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA] decreases reaction
/ increases expression
mRNA 21315065
D013755 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) tamibarotene promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA] increases expression
/ increases reaction
mRNA 16484594
D013755 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) Tetradecanoylphorbol Acetate results in decreased expression of CD36 mRNA decreases expression
mRNA 12664607
D013755 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA increases expression
mRNA 16484594
21315065
D013755 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) Thioctic Acid inhibits the reaction [arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA]] decreases reaction
/ increases expression
mRNA 21315065
D013755 920 CD4
CD4mut
CD4 molecule [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CD4 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 958 CD40
Bp50
CDW40
TNFRSF5
p50
CD40 molecule, TNF receptor superfamily member 5 Apigenin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16601352
D013755 958 CD40
Bp50
CDW40
TNFRSF5
p50
CD40 molecule, TNF receptor superfamily member 5 fisetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16601352
D013755 958 CD40
Bp50
CDW40
TNFRSF5
p50
CD40 molecule, TNF receptor superfamily member 5 Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16601352
D013755 958 CD40
Bp50
CDW40
TNFRSF5
p50
CD40 molecule, TNF receptor superfamily member 5 Luteolin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD40 protein] decreases reaction
/ increases expression
protein 16601352
D013755 958 CD40
Bp50
CDW40
TNFRSF5
p50
CD40 molecule, TNF receptor superfamily member 5 Quercetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16601352
D013755 958 CD40
Bp50
CDW40
TNFRSF5
p50
CD40 molecule, TNF receptor superfamily member 5 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CD40 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 959 CD40LG
CD154
CD40L
HIGM1
IGM
IMD3
T-BAM
TNFSF5
TRAP
gp39
hCD40L
CD40 ligand Tetradecanoylphorbol Acetate results in increased expression of CD40LG protein increases expression
protein 11297035
D013755 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 960 CD44
CDW44
CSPG8
ECMR-III
HCELL
HUTCH-I
IN
LHR
MC56
MDU2
MDU3
MIC4
Pgp1
CD44 molecule (Indian blood group) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 965 CD58
LFA-3
LFA3
ag3
CD58 molecule [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CD58 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 969 CD69
AIM
BL-AC/P26
CLEC2C
EA1
GP32/28
MLR-3
CD69 molecule Tetradecanoylphorbol Acetate results in increased expression of CD69 protein increases expression
protein 12749906
17962511
D013755 928 CD9
BTCC-1
DRAP-27
MIC3
MRP-1
TSPAN-29
TSPAN29
CD9 molecule Tetradecanoylphorbol Acetate results in increased expression of CD9 protein increases expression
protein 10910098
D013755 928 CD9
BTCC-1
DRAP-27
MIC3
MRP-1
TSPAN-29
TSPAN29
CD9 molecule [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CD9 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 991 CDC20
CDC20A
bA276H19.3
p55CDC
cell division cycle 20 Tetradecanoylphorbol Acetate results in increased expression of CDC20 mRNA increases expression
mRNA 19031421
D013755 991 CDC20
CDC20A
bA276H19.3
p55CDC
cell division cycle 20 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDC20 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 994 CDC25B
cell division cycle 25B (EC:3.1.3.48) Tetradecanoylphorbol Acetate results in increased expression of CDC25B mRNA increases expression
mRNA 19031421
D013755 995 CDC25C
CDC25
PPP1R60
cell division cycle 25C (EC:3.1.3.48) Tetradecanoylphorbol Acetate results in increased phosphorylation of CDC25C protein increases phosphorylation
protein 21375462
D013755 1015 CDH17
CDH16
HPT-1
HPT1
cadherin 17, LI cadherin (liver-intestine) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CDH17 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 1015 CDH17
CDH16
HPT-1
HPT1
cadherin 17, LI cadherin (liver-intestine) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CDH17 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 1015 CDH17
CDH16
HPT-1
HPT1
cadherin 17, LI cadherin (liver-intestine) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CDH17 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) Tetradecanoylphorbol Acetate results in decreased phosphorylation of CDK2 protein decreases phosphorylation
protein 15978937
D013755 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) Tetradecanoylphorbol Acetate results in increased activity of CDK2 protein increases activity
protein 12421932
D013755 1017 CDK2
p33(CDK2)
cyclin-dependent kinase 2 (EC:2.7.11.22) Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of CDK2 protein] increases activity
/ increases reaction
protein 12421932
D013755 1019 CDK4
CMM3
PSK-J3
cyclin-dependent kinase 4 (EC:2.7.11.22) Tetradecanoylphorbol Acetate results in decreased expression of CDK4 mRNA decreases expression
mRNA 15978937
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] decreases reaction
/ increases expression
protein 15978937
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] decreases reaction
/ increases expression
protein 15978937
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] decreases reaction
/ increases expression
protein 15976015
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] decreases reaction
/ increases expression
protein 15978937
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CDKN1A mRNA affects cotreatment
/ increases expression
mRNA 18958680
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] decreases reaction
/ increases expression
protein 15976015
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] decreases reaction
/ increases expression
protein 15978937
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) Tetradecanoylphorbol Acetate promotes the reaction [SP1 protein binds to CDKN1A promoter] affects binding
/ increases reaction
promoter 15978937
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) Tetradecanoylphorbol Acetate results in increased expression of CDKN1A mRNA increases expression
mRNA 10910055
15978937
D013755 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein increases expression
protein 9348195
15976015
15978937
18223691
D013755 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] decreases expression
/ decreases reaction
/ increases reaction
protein 12421932
D013755 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein decreases expression
protein 12421932
D013755 1027 CDKN1B
CDKN4
KIP1
MEN1B
MEN4
P27KIP1
cyclin-dependent kinase inhibitor 1B (p27, Kip1) Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein] decreases expression
/ increases reaction
protein 12421932
D013755 1028 CDKN1C
BWCR
BWS
KIP2
WBS
p57
p57Kip2
cyclin-dependent kinase inhibitor 1C (p57, Kip2) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDKN1C mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1029 CDKN2A
ARF
CDK4I
CDKN2
CMM2
INK4
INK4A
MLM
MTS-1
MTS1
P14
P14ARF
P16
P16-INK4A
P16INK4
P16INK4A
P19
P19ARF
TP16
cyclin-dependent kinase inhibitor 2A [arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CDKN2A mRNA affects cotreatment
/ decreases expression
mRNA 18922899
D013755 1030 CDKN2B
CDK4I
INK4B
MTS2
P15
TP15
p15INK4b
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN2B protein] decreases expression
/ increases reaction
protein 12421932
D013755 1031 CDKN2C
INK4C
p18
p18-INK4C
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDKN2C mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1147 CHUK
IKBKA
IKK-alpha
IKK1
IKKA
NFKBIKA
TCF16
conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of CHUK protein] decreases reaction
/ increases activity
protein 15498850
D013755 1147 CHUK
IKBKA
IKK-alpha
IKK1
IKKA
NFKBIKA
TCF16
conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) Tetradecanoylphorbol Acetate results in increased activity of CHUK protein increases activity
protein 15498850
D013755 1164 CKS2
CKSHS2
CDC28 protein kinase regulatory subunit 2 Tetradecanoylphorbol Acetate results in increased expression of CKS2 mRNA increases expression
mRNA 19031421
D013755 1364 CLDN4
CPE-R
CPER
CPETR
CPETR1
WBSCR8
hCPE-R
claudin 4 Tetradecanoylphorbol Acetate results in increased expression of CLDN4 mRNA increases expression
mRNA 19945525
D013755 1201 CLN3
BTS
JNCL
ceroid-lipofuscinosis, neuronal 3 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CLN3 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 1201 CLN3
BTS
JNCL
ceroid-lipofuscinosis, neuronal 3 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CLN3 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 8418 CMAHP
CMAH
CSAH
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CMAHP mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1240 CMKLR1
CHEMERINR
ChemR23
DEZ
RVER1
chemokine-like receptor 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CMKLR1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1264 CNN1
SMCC
Sm-Calp
calponin 1, basic, smooth muscle Tetradecanoylphorbol Acetate results in decreased expression of CNN1 mRNA decreases expression
mRNA 15380616
D013755 1264 CNN1
SMCC
Sm-Calp
calponin 1, basic, smooth muscle Tetradecanoylphorbol Acetate results in decreased expression of CNN1 protein decreases expression
protein 15380616
D013755 27255 CNTN6
NB3
contactin 6 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CNTN6 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1278 COL1A2
OI4
collagen, type I, alpha 2 [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of COL1A2 mRNA affects cotreatment
/ increases expression
mRNA 18922899
D013755 1278 COL1A2
OI4
collagen, type I, alpha 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of COL1A2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1291 COL6A1
OPLL
collagen, type VI, alpha 1 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 1291 COL6A1
OPLL
collagen, type VI, alpha 1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of COL6A1 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 1312 COMT
catechol-O-methyltransferase (EC:2.1.1.6) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of COMT mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 1312 COMT
catechol-O-methyltransferase (EC:2.1.1.6) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of COMT mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 4513 COX2
COII
MTCO2
MT-CO2
cytochrome c oxidase subunit II anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of COX2 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4513 COX2
COII
MTCO2
MT-CO2
cytochrome c oxidase subunit II Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of COX2 mRNA] decreases reaction
/ increases expression
mRNA 20004183
D013755 4513 COX2
COII
MTCO2
MT-CO2
cytochrome c oxidase subunit II Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of COX2 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4513 COX2
COII
MTCO2
MT-CO2
cytochrome c oxidase subunit II SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of COX2 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4513 COX2
COII
MTCO2
MT-CO2
cytochrome c oxidase subunit II Tetradecanoylphorbol Acetate results in increased expression of COX2 mRNA increases expression
mRNA 20004183
D013755 4513 COX2
COII
MTCO2
MT-CO2
cytochrome c oxidase subunit II Tetradecanoylphorbol Acetate results in increased expression of COX2 protein increases expression
protein 20004183
D013755 4513 COX2
COII
MTCO2
MT-CO2
cytochrome c oxidase subunit II U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of COX2 protein] decreases reaction
/ increases expression
protein 20004183
D013755 1385 CREB1
CREB
cAMP responsive element binding protein 1 GW 1929 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of CREB1 protein] decreases reaction
/ increases phosphorylation
protein 20032081
D013755 1385 CREB1
CREB
cAMP responsive element binding protein 1 rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of CREB1 protein] decreases reaction
/ increases phosphorylation
protein 20032081
D013755 1385 CREB1
CREB
cAMP responsive element binding protein 1 Tetradecanoylphorbol Acetate results in increased activity of CREB1 protein increases activity
protein 18791200
D013755 1385 CREB1
CREB
cAMP responsive element binding protein 1 Tetradecanoylphorbol Acetate results in increased phosphorylation of CREB1 protein increases phosphorylation
protein 20032081
D013755 1387 CREBBP
CBP
KAT3A
RSTS
CREB binding protein (EC:2.3.1.48) CREBBP protein inhibits the reaction [ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]] decreases reaction
/ increases expression
protein 11278336
D013755 1390 CREM
CREM-2
ICER
hCREM-2
cAMP responsive element modulator [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CREM mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 1390 CREM
CREM-2
ICER
hCREM-2
cAMP responsive element modulator pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CREM mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 1390 CREM
CREM-2
ICER
hCREM-2
cAMP responsive element modulator [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CREM mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 56253 CRTAM
CD355
cytotoxic and regulatory T cell molecule [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CRTAM mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1407 CRY1
PHLL1
cryptochrome 1 (photolyase-like) Tetradecanoylphorbol Acetate results in increased expression of CRY1 mRNA increases expression
mRNA 19031421
D013755 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CSF2 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein affects cotreatment
/ increases expression
protein 17051331
D013755 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CSF2 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CSF2 protein affects cotreatment
/ increases expression
protein 17572062
D013755 1437 CSF2
GMCSF
colony stimulating factor 2 (granulocyte-macrophage) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CSF2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1440 CSF3
C17orf33
CSF3OS
GCSF
G-CSF
colony stimulating factor 3 (granulocyte) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CSF3 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1487 CTBP1
BARS
C-terminal binding protein 1 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CTBP1 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 1487 CTBP1
BARS
C-terminal binding protein 1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CTBP1 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 8065 CUL5
VACM-1
VACM1
cullin 5 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CUL5 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 8065 CUL5
VACM-1
VACM1
cullin 5 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CUL5 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 8065 CUL5
VACM-1
VACM1
cullin 5 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CUL5 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 6376 CX3CL1
ABCD-3
C3Xkine
CXC3
CXC3C
NTN
NTT
SCYD1
fractalkine
neurotactin
chemokine (C-X3-C motif) ligand 1 Tetradecanoylphorbol Acetate results in decreased expression of CX3CL1 mRNA decreases expression
mRNA 19850645
D013755 6387 CXCL12
IRH
PBSF
SCYB12
SDF1
TLSF
TPAR1
SDF1A
SDF1B
chemokine (C-X-C motif) ligand 12 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of CXCL12 mRNA]] decreases reaction
/ increases expression
mRNA 22643241
D013755 6387 CXCL12
IRH
PBSF
SCYB12
SDF1
TLSF
TPAR1
SDF1A
SDF1B
chemokine (C-X-C motif) ligand 12 Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of CXCL12 mRNA] decreases reaction
/ increases expression
mRNA 22643241
D013755 6374 CXCL5
ENA-78
SCYB5
chemokine (C-X-C motif) ligand 5 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CXCL5 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6372 CXCL6
CKA-3
GCP-2
GCP2
SCYB6
chemokine (C-X-C motif) ligand 6 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CXCL6 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3577 CXCR1
C-C
C-C-CKR-1
CD128
CD181
CDw128a
CKR-1
CMKAR1
IL8R1
IL8RA
IL8RBA
chemokine (C-X-C motif) receptor 1 [Ionophores co-treated with Tetradecanoylphorbol Acetate] results in decreased localization of CXCR1 protein affects cotreatment
/ decreases localization
protein 15265017
D013755 3577 CXCR1
C-C
C-C-CKR-1
CD128
CD181
CDw128a
CKR-1
CMKAR1
IL8R1
IL8RA
IL8RBA
chemokine (C-X-C motif) receptor 1 SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCR1 mRNA] increases expression
/ increases reaction
mRNA 21045076
D013755 3577 CXCR1
C-C
C-C-CKR-1
CD128
CD181
CDw128a
CKR-1
CMKAR1
IL8R1
IL8RA
IL8RBA
chemokine (C-X-C motif) receptor 1 Tetradecanoylphorbol Acetate results in increased expression of CXCR1 mRNA increases expression
mRNA 21045076
D013755 3579 CXCR2
CD182
CDw128b
CMKAR2
IL8R2
IL8RA
IL8RB
chemokine (C-X-C motif) receptor 2 [Ionophores co-treated with Tetradecanoylphorbol Acetate] results in decreased localization of CXCR2 protein affects cotreatment
/ decreases localization
protein 15265017
D013755 1535 CYBA
p22-PHOX
cytochrome b-245, alpha polypeptide Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBA mRNA] decreases reaction
/ increases expression
mRNA 11172467
D013755 1535 CYBA
p22-PHOX
cytochrome b-245, alpha polypeptide CYBA protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] affects reaction
/ increases expression
protein 21705328
D013755 1535 CYBA
p22-PHOX
cytochrome b-245, alpha polypeptide Tetradecanoylphorbol Acetate results in increased expression of CYBA mRNA increases expression
mRNA 11172467
D013755 1535 CYBA
p22-PHOX
cytochrome b-245, alpha polypeptide troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBA mRNA] decreases reaction
/ increases expression
mRNA 11172467
D013755 1536 CYBB
AMCBX2
CGD
GP91-1
GP91-PHOX
GP91PHOX
NOX2
p91-PHOX
cytochrome b-245, beta polypeptide Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA] decreases reaction
/ increases expression
mRNA 9794432
D013755 1536 CYBB
AMCBX2
CGD
GP91-1
GP91-PHOX
GP91PHOX
NOX2
p91-PHOX
cytochrome b-245, beta polypeptide Tetradecanoylphorbol Acetate results in increased expression of CYBB mRNA increases expression
mRNA 9794432
D013755 54205 CYCS
CYC
HCS
THC4
cytochrome c, somatic Tetradecanoylphorbol Acetate inhibits the reaction [myricetin affects the localization of CYCS protein] affects localization
/ decreases reaction
protein 15748703
D013755 1585 CYP11B2
ALDOS
CPN2
CYP11B
CYP11BL
CYPXIB2
P-450C18
P450C18
P450aldo
cytochrome P450, family 11, subfamily B, polypeptide 2 (EC:1.14.15.4 1.14.15.5) Tetradecanoylphorbol Acetate results in decreased expression of CYP11B2 mRNA decreases expression
mRNA 15666830
D013755 1588 CYP19A1
ARO
ARO1
CPV1
CYAR
CYP19
CYPXIX
P-450AROM
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] affects cotreatment
/ decreases reaction
/ increases expression
/ increases reaction
mRNA 16357189
D013755 1588 CYP19A1
ARO
ARO1
CPV1
CYAR
CYP19
CYPXIX
P-450AROM
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) [Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA affects cotreatment
/ increases expression
mRNA 16357189
D013755 1588 CYP19A1
ARO
ARO1
CPV1
CYAR
CYP19
CYPXIX
P-450AROM
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA] affects cotreatment
/ increases expression
/ increases reaction
mRNA 16357189
D013755 1588 CYP19A1
ARO
ARO1
CPV1
CYAR
CYP19
CYPXIX
P-450AROM
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate results in decreased activity of CYP19A1 protein decreases activity
protein 10338361
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) CYP1A1 protein affects the susceptibility to Tetradecanoylphorbol Acetate affects response to substance
protein 8242868
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CYP1A1 mRNA affects cotreatment
/ increases expression
mRNA 18958680
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP1A1 mRNA affects cotreatment
/ increases expression
mRNA 18958680
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP1A1 protein affects cotreatment
/ increases expression
protein 18958680
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate affects the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] affects reaction
/ increases activity
protein 8396892
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] affects reaction
/ increases expression
mRNA 8396892
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 22643241
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1A1 protein results in increased abundance of 2-methoxyestradiol]] decreases reaction
/ increases abundance
/ increases reaction
protein 9706865
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] decreases reaction
/ increases activity
protein 9706865
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] decreases reaction
/ increases expression
mRNA 9706865
11728381
D013755 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) TGFB1 protein promotes the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 11728381
D013755 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) Tetradecanoylphorbol Acetate promotes the reaction [FOS protein binds to CYP1A2 enhancer] affects binding
/ increases reaction
enhancer 10620351
D013755 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) Tetradecanoylphorbol Acetate promotes the reaction [JUND protein binds to CYP1A2 enhancer] affects binding
/ increases reaction
enhancer 10620351
D013755 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) Tetradecanoylphorbol Acetate promotes the reaction [JUN protein binds to CYP1A2 enhancer] affects binding
/ increases reaction
enhancer 10620351
D013755 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] decreases reaction
/ increases expression
mRNA 11728381
D013755 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased abundance of 4-methoxyestradiol]] increases abundance
/ increases reaction
protein 9706865
D013755 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1B1 protein] increases activity
/ increases reaction
protein 9706865
D013755 1545 CYP1B1
CP1B
CYPIB1
GLC3A
P4501B1
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) Tetradecanoylphorbol Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] increases expression
/ increases reaction
mRNA 9706865
D013755 1571 CYP2E1
CPE1
CYP2E
P450-J
P450C2E
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]] decreases reaction
/ increases oxidation
/ increases reaction
protein 9143349
D013755 1571 CYP2E1
CPE1
CYP2E
P450-J
P450C2E
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) Tetradecanoylphorbol Acetate inhibits the reaction [Cycloheximide inhibits the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol]] decreases reaction
/ increases oxidation
protein 8531136
D013755 1571 CYP2E1
CPE1
CYP2E
P450-J
P450C2E
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased oxidation of 4-nitrophenol] increases oxidation
/ increases reaction
protein 8531136
9143349
D013755 1571 CYP2E1
CPE1
CYP2E
P450-J
P450C2E
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) Tetradecanoylphorbol Acetate promotes the reaction [CYP2E1 protein results in increased susceptibility to Ethanol] increases reaction
/ increases response to substance
protein 8798623
D013755 1571 CYP2E1
CPE1
CYP2E
P450-J
P450C2E
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) Tetradecanoylphorbol Acetate results in increased expression of CYP2E1 protein increases expression
protein 8798623
D013755 1581 CYP7A1
CP7A
CYP7
CYPVII
cytochrome P450, family 7, subfamily A, polypeptide 1 (EC:1.14.13.17) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1612 DAPK1
DAPK
death-associated protein kinase 1 (EC:2.7.11.1) Tetradecanoylphorbol Acetate results in increased expression of DAPK1 mRNA increases expression
mRNA 10910055
D013755 1638 DCT
TRP-2
TYRP2
dopachrome tautomerase (EC:5.3.3.12) Tetradecanoylphorbol Acetate results in decreased expression of DCT mRNA decreases expression
mRNA 15892717
D013755 1638 DCT
TRP-2
TYRP2
dopachrome tautomerase (EC:5.3.3.12) trichostatin A inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of DCT mRNA] decreases expression
/ decreases reaction
mRNA 15892717
D013755 1638 DCT
TRP-2
TYRP2
dopachrome tautomerase (EC:5.3.3.12) trichostatin A inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of DCT protein] decreases expression
/ decreases reaction
protein 15892717
D013755 1735 DIO3
5DIII
D3
DIOIII
TXDI3
deiodinase, iodothyronine, type III (EC:1.97.1.11) Tetradecanoylphorbol Acetate results in increased activity of DIO3 protein increases activity
protein 16935842
D013755 8788 DLK1
DLK
DLK-1
Delta1
FA1
PREF1
Pref-1
ZOG
pG2
delta-like 1 homolog (Drosophila) DLK1 protein affects the susceptibility to Tetradecanoylphorbol Acetate affects response to substance
protein 18575777
D013755 1806 DPYD
DHP
DHPDHASE
DPD
dihydropyrimidine dehydrogenase (EC:1.3.1.2) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which binds to DPYD promoter] affects binding
/ affects cotreatment
/ increases reaction
promoter 15705907
D013755 1806 DPYD
DHP
DHPDHASE
DPD
dihydropyrimidine dehydrogenase (EC:1.3.1.2) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of DPYD mRNA] affects binding
/ affects cotreatment
/ increases expression
/ increases reaction
mRNA 15705907
D013755 1806 DPYD
DHP
DHPDHASE
DPD
dihydropyrimidine dehydrogenase (EC:1.3.1.2) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of DPYD mRNA affects cotreatment
/ increases expression
mRNA 15705907
D013755 1843 DUSP1
CL100
HVH1
MKP-1
MKP1
PTPN10
dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of DUSP1 mRNA] decreases reaction
/ increases expression
mRNA 20858459
D013755 1843 DUSP1
CL100
HVH1
MKP-1
MKP1
PTPN10
dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) [fluticasone co-treated with Tetradecanoylphorbol Acetate] results in increased expression of DUSP1 mRNA affects cotreatment
/ increases expression
mRNA 15860753
D013755 1843 DUSP1
CL100
HVH1
MKP-1
MKP1
PTPN10
dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) Tetradecanoylphorbol Acetate results in increased expression of DUSP1 mRNA increases expression
mRNA 20858459
D013755 51207 DUSP13
BEDP
DUSP13A
DUSP13B
MDSP
SKRP4
TMDP
dual specificity phosphatase 13 (EC:3.1.3.16 3.1.3.48) Tetradecanoylphorbol Acetate results in increased expression of DUSP13 mRNA increases expression
mRNA 19031421
D013755 1846 DUSP4
HVH2
MKP-2
MKP2
TYP
dual specificity phosphatase 4 (EC:3.1.3.16 3.1.3.48) bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of DUSP4 mRNA]] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 1846 DUSP4
HVH2
MKP-2
MKP2
TYP
dual specificity phosphatase 4 (EC:3.1.3.16 3.1.3.48) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of DUSP4 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 1846 DUSP4
HVH2
MKP-2
MKP2
TYP
dual specificity phosphatase 4 (EC:3.1.3.16 3.1.3.48) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of DUSP4 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 1874 E2F4
E2F-4
E2F transcription factor 4, p107/p130-binding 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of E2F4 protein] decreases reaction
/ increases expression
protein 20479004
D013755 1874 E2F4
E2F-4
E2F transcription factor 4, p107/p130-binding E2F4 protein promotes the reaction [PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]] increases expression
/ increases reaction
protein 20479004
D013755 1874 E2F4
E2F-4
E2F transcription factor 4, p107/p130-binding E2F4 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] increases expression
/ increases reaction
protein 20479004
D013755 1874 E2F4
E2F-4
E2F transcription factor 4, p107/p130-binding juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of E2F4 protein] decreases reaction
/ increases expression
protein 20479004
D013755 1874 E2F4
E2F-4
E2F transcription factor 4, p107/p130-binding PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of E2F4 protein] increases expression
/ increases reaction
protein 20479004
D013755 1874 E2F4
E2F-4
E2F transcription factor 4, p107/p130-binding Tetradecanoylphorbol Acetate results in increased expression of E2F4 protein increases expression
protein 20479004
D013755 8411 EEA1
MST105
MSTP105
ZFYVE2
early endosome antigen 1 Tetradecanoylphorbol Acetate results in increased localization of [SLC6A3 protein co-treated with EEA1 protein] affects cotreatment
/ increases localization
protein 22683840
D013755 1945 EFNA4
EFL4
EPLG4
LERK4
ephrin-A4 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of EFNA4 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1950 EGF
HOMG4
URG
epidermal growth factor pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGF protein] decreases reaction
/ increases expression
protein 19447859
D013755 1950 EGF
HOMG4
URG
epidermal growth factor Tetradecanoylphorbol Acetate results in increased expression of EGF protein increases expression
protein 19447859
D013755 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGFR protein] decreases reaction
/ increases expression
protein 19447859
D013755 1956 EGFR
ERBB
ERBB1
HER1
PIG61
mENA
epidermal growth factor receptor (EC:2.7.10.1) Tetradecanoylphorbol Acetate results in increased expression of EGFR protein increases expression
protein 19447859
D013755 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein] decreases reaction
/ increases expression
protein 20479004
D013755 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 EGR1 protein promotes the reaction [PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]] increases expression
/ increases reaction
protein 20479004
D013755 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 EGR1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] increases expression
/ increases reaction
protein 20479004
D013755 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein] decreases reaction
/ increases expression
protein 20479004
D013755 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein] increases expression
/ increases reaction
protein 20479004
D013755 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA increases expression
mRNA 10739673
10779383
10910055
D013755 1958 EGR1
AT225
G0S30
KROX-24
NGFI-A
TIS8
ZIF-268
ZNF225
early growth response 1 Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein increases expression
protein 10739673
20479004
D013755 1959 EGR2
AT591
CMT1D
CMT4E
KROX20
early growth response 2 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 1959 EGR2
AT591
CMT1D
CMT4E
KROX20
early growth response 2 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 1959 EGR2
AT591
CMT1D
CMT4E
KROX20
early growth response 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 1961 EGR4
NGFI-C
NGFIC
PAT133
early growth response 4 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of EGR4 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with SB 203580] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4E protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 12781867
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4E protein] decreases reaction
/ increases phosphorylation
protein 9545260
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4E protein]] decreases reaction
/ increases phosphorylation
/ increases reaction
protein 9545260
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E CGP 57380 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4E protein] decreases reaction
/ increases phosphorylation
protein 12781867
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4E protein] decreases reaction
/ increases phosphorylation
protein 9545260
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4E protein]] decreases reaction
/ increases phosphorylation
/ increases reaction
protein 9545260
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E Tetradecanoylphorbol Acetate inhibits the reaction [EIF4EBP1 protein binds to EIF4E protein] affects binding
/ decreases reaction
protein 12781867
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4E protein increases phosphorylation
protein 9545260
12781867
D013755 1977 EIF4E
AUTS19
CBP
EIF4E1
EIF4EL1
EIF4F
eukaryotic translation initiation factor 4E U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4E protein] decreases reaction
/ increases phosphorylation
protein 12781867
D013755 1978 EIF4EBP1
4E-BP1
4EBP1
BP-1
PHAS-I
eukaryotic translation initiation factor 4E binding protein 1 Tetradecanoylphorbol Acetate inhibits the reaction [EIF4EBP1 protein binds to EIF4E protein] affects binding
/ decreases reaction
protein 12781867
D013755 1978 EIF4EBP1
4E-BP1
4EBP1
BP-1
PHAS-I
eukaryotic translation initiation factor 4E binding protein 1 Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4EBP1 protein increases phosphorylation
protein 12781867
D013755 1981 EIF4G1
EIF-4G1
EIF4F
EIF4G
EIF4GI
P220
PARK18
eukaryotic translation initiation factor 4 gamma, 1 [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with SB 203580] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 12781867
D013755 1981 EIF4G1
EIF-4G1
EIF4F
EIF4G
EIF4GI
P220
PARK18
eukaryotic translation initiation factor 4 gamma, 1 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein] decreases reaction
/ increases phosphorylation
protein 12781867
D013755 1981 EIF4G1
EIF-4G1
EIF4F
EIF4G
EIF4GI
P220
PARK18
eukaryotic translation initiation factor 4 gamma, 1 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein] decreases reaction
/ increases phosphorylation
protein 12781867
D013755 1981 EIF4G1
EIF-4G1
EIF4F
EIF4G
EIF4GI
P220
PARK18
eukaryotic translation initiation factor 4 gamma, 1 U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein] decreases reaction
/ increases phosphorylation
protein 12781867
D013755 1982 EIF4G2
AAG1
DAP5
NAT1
P97
eukaryotic translation initiation factor 4 gamma, 2 Tetradecanoylphorbol Acetate results in increased expression of EIF4G2 protein increases expression
protein 18491231
D013755 1983 EIF5
EIF-5
EIF-5A
eukaryotic translation initiation factor 5 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of EIF5 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2002 ELK1
ELK1, member of ETS oncogene family Tetradecanoylphorbol Acetate results in increased activity of ELK1 protein increases activity
protein 18791200
D013755 2002 ELK1
ELK1, member of ETS oncogene family Tetradecanoylphorbol Acetate results in increased phosphorylation of ELK1 protein increases phosphorylation
protein 21375462
D013755 2021 ENDOG
endonuclease G [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] affects the localization of ENDOG protein affects cotreatment
/ affects localization
protein 17309078
D013755 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of ERBB2 protein] increases expression
/ increases reaction
protein 20479004
D013755 2064 ERBB2
CD340
HER-2
HER-2/neu
HER2
MLN_19
NEU
NGL
TKR1
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) Tetradecanoylphorbol Acetate results in increased expression of ERBB2 protein increases expression
protein 20479004
D013755 2066 ERBB4
ALS19
HER4
p180erbB4
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 (EC:2.7.10.1) bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased cleavage of ERBB4 protein] decreases reaction
/ increases cleavage
protein 9685416
D013755 2066 ERBB4
ALS19
HER4
p180erbB4
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 (EC:2.7.10.1) Tetradecanoylphorbol Acetate results in increased cleavage of ERBB4 protein increases cleavage
protein 9685416
D013755 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ESR1 mRNA] decreases reaction
/ increases expression
mRNA 20559769
D013755 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 Plant Extracts promotes the reaction [Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ESR1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 20559769
D013755 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ESR1 mRNA] decreases reaction
/ increases expression
mRNA 20559769
D013755 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 Tetradecanoylphorbol Acetate results in decreased expression of ESR1 mRNA decreases expression
mRNA 9706865
D013755 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 Tetradecanoylphorbol Acetate results in decreased expression of ESR1 protein decreases expression
protein 10633228
D013755 2099 ESR1
ER
ESR
ESRA
ESTRR
Era
NR3A1
estrogen receptor 1 Tetradecanoylphorbol Acetate results in increased expression of ESR1 mRNA increases expression
mRNA 20559769
D013755 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) Ethinyl Estradiol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of ESR2 protein] decreases expression
/ decreases reaction
protein 10633228
D013755 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ESR2 mRNA] decreases reaction
/ increases expression
mRNA 20559769
D013755 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) Plant Extracts promotes the reaction [Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ESR2 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 20559769
D013755 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ESR2 mRNA] decreases reaction
/ increases expression
mRNA 20559769
D013755 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) Tetradecanoylphorbol Acetate results in decreased expression of ESR2 protein decreases expression
protein 10633228
D013755 2100 ESR2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
estrogen receptor 2 (ER beta) Tetradecanoylphorbol Acetate results in increased expression of ESR2 mRNA increases expression
mRNA 20559769
D013755 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) ochratoxin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of F3 protein] decreases reaction
/ increases expression
protein 18289624
D013755 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of F3 protein] decreases reaction
/ increases activity
/ increases expression
protein 9974427
D013755 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of F3 mRNA] decreases reaction
/ increases expression
mRNA 9974427
D013755 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of F3 protein increases activity
/ increases expression
protein 9974427
D013755 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) Tetradecanoylphorbol Acetate results in increased expression of F3 mRNA increases expression
mRNA 9974427
D013755 2152 F3
CD142
TF
TFA
coagulation factor III (thromboplastin, tissue factor) Tetradecanoylphorbol Acetate results in increased expression of F3 protein increases expression
protein 18289624
D013755 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) Tamoxifen inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 20529085
D013755 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG mRNA affects cotreatment
/ decreases expression
mRNA 20529085
D013755 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Estradiol] results in decreased expression of FASLG protein affects cotreatment
/ decreases expression
protein 20529085
D013755 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Testosterone] results in increased expression of FASLG mRNA affects cotreatment
/ increases expression
mRNA 20529085
D013755 356 FASLG
ALPS1B
APT1LG1
APTL
CD178
CD95-L
CD95L
FASL
TNFSF6
Fas ligand (TNF superfamily, member 6) [Tetradecanoylphorbol Acetate co-treated with Ionomycin co-treated with Testosterone] results in increased expression of FASLG protein affects cotreatment
/ increases expression
protein 20529085
D013755 2237 FEN1
FEN-1
MF1
RAD2
flap structure-specific endonuclease 1 Tetradecanoylphorbol Acetate results in increased expression of FEN1 mRNA increases expression
mRNA 19031421
D013755 8823 FGF16
FGF-16
MF4
fibroblast growth factor 16 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FGF16 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2247 FGF2
BFGF
FGF-2
FGFB
HBGF-2
fibroblast growth factor 2 (basic) Tetradecanoylphorbol Acetate results in increased secretion of FGF2 protein increases secretion
protein 11874475
D013755 2289 FKBP5
AIG6
FKBP51
FKBP54
P54
PPIase
Ptg-10
FK506 binding protein 5 (EC:5.2.1.8) BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA] increases expression
/ increases reaction
mRNA 20858459
D013755 2289 FKBP5
AIG6
FKBP51
FKBP54
P54
PPIase
Ptg-10
FK506 binding protein 5 (EC:5.2.1.8) Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA increases expression
mRNA 20858459
D013755 2321 FLT1
FLT
FLT-1
VEGFR-1
VEGFR1
fms-related tyrosine kinase 1 (EC:2.7.10.1) ATP7A protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FLT1 mRNA] increases expression
/ increases reaction
mRNA 19205902
D013755 2321 FLT1
FLT
FLT-1
VEGFR-1
VEGFR1
fms-related tyrosine kinase 1 (EC:2.7.10.1) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of FLT1 protein] decreases reaction
/ increases secretion
protein 22197494
D013755 2321 FLT1
FLT
FLT-1
VEGFR-1
VEGFR1
fms-related tyrosine kinase 1 (EC:2.7.10.1) Tetradecanoylphorbol Acetate results in increased expression of FLT1 mRNA increases expression
mRNA 19205902
D013755 2321 FLT1
FLT
FLT-1
VEGFR-1
VEGFR1
fms-related tyrosine kinase 1 (EC:2.7.10.1) Tetradecanoylphorbol Acetate results in increased secretion of FLT1 protein increases secretion
protein 22197494
D013755 2330 FMO5
flavin containing monooxygenase 5 (EC:1.14.13.8) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FMO5 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2335 FN1
CIG
ED-B
FINC
FN
FNZ
GFND
GFND2
LETS
MSF
fibronectin 1 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of FN1 protein] decreases reaction
/ increases secretion
protein 15086456
D013755 2335 FN1
CIG
ED-B
FINC
FN
FNZ
GFND
GFND2
LETS
MSF
fibronectin 1 calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of FN1 protein] decreases reaction
/ increases secretion
protein 15086456
D013755 2335 FN1
CIG
ED-B
FINC
FN
FNZ
GFND
GFND2
LETS
MSF
fibronectin 1 Tetradecanoylphorbol Acetate results in increased secretion of FN1 protein increases secretion
protein 15086456
D013755 2335 FN1
CIG
ED-B
FINC
FN
FNZ
GFND
GFND2
LETS
MSF
fibronectin 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FN1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of FOS protein] affects localization
/ decreases reaction
protein 20590612
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of FOS protein] affects localization
/ decreases reaction
protein 20599481
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of FOS protein] decreases reaction
/ increases activity
/ increases expression
protein 22634262
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOS protein]] affects cotreatment
/ decreases reaction
/ increases expression
protein 15477007
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS mRNA] decreases reaction
/ increases expression
mRNA 17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS protein] decreases reaction
/ increases expression
protein 17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Capsaicin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOS protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 9580328
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog [FOS protein co-treated with JUN protein] inhibits the reaction [pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 protein]] affects cotreatment
/ decreases reaction
/ increases expression
protein 17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS protein] decreases reaction
/ increases expression
protein 19375915
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]] affects binding
/ increases activity
/ increases reaction
protein 22561169
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS protein] increases expression
/ increases reaction
protein 22561169
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Metformin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of FOS protein] affects localization
/ decreases reaction
protein 20590612
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog piperine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of FOS protein] affects localization
/ decreases reaction
protein 21354279
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS mRNA] decreases reaction
/ increases expression
mRNA 17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOS protein] decreases reaction
/ increases expression
protein 17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of FOS protein] decreases reaction
/ increases activity
/ increases expression
protein 22634262
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOS protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 15477007
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of FOS protein] affects localization
/ decreases reaction
protein 20599481
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Tetradecanoylphorbol Acetate affects the localization of FOS protein affects localization
protein 20152819
20590612
20599481
21354279
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which binds to DPYD promoter] affects binding
/ affects cotreatment
/ increases reaction
protein 15705907
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of DPYD mRNA] affects binding
/ affects cotreatment
/ increases expression
/ increases reaction
protein 15705907
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOS protein affects cotreatment
/ increases expression
protein 9580328
15477007
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Tetradecanoylphorbol Acetate promotes the reaction [FOS protein binds to CYP1A2 enhancer] affects binding
/ increases reaction
protein 10620351
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter] affects binding
/ increases reaction
protein 17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein] affects binding
/ increases activity
protein 16116958
22561169
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of FOS protein increases activity
/ increases expression
protein 22634262
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Tetradecanoylphorbol Acetate results in increased expression of FOS mRNA increases expression
mRNA 7963561
8631129
10739673
10910055
17360982
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog Tetradecanoylphorbol Acetate results in increased expression of FOS protein increases expression
protein 17360982
19375915
22561169
D013755 2353 FOS
AP-1
C-FOS
p55
FBJ murine osteosarcoma viral oncogene homolog W 7 inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of FOS protein] affects localization
/ decreases reaction
protein 20590612
D013755 2354 FOSB
AP-1
G0S3
GOS3
GOSB
FBJ murine osteosarcoma viral oncogene homolog B Tetradecanoylphorbol Acetate results in increased expression of FOSB protein increases expression
protein 17148446
D013755 8061 FOSL1
FRA
FRA1
fra-1
FOS-like antigen 1 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOSL1 protein]] decreases reaction
/ increases expression
protein 17148446
D013755 8061 FOSL1
FRA
FRA1
fra-1
FOS-like antigen 1 Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [FOSL1 protein binds to JUNB protein]] affects binding
/ decreases reaction
/ increases reaction
protein 17148446
D013755 8061 FOSL1
FRA
FRA1
fra-1
FOS-like antigen 1 Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOSL1 protein] decreases reaction
/ increases expression
protein 17148446
D013755 8061 FOSL1
FRA
FRA1
fra-1
FOS-like antigen 1 Tetradecanoylphorbol Acetate promotes the reaction [FOSL1 protein binds to JUNB protein] affects binding
/ increases reaction
protein 17148446
D013755 8061 FOSL1
FRA
FRA1
fra-1
FOS-like antigen 1 Tetradecanoylphorbol Acetate results in increased expression of FOSL1 protein increases expression
protein 17148446
D013755 2355 FOSL2
FRA2
FOS-like antigen 2 Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of FOSL2 protein] decreases reaction
/ increases expression
protein 17148446
D013755 2355 FOSL2
FRA2
FOS-like antigen 2 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOSL2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 2355 FOSL2
FRA2
FOS-like antigen 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOSL2 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 2355 FOSL2
FRA2
FOS-like antigen 2 Tetradecanoylphorbol Acetate results in increased expression of FOSL2 protein increases expression
protein 17148446
D013755 2355 FOSL2
FRA2
FOS-like antigen 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of FOSL2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 FOXO3 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2] affects reaction
/ increases expression
protein 21705328
D013755 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 Tetradecanoylphorbol Acetate results in decreased phosphorylation of FOXO3 protein decreases phosphorylation
protein 21705328
D013755 2309 FOXO3
AF6q21
FKHRL1
FKHRL1P2
FOXO2
FOXO3A
forkhead box O3 Tetradecanoylphorbol Acetate results in increased activity of FOXO3 protein increases activity
protein 21705328
D013755 2533 FYB
ADAP
PRO0823
SLAP-130
FYN binding protein [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of FYB mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 2533 FYB
ADAP
PRO0823
SLAP-130
FYN binding protein pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of FYB mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 2533 FYB
ADAP
PRO0823
SLAP-130
FYN binding protein [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of FYB mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 1647 GADD45A
DDIT1
GADD45
growth arrest and DNA-damage-inducible, alpha Tetradecanoylphorbol Acetate results in increased expression of GADD45A mRNA increases expression
mRNA 10910055
D013755 2623 GATA1
ERYF1
GATA-1
GF-1
GF1
NF-E1
NFE1
XLANP
XLTDA
XLTT
GATA binding protein 1 (globin transcription factor 1) Tetradecanoylphorbol Acetate promotes the reaction [GATA1 protein binds to GSTP1 promoter] affects binding
/ increases reaction
protein 14623254
D013755 2623 GATA1
ERYF1
GATA-1
GF-1
GF1
NF-E1
NFE1
XLANP
XLTDA
XLTT
GATA binding protein 1 (globin transcription factor 1) Tetradecanoylphorbol Acetate results in increased activity of GATA1 protein increases activity
protein 14623254
D013755 2624 GATA2
DCML
MONOMAC
NFE1B
GATA binding protein 2 tellimagrandin I promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of GATA2 mRNA] increases expression
/ increases reaction
mRNA 14757314
D013755 2624 GATA2
DCML
MONOMAC
NFE1B
GATA binding protein 2 Tetradecanoylphorbol Acetate results in increased expression of GATA2 mRNA increases expression
mRNA 14757314
D013755 2729 GCLC
GCL
GCS
GLCL
GLCLC
glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) [Tetradecanoylphorbol Acetate co-treated with rosuvastatin] results in increased expression of GCLC mRNA affects cotreatment
/ increases expression
mRNA 18154958
D013755 2729 GCLC
GCL
GCS
GLCL
GLCLC
glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) Tetradecanoylphorbol Acetate results in increased expression of GCLC mRNA increases expression
mRNA 18154958
D013755 2662 GDF10
BMP-3b
BMP3B
growth differentiation factor 10 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of GDF10 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2672 GFI1
GFI-1
GFI1A
SCN2
ZNF163
growth factor independent 1 transcription repressor Tetradecanoylphorbol Acetate results in decreased expression of GFI1 mRNA decreases expression
mRNA 16888099
D013755 2675 GFRA2
GDNFRB
NRTNR-ALPHA
NTNRA
RETL2
TRNR2
GDNF family receptor alpha 2 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GFRA2 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 2675 GFRA2
GDNFRB
NRTNR-ALPHA
NTNRA
RETL2
TRNR2
GDNF family receptor alpha 2 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GFRA2 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 2675 GFRA2
GDNFRB
NRTNR-ALPHA
NTNRA
RETL2
TRNR2
GDNF family receptor alpha 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GFRA2 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 2694 GIF
IF
IFMH
INF
TCN3
gastric intrinsic factor (vitamin B synthesis) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of GIF mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2697 GJA1
AVSD3
CMDR
CX43
DFNB38
GJAL
HLHS1
HSS
ODDD
gap junction protein, alpha 1, 43kDa Ethinyl Estradiol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GJA1 protein] decreases reaction
/ increases expression
protein 10633228
D013755 2697 GJA1
AVSD3
CMDR
CX43
DFNB38
GJAL
HLHS1
HSS
ODDD
gap junction protein, alpha 1, 43kDa Tetradecanoylphorbol Acetate results in increased expression of GJA1 protein increases expression
protein 10633228
D013755 2697 GJA1
AVSD3
CMDR
CX43
DFNB38
GJAL
HLHS1
HSS
ODDD
gap junction protein, alpha 1, 43kDa Tetradecanoylphorbol Acetate results in increased phosphorylation of GJA1 protein increases phosphorylation
protein 11711124
D013755 10578 GNLY
519
D2S69E
LAG-2
LAG2
NKG5
TLA519
granulysin [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GNLY mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 10578 GNLY
519
D2S69E
LAG-2
LAG2
NKG5
TLA519
granulysin pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GNLY mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 10578 GNLY
519
D2S69E
LAG-2
LAG2
NKG5
TLA519
granulysin [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GNLY mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 2798 GNRHR
GNRHR1
GRHR
HH7
LHRHR
LRHR
gonadotropin-releasing hormone receptor [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of GNRHR mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2876 GPX1
GPXD
GSHPX1
glutathione peroxidase 1 (EC:1.11.1.9) Tetradecanoylphorbol Acetate results in increased expression of GPX1 protein increases expression
protein 10432307
D013755 2879 GPX4
GPx-4
GSHPx-4
MCSP
PHGPx
snGPx
snPHGPx
glutathione peroxidase 4 (EC:1.11.1.12) Tetradecanoylphorbol Acetate results in decreased expression of GPX4 protein decreases expression
protein 10432307
D013755 2896 GRN
CLN11
GEP
GP88
PCDGF
PEPI
PGRN
granulin Tetradecanoylphorbol Acetate results in increased expression of GRN mRNA increases expression
mRNA 16873554
D013755 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) beta-lapachone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] decreases reaction
/ increases expression
mRNA 15313406
D013755 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) Capsaicin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] decreases reaction
/ increases expression
mRNA 15313406
D013755 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) Emodin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] decreases reaction
/ increases expression
mRNA 15313406
D013755 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) sanguinarine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] decreases reaction
/ increases expression
mRNA 15313406
D013755 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) Tetradecanoylphorbol Acetate promotes the reaction [GATA1 protein binds to GSTP1 promoter] affects binding
/ increases reaction
promoter 14623254
D013755 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) Tetradecanoylphorbol Acetate results in decreased expression of GSTP1 mRNA decreases expression
mRNA 14623254
D013755 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) Tetradecanoylphorbol Acetate results in decreased expression of GSTP1 protein decreases expression
protein 14623254
D013755 2950 GSTP1
DFN7
FAEES3
GST3
GSTP
PI
glutathione S-transferase pi 1 (EC:2.5.1.18) Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA increases expression
mRNA 15313406
15533597
D013755 2968 GTF2H4
P52
TFB2
TFIIH
general transcription factor IIH, polypeptide 4, 52kDa Tetradecanoylphorbol Acetate results in increased expression of GTF2H4 mRNA increases expression
mRNA 19031421
D013755 2993 GYPA
CD235a
GPA
GPErik
GPSAT
HGpMiV
HGpMiXI
HGpSta(C)
MN
MNS
PAS-2
glycophorin A (MNS blood group) chebulinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GYPA protein] decreases reaction
/ increases expression
protein 14769215
D013755 2993 GYPA
CD235a
GPA
GPErik
GPSAT
HGpMiV
HGpMiXI
HGpSta(C)
MN
MNS
PAS-2
glycophorin A (MNS blood group) Tetradecanoylphorbol Acetate results in increased expression of GYPA protein increases expression
protein 14769215
D013755 3030 HADHA
ECHA
GBP
HADH
LCEH
LCHAD
MTPA
TP-ALPHA
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit (EC:4.2.1.17 1.1.1.211) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3030 HADHA
ECHA
GBP
HADH
LCEH
LCHAD
MTPA
TP-ALPHA
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit (EC:4.2.1.17 1.1.1.211) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 3035 HARS
HRS
USH3B
histidyl-tRNA synthetase (EC:6.1.1.21) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HARS mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 3035 HARS
HRS
USH3B
histidyl-tRNA synthetase (EC:6.1.1.21) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HARS mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 1839 HBEGF
DTR
DTS
DTSF
HEGFL
heparin-binding EGF-like growth factor Tetradecanoylphorbol Acetate results in increased expression of HBEGF mRNA increases expression
mRNA 10910055
D013755 1839 HBEGF
DTR
DTS
DTSF
HEGFL
heparin-binding EGF-like growth factor [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of HBEGF mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3055 HCK
JTK9
p59Hck
p61Hck
hemopoietic cell kinase (EC:2.7.10.2) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3055 HCK
JTK9
p59Hck
p61Hck
hemopoietic cell kinase (EC:2.7.10.2) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 3067 HDC
histidine decarboxylase (EC:4.1.1.22) Tetradecanoylphorbol Acetate results in increased activity of HDC protein increases activity
protein 10428506
D013755 3082 HGF
DFNB39
F-TCF
HGFB
HPTA
SF
hepatocyte growth factor (hepapoietin A; scatter factor) Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HGF protein] decreases reaction
/ increases expression
protein 15802798
D013755 3082 HGF
DFNB39
F-TCF
HGFB
HPTA
SF
hepatocyte growth factor (hepapoietin A; scatter factor) Tetradecanoylphorbol Acetate results in increased expression of HGF mRNA increases expression
mRNA 15802798
D013755 3082 HGF
DFNB39
F-TCF
HGFB
HPTA
SF
hepatocyte growth factor (hepapoietin A; scatter factor) Tetradecanoylphorbol Acetate results in increased expression of HGF protein increases expression
protein 15802798
D013755 3082 HGF
DFNB39
F-TCF
HGFB
HPTA
SF
hepatocyte growth factor (hepapoietin A; scatter factor) TGFB1 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HGF protein] decreases reaction
/ increases expression
protein 15802798
D013755 3082 HGF
DFNB39
F-TCF
HGFB
HPTA
SF
hepatocyte growth factor (hepapoietin A; scatter factor) Ursodeoxycholic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HGF mRNA] decreases reaction
/ increases expression
mRNA 15802798
D013755 3082 HGF
DFNB39
F-TCF
HGFB
HPTA
SF
hepatocyte growth factor (hepapoietin A; scatter factor) Ursodeoxycholic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HGF protein] decreases reaction
/ increases expression
protein 15802798
D013755 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HIF1A protein alternative form] decreases reaction
/ increases expression
protein 14695184
D013755 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) Dithiothreitol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HIF1A protein alternative form] decreases reaction
/ increases expression
protein 14695184
D013755 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) Tetradecanoylphorbol Acetate inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA] decreases reaction
/ increases expression
mRNA 11424089
D013755 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) Tetradecanoylphorbol Acetate results in increased expression of HIF1A mRNA alternative form increases expression
mRNA 14695184
D013755 3091 HIF1A
HIF-1A
HIF-1alpha
HIF1
HIF1-ALPHA
MOP1
PASD8
bHLHe78
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) Tetradecanoylphorbol Acetate results in increased expression of HIF1A protein alternative form increases expression
protein 14695184
D013755 3146 HMGB1
HMG1
HMG3
SBP-1
high mobility group box 1 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HMGB1 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 3146 HMGB1
HMG1
HMG3
SBP-1
high mobility group box 1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HMGB1 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 3156 HMGCR
LDLCQ3
3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) Tetradecanoylphorbol Acetate results in increased expression of HMGCR mRNA increases expression
mRNA 12044893
D013755 3157 HMGCS1
HMGCS
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) (EC:2.3.3.10) Tetradecanoylphorbol Acetate results in increased expression of HMGCS1 mRNA increases expression
mRNA 12044893
D013755 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HMOX1 mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 3248 HPGD
15-PGDH
PGDH
PGDH1
PHOAR1
SDR36C1
hydroxyprostaglandin dehydrogenase 15-(NAD) (EC:1.1.1.141) Indomethacin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of HPGD mRNA] increases expression
/ increases reaction
mRNA 11237475
D013755 3248 HPGD
15-PGDH
PGDH
PGDH1
PHOAR1
SDR36C1
hydroxyprostaglandin dehydrogenase 15-(NAD) (EC:1.1.1.141) Tetradecanoylphorbol Acetate inhibits the reaction [Dexamethasone results in increased expression of and results in increased activity of HPGD protein] decreases reaction
/ increases activity
/ increases expression
protein 15680906
D013755 3248 HPGD
15-PGDH
PGDH
PGDH1
PHOAR1
SDR36C1
hydroxyprostaglandin dehydrogenase 15-(NAD) (EC:1.1.1.141) Tetradecanoylphorbol Acetate results in increased expression of HPGD mRNA increases expression
mRNA 11237475
D013755 3265 HRAS
C-BAS/HAS
C-H-RAS
C-HA-RAS1
CTLO
H-RASIDX
HAMSV
HRAS1
K-RAS
N-RAS
RASH1
Harvey rat sarcoma viral oncogene homolog [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of HRAS mRNA affects cotreatment
/ increases expression
mRNA 18922899
D013755 3306 HSPA2
HSP70-2
HSP70-3
heat shock 70kDa protein 2 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of HSPA2 mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 3306 HSPA2
HSP70-2
HSP70-3
heat shock 70kDa protein 2 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA2 mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 3310 HSPA6
heat shock 70kDa protein 6 (HSP70B') [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA6 mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 3312 HSPA8
HSC54
HSC70
HSC71
HSP71
HSP73
HSPA10
LAP1
NIP71
heat shock 70kDa protein 8 bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA8 mRNA]] affects cotreatment
/ decreases reaction
/ increases expression
/ increases reaction
mRNA 15477007
D013755 3312 HSPA8
HSC54
HSC70
HSC71
HSP71
HSP73
HSPA10
LAP1
NIP71
heat shock 70kDa protein 8 pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA8 mRNA] affects cotreatment
/ increases expression
/ increases reaction
mRNA 15477007
D013755 3313 HSPA9
CSA
GRP-75
GRP75
HSPA9B
MOT
MOT2
MTHSP75
PBP74
heat shock 70kDa protein 9 (mortalin) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA9 mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 3381 IBSP
BNSP
BSP
BSP-II
SP-II
integrin-binding sialoprotein [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IBSP mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 Tetradecanoylphorbol Acetate promotes the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA] increases expression
/ increases reaction
mRNA 20920494
D013755 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 Tetradecanoylphorbol Acetate promotes the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] increases expression
/ increases reaction
protein 20920494
D013755 3458 IFNG
IFG
IFI
interferon, gamma Aspirin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IFNG protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 15379866
D013755 3458 IFNG
IFG
IFI
interferon, gamma [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG protein affects cotreatment
/ increases expression
protein 14994387
D013755 3458 IFNG
IFG
IFI
interferon, gamma Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 3458 IFNG
IFG
IFI
interferon, gamma [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of IFNG promoter affects cotreatment
/ increases activity
promoter 21569788
D013755 3458 IFNG
IFG
IFI
interferon, gamma [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IFNG protein affects cotreatment
/ increases secretion
protein 17685462
D013755 3458 IFNG
IFG
IFI
interferon, gamma [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG protein affects cotreatment
/ increases expression
protein 17051331
D013755 3458 IFNG
IFG
IFI
interferon, gamma monocyte locomotion inhibitory factor inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IFNG protein] decreases reaction
/ increases secretion
protein 16374615
D013755 3458 IFNG
IFG
IFI
interferon, gamma nickel chloride inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of IFNG promoter] affects cotreatment
/ decreases reaction
/ increases activity
promoter 21569788
D013755 3458 IFNG
IFG
IFI
interferon, gamma resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16154495
D013755 3458 IFNG
IFG
IFI
interferon, gamma sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IFNG protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 3458 IFNG
IFG
IFI
interferon, gamma Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IFNG protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 3458 IFNG
IFG
IFI
interferon, gamma Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IFNG protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 3458 IFNG
IFG
IFI
interferon, gamma Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 3458 IFNG
IFG
IFI
interferon, gamma [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein affects cotreatment
/ increases expression
protein 1371491
D013755 3458 IFNG
IFG
IFI
interferon, gamma [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG mRNA affects cotreatment
/ increases expression
mRNA 12812920
D013755 3458 IFNG
IFG
IFI
interferon, gamma [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG protein affects cotreatment
/ increases expression
protein 12812920
15358692
16154495
17572062
D013755 3458 IFNG
IFG
IFI
interferon, gamma [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IFNG protein affects cotreatment
/ increases secretion
protein 15379866
D013755 3458 IFNG
IFG
IFI
interferon, gamma Tetradecanoylphorbol Acetate inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] decreases reaction
/ increases expression
/ increases reaction
protein 18953428
D013755 3458 IFNG
IFG
IFI
interferon, gamma Tetradecanoylphorbol Acetate results in increased expression of IFNG mRNA increases expression
mRNA 18541274
D013755 3458 IFNG
IFG
IFI
interferon, gamma Tetradecanoylphorbol Acetate results in increased secretion of IFNG protein increases secretion
protein 16374615
D013755 3458 IFNG
IFG
IFI
interferon, gamma Zinc deficiency affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNG mRNA] affects cotreatment
/ affects reaction
/ increases expression
mRNA 12812920
D013755 3460 IFNGR2
AF-1
IFGR2
IFNGT1
interferon gamma receptor 2 (interferon gamma transducer 1) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNGR2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3460 IFNGR2
AF-1
IFGR2
IFNGT1
interferon gamma receptor 2 (interferon gamma transducer 1) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IFNGR2 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 3488 IGFBP5
IBP5
insulin-like growth factor binding protein 5 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP5 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3490 IGFBP7
AGM
FSTL2
IBP-7
IGFBP-7
IGFBP-7v
IGFBPRP1
MAC25
PSF
RAMSVPS
TAF
insulin-like growth factor binding protein 7 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP7 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3543 IGLL1
14.1
AGM2
CD179b
IGL1
IGL5
IGLJ14.1
IGLL
IGO
IGVPB
VPREB2
immunoglobulin lambda-like polypeptide 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGLL1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3551 IKBKB
IKK-beta
IKK2
IKKB
NFKBIKB
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of IKBKB protein] decreases reaction
/ increases activity
protein 20584749
D013755 3551 IKBKB
IKK-beta
IKK2
IKKB
NFKBIKB
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) Dithiothreitol inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of IKBKB protein]] decreases reaction
/ increases activity
protein 20584749
D013755 3551 IKBKB
IKK-beta
IKK2
IKKB
NFKBIKB
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) Tetradecanoylphorbol Acetate results in increased activity of IKBKB protein increases activity
protein 20584749
D013755 8517 IKBKG
AMCBX1
FIP-3
FIP3
Fip3p
IKK-gamma
IP
IP1
IP2
IPD2
NEMO
ZC2HC9
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma capsiate analog inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased activity of IKBKG protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 12115659
D013755 8517 IKBKG
AMCBX1
FIP-3
FIP3
Fip3p
IKK-gamma
IP
IP1
IP2
IPD2
NEMO
ZC2HC9
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma [Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased activity of IKBKG protein affects cotreatment
/ increases activity
protein 12115659
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 benzoquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17572062
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 catechol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17572062
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 Clenbuterol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL10 protein] decreases reaction
/ increases expression
protein 15502056
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 Dobutamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL10 protein] decreases reaction
/ increases expression
protein 15502056
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 hydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17572062
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 hydroxyhydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17572062
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL10 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL10 protein affects cotreatment
/ increases expression
protein 17051331
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 monocyte locomotion inhibitory factor promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL10 protein] increases reaction
/ increases secretion
protein 16374615
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL10 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IL10 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IL10 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein affects cotreatment
/ increases expression
protein 17572062
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 Tetradecanoylphorbol Acetate results in decreased expression of IL10 mRNA decreases expression
mRNA 15614042
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 Tetradecanoylphorbol Acetate results in increased expression of IL10 protein increases expression
protein 15502056
D013755 3586 IL10
CSIF
GVHDS
IL-10
IL10A
TGIF
interleukin 10 Tetradecanoylphorbol Acetate results in increased secretion of IL10 protein increases secretion
protein 16374615
D013755 3589 IL11
AGIF
IL-11
interleukin 11 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL11 mRNA] decreases reaction
/ increases expression
mRNA 22138297
D013755 3589 IL11
AGIF
IL-11
interleukin 11 Ro 31-8220 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL11 mRNA] decreases reaction
/ increases expression
mRNA 22138297
D013755 3589 IL11
AGIF
IL-11
interleukin 11 Tetradecanoylphorbol Acetate results in increased expression of IL11 mRNA increases expression
mRNA 22138297
D013755 3593 IL12B
CLMF
CLMF2
IL-12B
NKSF
NKSF2
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) Tetradecanoylphorbol Acetate results in increased expression of IL12B mRNA increases expression
mRNA 15614042
D013755 3594 IL12RB1
CD212
IL-12R-BETA1
IL12RB
interleukin 12 receptor, beta 1 Tetradecanoylphorbol Acetate results in increased expression of IL12RB1 protein increases expression
protein 11441113
D013755 3595 IL12RB2
interleukin 12 receptor, beta 2 Tetradecanoylphorbol Acetate results in increased expression of IL12RB2 protein increases expression
protein 11441113
D013755 3595 IL12RB2
interleukin 12 receptor, beta 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL12RB2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3596 IL13
IL-13
P600
interleukin 13 Tetradecanoylphorbol Acetate results in increased expression of IL13 mRNA increases expression
mRNA 10428506
D013755 8809 IL18R1
CD218a
CDw218a
IL-1Rrp
IL18RA
IL1RRP
interleukin 18 receptor 1 [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL18R1 protein affects cotreatment
/ increases expression
protein 14994387
D013755 3552 IL1A
IL-1A
IL1
IL1-ALPHA
IL1F1
interleukin 1, alpha SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1A mRNA] increases expression
/ increases reaction
mRNA 21045076
D013755 3552 IL1A
IL-1A
IL1
IL1-ALPHA
IL1F1
interleukin 1, alpha Tetradecanoylphorbol Acetate results in increased expression of IL1A mRNA increases expression
mRNA 21045076
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA affects cotreatment
/ increases expression
mRNA 21515303
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21515303
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta cinnamic aldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21807015
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21807015
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 18958421
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein affects cotreatment
/ increases secretion
protein 17685462
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein affects cotreatment
/ increases secretion
protein 21807015
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta monocyte locomotion inhibitory factor inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL1B protein] decreases reaction
/ increases secretion
protein 16374615
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B protein] decreases reaction
/ increases expression
protein 10072544
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 17588137
18958421
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17588137
18958421
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 18958421
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA affects cotreatment
/ increases expression
mRNA 17588137
18958421
22322153
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein affects cotreatment
/ increases secretion
protein 17588137
18958421
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL1B protein affects cotreatment
/ increases expression
protein 17572062
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Tetradecanoylphorbol Acetate results in increased expression of IL1B protein increases expression
protein 12812920
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Tetradecanoylphorbol Acetate results in increased secretion of IL1B protein increases secretion
protein 16374615
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Triclosan inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with TNF protein] results in increased expression of IL1B protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 9584910
D013755 3553 IL1B
IL-1
IL1-BETA
IL1F2
interleukin 1, beta Zinc deficiency promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B protein] increases expression
/ increases reaction
protein 12812920
D013755 3554 IL1R1
CD121A
D2S1473
IL-1R-alpha
IL1R
IL1RA
P80
interleukin 1 receptor, type I SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1R1 mRNA] increases expression
/ increases reaction
mRNA 21045076
D013755 3554 IL1R1
CD121A
D2S1473
IL-1R-alpha
IL1R
IL1RA
P80
interleukin 1 receptor, type I Tetradecanoylphorbol Acetate results in increased expression of IL1R1 mRNA increases expression
mRNA 21045076
D013755 7850 IL1R2
CD121b
CDw121b
IL-1R-2
IL-1RT-2
IL-1RT2
IL1R2c
IL1RB
interleukin 1 receptor, type II SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1R2 mRNA] increases expression
/ increases reaction
mRNA 21045076
D013755 7850 IL1R2
CD121b
CDw121b
IL-1R-2
IL-1RT-2
IL-1RT2
IL1R2c
IL1RB
interleukin 1 receptor, type II Tetradecanoylphorbol Acetate results in increased expression of IL1R2 mRNA increases expression
mRNA 21045076
D013755 3556 IL1RAP
C3orf13
IL-1RAcP
IL1R3
interleukin 1 receptor accessory protein [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL1RAP mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 26280 IL1RAPL2
IL-1R9
IL1R9
IL1RAPL-2
TIGIRR-1
interleukin 1 receptor accessory protein-like 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL1RAPL2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3557 IL1RN
DIRA
ICIL-1RA
IL-1RN
IL-1ra
IL-1ra3
IL1F3
IL1RA
IRAP
MVCD4
interleukin 1 receptor antagonist NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1RN protein] decreases reaction
/ increases expression
protein 10072544
D013755 3557 IL1RN
DIRA
ICIL-1RA
IL-1RN
IL-1ra
IL-1ra3
IL1F3
IL1RA
IRAP
MVCD4
interleukin 1 receptor antagonist Tetradecanoylphorbol Acetate results in increased expression of IL1RN protein increases expression
protein 10072544
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [norcantharidin inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein]] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21075198
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 2-arachidonylglycerol metabolite inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased secretion of IL2 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21511917
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein] increases reaction
/ increases secretion
protein 12421932
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 alitretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein] increases reaction
/ increases secretion
protein 12421932
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Aspirin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 15379866
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 ciglitazone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased secretion of IL2 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21511917
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Go 6976 inhibits the reaction [pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]] affects cotreatment
/ decreases reaction
/ increases expression
/ increases reaction
protein 16241859
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 hydroquinone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 protein] decreases reaction
/ increases expression
protein 9571986
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 IL2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNA2 protein] increases expression
/ increases reaction
protein 12421932
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 IL2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNE1 protein] increases expression
/ increases reaction
protein 12421932
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 IL2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RB1 protein] increases phosphorylation
/ increases reaction
protein 12421932
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of IL2 promoter affects cotreatment
/ increases activity
promoter 21569788
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL2 protein affects cotreatment
/ increases expression
protein 12165276
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein affects cotreatment
/ increases secretion
protein 17685462
21075198
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 lenalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein] affects cotreatment
/ increases reaction
/ increases secretion
protein 16241859
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL2 protein affects cotreatment
/ increases expression
protein 17051331
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA] increases expression
/ increases reaction
mRNA 22561169
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 protein] increases expression
/ increases reaction
protein 22561169
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Mesalamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 protein] decreases reaction
/ increases expression
protein 7815356
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 monocyte locomotion inhibitory factor promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein] increases reaction
/ increases secretion
protein 16374615
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 nickel chloride inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of IL2 promoter] affects cotreatment
/ decreases reaction
/ increases activity
promoter 21569788
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 norcantharidin inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21075198
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 18423386
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA] affects cotreatment
/ increases expression
/ increases reaction
mRNA 16241859
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 16241859
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein] affects cotreatment
/ increases reaction
/ increases secretion
protein 16241859
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Pyrazoles analog inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 11592964
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Pyrazoles analog inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 mRNA] affects cotreatment
/ decreases reaction
/ increases secretion
mRNA 11592964
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16154495
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 rottlerin inhibits the reaction [pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein]] affects cotreatment
/ decreases reaction
/ increases expression
/ increases reaction
protein 16241859
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 SB 203580 inhibits the reaction [norcantharidin inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein]] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21075198
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IL2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IL2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 T 0070907 inhibits the reaction [2-arachidonylglycerol metabolite inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased secretion of IL2 protein]] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21511917
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 T 0070907 inhibits the reaction [ciglitazone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased secretion of IL2 protein]] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21511917
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 T 0070907 promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased secretion of IL2 protein] affects cotreatment
/ increases reaction
/ increases secretion
protein 21511917
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein affects cotreatment
/ increases expression
protein 1371491
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased secretion of IL2 protein affects cotreatment
/ increases secretion
protein 21511917
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA affects cotreatment
/ increases expression
mRNA 11592964
12812920
15477007
16241859
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein affects cotreatment
/ increases expression
protein 12812920
16154495
16241859
17572062
18423386
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 mRNA affects cotreatment
/ increases secretion
mRNA 11592964
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein affects cotreatment
/ increases secretion
protein 15379866
16241859
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA increases expression
mRNA 16055081
22561169
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Tetradecanoylphorbol Acetate results in increased expression of IL2 protein increases expression
protein 7815356
9571986
12749906
22561169
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein increases secretion
protein 12421932
16374615
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein] increases reaction
/ increases secretion
protein 12421932
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Zinc deficiency affects the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA] affects cotreatment
/ affects reaction
/ increases expression
mRNA 12812920
D013755 3558 IL2
IL-2
TCGF
lymphokine
interleukin 2 Zinc Sulfate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA] decreases reaction
/ increases expression
mRNA 16055081
D013755 3559 IL2RA
CD25
IDDM10
IL2R
TCGFR
interleukin 2 receptor, alpha [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2RA protein affects cotreatment
/ increases secretion
protein 8586487
D013755 3559 IL2RA
CD25
IDDM10
IL2R
TCGFR
interleukin 2 receptor, alpha Mesalamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2RA protein] decreases reaction
/ increases expression
protein 7815356
D013755 3559 IL2RA
CD25
IDDM10
IL2R
TCGFR
interleukin 2 receptor, alpha Sirolimus inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2RA protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 8586487
D013755 3559 IL2RA
CD25
IDDM10
IL2R
TCGFR
interleukin 2 receptor, alpha Sirolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2RA protein] decreases reaction
/ increases secretion
protein 8586487
D013755 3559 IL2RA
CD25
IDDM10
IL2R
TCGFR
interleukin 2 receptor, alpha Sulfasalazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2RA protein] decreases reaction
/ increases expression
protein 7815356
D013755 3559 IL2RA
CD25
IDDM10
IL2R
TCGFR
interleukin 2 receptor, alpha Tetradecanoylphorbol Acetate results in increased expression of IL2RA protein increases expression
protein 7815356
12421932
12749906
D013755 3559 IL2RA
CD25
IDDM10
IL2R
TCGFR
interleukin 2 receptor, alpha Tetradecanoylphorbol Acetate results in increased secretion of IL2RA protein increases secretion
protein 8586487
D013755 3559 IL2RA
CD25
IDDM10
IL2R
TCGFR
interleukin 2 receptor, alpha [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2RA mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3560 IL2RB
CD122
IL15RB
P70-75
interleukin 2 receptor, beta [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2RB mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3560 IL2RB
CD122
IL15RB
P70-75
interleukin 2 receptor, beta pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2RB mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3560 IL2RB
CD122
IL15RB
P70-75
interleukin 2 receptor, beta [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2RB mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 3562 IL3
IL-3
MCGF
MULTI-CSF
interleukin 3 (colony-stimulating factor, multiple) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL3 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA affects cotreatment
/ increases expression
mRNA 21515303
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21515303
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL4 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4] affects cotreatment
/ decreases reaction
/ increases expression
16601352
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 plant extract, Houttuynia cordata inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 18325701
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL4 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein affects cotreatment
/ increases expression
protein 1371491
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 protein affects cotreatment
/ increases expression
protein 17572062
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 Tetradecanoylphorbol Acetate results in increased expression of IL4 mRNA increases expression
mRNA 10428506
D013755 3565 IL4
BCGF-1
BCGF1
BSF-1
BSF1
IL-4
interleukin 4 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL4 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL5 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) monocyte locomotion inhibitory factor inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL5 protein] decreases reaction
/ increases secretion
protein 16374615
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) plant extract, Houttuynia cordata inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 18325701
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL5 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein affects cotreatment
/ increases expression
protein 1371491
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL5 protein affects cotreatment
/ increases expression
protein 17572062
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) Tetradecanoylphorbol Acetate results in increased expression of IL5 mRNA increases expression
mRNA 16116958
D013755 3567 IL5
EDF
IL-5
TRF
interleukin 5 (colony-stimulating factor, eosinophil) Tetradecanoylphorbol Acetate results in increased secretion of IL5 protein increases secretion
protein 16374615
D013755 3568 IL5RA
CD125
CDw125
HSIL5R3
IL5R
interleukin 5 receptor, alpha Tetradecanoylphorbol Acetate results in decreased expression of IL5RA mRNA decreases expression
mRNA 8049355
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA affects cotreatment
/ increases expression
mRNA 21515303
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21515303
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 18958421
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL6 protein affects cotreatment
/ increases secretion
protein 17685462
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 protein affects cotreatment
/ increases expression
protein 17051331
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) monocyte locomotion inhibitory factor inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL6 protein] decreases reaction
/ increases secretion
protein 16374615
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL6 protein] decreases reaction
/ increases expression
protein 10072544
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19118619
19665545
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 19118619
19665545
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 17588137
18958421
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17588137
18958421
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 19416633
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19416633
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 18958421
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL6 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IL6 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of IL6 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) tepoxalin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL6 mRNA] decreases reaction
/ increases expression
mRNA 7759567
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein affects cotreatment
/ increases expression
/ increases secretion
protein 19416633
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA affects cotreatment
/ increases expression
mRNA 17588137
18958421
19118619
19416633
19665545
22322153
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein affects cotreatment
/ increases secretion
protein 17588137
18958421
19118619
19665545
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL6 mRNA affects cotreatment
/ increases expression
mRNA 18434080
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL6 protein affects cotreatment
/ increases expression
protein 17572062
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of IL6 mRNA] increases expression
/ increases reaction
mRNA 22643241
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased secretion of IL6 protein] increases reaction
/ increases secretion
protein 22643241
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Tetradecanoylphorbol Acetate results in increased expression of IL6 mRNA increases expression
mRNA 7759567
10428506
D013755 3569 IL6
BSF2
HGF
HSF
IFNB2
IL-6
interleukin 6 (interferon, beta 2) Tetradecanoylphorbol Acetate results in increased secretion of IL6 protein increases secretion
protein 16374615
19910455
D013755 3570 IL6R
CD126
IL-6R-1
IL-6RA
IL6Q
IL6RA
IL6RQ
gp80
interleukin 6 receptor [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL6R mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 16091123
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 16091123
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 1-Butanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 12039947
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 17366569
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 alpha-Tocopherol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 19135038
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 mRNA] increases expression
/ increases reaction
mRNA 20858459
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 beta Carotene promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL8 protein] increases reaction
/ increases secretion
protein 19135038
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL8 mRNA affects cotreatment
/ increases expression
mRNA 15286717
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL8 protein affects cotreatment
/ increases expression
protein 15286717
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Clenbuterol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 15502056
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [Zinc deficiency results in decreased expression of IL8 protein]] decreases expression
/ decreases reaction
protein 12812920
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 12812920
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [Zinc deficiency results in decreased expression of IL8 protein]] decreases expression
/ decreases reaction
protein 12812920
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of IL8 protein] decreases reaction
/ increases expression
/ increases secretion
protein 12765200
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 12765200
20858459
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Dobutamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 15502056
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Doxycycline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 16134060
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL8 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 18958421
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL8 protein affects cotreatment
/ increases secretion
protein 17685462
21075198
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 19135038
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 10072544
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL8 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19118619
19665545
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 19118619
19665545
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL8 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 17588137
18958421
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17588137
18958421
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 19135038
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 19416633
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL8 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19416633
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of IL8 protein] decreases reaction
/ increases expression
/ increases secretion
protein 12765200
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL8 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 18958421
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 16091123
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 mRNA] decreases reaction
/ increases expression
mRNA 16376386
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL8 protein] decreases reaction
/ increases secretion
protein 16376386
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL8 protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 16134060
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL8 protein affects cotreatment
/ increases expression
/ increases secretion
protein 19416633
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL8 mRNA affects cotreatment
/ increases expression
mRNA 17588137
18958421
19118619
19416633
19665545
22322153
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL8 protein affects cotreatment
/ increases secretion
protein 16134060
17588137
18958421
19118619
19665545
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL8 mRNA affects cotreatment
/ increases expression
mRNA 18434080
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL8 protein affects cotreatment
/ increases expression
protein 17572062
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Tetradecanoylphorbol Acetate inhibits the reaction [Zinc deficiency results in decreased expression of IL8 protein] decreases expression
/ decreases reaction
protein 12812920
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Tetradecanoylphorbol Acetate promotes the reaction [Lipopolysaccharides results in increased expression of IL8 mRNA] increases expression
/ increases reaction
mRNA 20920494
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Tetradecanoylphorbol Acetate promotes the reaction [Lipopolysaccharides results in increased expression of IL8 protein] increases expression
/ increases reaction
protein 20920494
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of IL8 protein increases expression
/ increases secretion
protein 12765200
19416633
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Tetradecanoylphorbol Acetate results in increased expression of IL8 mRNA increases expression
mRNA 12765200
16091123
16376386
17366569
20858459
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Tetradecanoylphorbol Acetate results in increased expression of IL8 protein increases expression
protein 9628260
12812920
15502056
16091123
D013755 3576 IL8
CXCL8
GCP-1
GCP1
LECT
LUCT
LYNAP
MDNCF
MONAP
NAF
NAP-1
NAP1
interleukin 8 Tetradecanoylphorbol Acetate results in increased secretion of IL8 protein increases secretion
protein 8006454
16376386
17366569
19135038
D013755 3581 IL9R
CD129
IL-9R
interleukin 9 receptor [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL9R mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 11213 IRAK3
ASRT5
IRAKM
interleukin-1 receptor-associated kinase 3 (EC:2.7.11.1) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IRAK3 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3662 IRF4
LSIRF
MUM1
NF-EM5
interferon regulatory factor 4 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IRF4 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3662 IRF4
LSIRF
MUM1
NF-EM5
interferon regulatory factor 4 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IRF4 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 3673 ITGA2
BR
CD49B
GPIa
HPA-5
VLA-2
VLAA2
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) Tetradecanoylphorbol Acetate results in increased expression of ITGA2 mRNA increases expression
mRNA 17669516
D013755 3674 ITGA2B
BDPLT16
BDPLT2
CD41
CD41B
GP2B
GPIIb
GT
GTA
HPA3
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) Tetradecanoylphorbol Acetate results in increased expression of ITGA2B protein increases expression
protein 10428506
D013755 3684 ITGAM
CD11B
CR3A
MAC-1
MAC1A
MO1A
SLEB6
integrin, alpha M (complement component 3 receptor 3 subunit) 4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] decreases reaction
/ increases localization
protein 10739673
D013755 3684 ITGAM
CD11B
CR3A
MAC-1
MAC1A
MO1A
SLEB6
integrin, alpha M (complement component 3 receptor 3 subunit) Tetradecanoylphorbol Acetate results in increased expression of ITGAM protein increases expression
protein 16430862
16617325
19135038
19428933
D013755 3684 ITGAM
CD11B
CR3A
MAC-1
MAC1A
MO1A
SLEB6
integrin, alpha M (complement component 3 receptor 3 subunit) Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein increases localization
protein 10739673
D013755 3684 ITGAM
CD11B
CR3A
MAC-1
MAC1A
MO1A
SLEB6
integrin, alpha M (complement component 3 receptor 3 subunit) Tosyllysine Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] decreases reaction
/ increases localization
protein 10739673
D013755 3684 ITGAM
CD11B
CR3A
MAC-1
MAC1A
MO1A
SLEB6
integrin, alpha M (complement component 3 receptor 3 subunit) Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of ITGAM protein] decreases reaction
/ increases localization
protein 10739673
D013755 3687 ITGAX
CD11C
SLEB6
integrin, alpha X (complement component 3 receptor 4 subunit) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ITGAX mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3689 ITGB2
CD18
LAD
LCAMB
LFA-1
MAC-1
MF17
MFI7
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) acteoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein] decreases reaction
/ increases expression
protein 16393473
D013755 3689 ITGB2
CD18
LAD
LCAMB
LFA-1
MAC-1
MF17
MFI7
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) crenatoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein] decreases reaction
/ increases expression
protein 16393473
D013755 3689 ITGB2
CD18
LAD
LCAMB
LFA-1
MAC-1
MF17
MFI7
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein] decreases reaction
/ increases expression
protein 16393473
D013755 3689 ITGB2
CD18
LAD
LCAMB
LFA-1
MAC-1
MF17
MFI7
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein increases expression
protein 16393473
D013755 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) tellimagrandin I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB3 protein] decreases reaction
/ increases expression
protein 14757314
D013755 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) Tetradecanoylphorbol Acetate results in increased expression of ITGB3 protein increases expression
protein 10910098
14757314
14769215
D013755 3694 ITGB6
integrin, beta 6 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ITGB6 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3713 IVL
involucrin Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IVL mRNA] decreases reaction
/ increases expression
mRNA 17148446
D013755 3713 IVL
involucrin Tetradecanoylphorbol Acetate results in increased expression of IVL mRNA increases expression
mRNA 17148446
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of JUN protein] affects localization
/ decreases reaction
protein 20590612
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of JUN protein] decreases reaction
/ increases activity
/ increases expression
protein 18628248
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of JUN protein] affects localization
/ decreases reaction
protein 20599481
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN protein]] affects cotreatment
/ decreases reaction
/ increases expression
/ increases reaction
protein 15477007
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN mRNA] decreases reaction
/ increases expression
mRNA 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN protein] decreases reaction
/ increases expression
protein 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of JUN protein] decreases reaction
/ increases activity
/ increases expression
protein 18628248
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased phosphorylation of JUN protein] decreases reaction
/ increases expression
/ increases phosphorylation
protein 18628248
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Capsaicin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 9580328
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of JUN protein] decreases reaction
/ increases activity
/ increases expression
protein 18628248
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN protein] decreases reaction
/ increases expression
protein 17148446
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of and results in increased phosphorylation of JUN protein] affects localization
/ decreases reaction
/ increases phosphorylation
protein 20152819
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene [FOS protein co-treated with JUN protein] inhibits the reaction [pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 protein]] affects cotreatment
/ decreases reaction
/ increases expression
protein 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of JUN protein] affects localization
/ decreases reaction
protein 20152819
21354279
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Heparin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of JUN protein] decreases reaction
/ increases activity
protein 1730747
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene JUN protein inhibits the reaction [ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]] decreases reaction
/ increases expression
protein 11278336
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]] affects binding
/ increases activity
/ increases reaction
protein 22561169
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN protein] increases expression
/ increases reaction
protein 22561169
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of JUN protein] increases phosphorylation
/ increases reaction
protein 22561169
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of JUN protein] decreases reaction
/ increases localization
protein 20082219
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Metformin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of JUN protein] affects localization
/ decreases reaction
protein 20590612
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Methohexital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15263067
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Pentobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15263067
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Pentosan Sulfuric Polyester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of JUN protein] decreases reaction
/ increases activity
protein 1730747
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene piperine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of JUN protein] affects localization
/ decreases reaction
protein 21354279
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of JUN protein] decreases reaction
/ increases phosphorylation
protein 21354279
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]] affects binding
/ decreases reaction
/ increases reaction
protein 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN mRNA] decreases reaction
/ increases expression
mRNA 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN protein] decreases reaction
/ increases expression
protein 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN protein] affects cotreatment
/ increases expression
/ increases reaction
protein 15477007
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased phosphorylation of JUN protein] decreases reaction
/ increases expression
/ increases phosphorylation
protein 18628248
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of JUN protein] affects localization
/ decreases reaction
protein 20599481
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of JUN protein] decreases reaction
/ increases activity
/ increases expression
protein 18628248
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased phosphorylation of JUN protein] decreases reaction
/ increases expression
/ increases phosphorylation
protein 18628248
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Secobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15263067
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate affects the localization of and results in increased phosphorylation of JUN protein affects localization
/ increases phosphorylation
protein 20152819
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate affects the localization of JUN protein affects localization
protein 20590612
20599481
21354279
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which binds to DPYD promoter] affects binding
/ affects cotreatment
/ increases reaction
protein 15705907
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of DPYD mRNA] affects binding
/ affects cotreatment
/ increases expression
/ increases reaction
protein 15705907
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN mRNA affects cotreatment
/ increases expression
mRNA 15263067
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN protein affects cotreatment
/ increases expression
protein 9580328
15477007
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter] affects binding
/ increases reaction
protein 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate promotes the reaction [JUN protein binds to CYP1A2 enhancer] affects binding
/ increases reaction
protein 10620351
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate promotes the reaction [Mitoxantrone results in increased expression of JUN mRNA] increases expression
/ increases reaction
mRNA 8219202
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate results in increased activity of JUN protein increases activity
protein 1730747
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein] affects binding
/ increases activity
protein 16116958
22561169
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate results in increased expression of and results in increased phosphorylation of JUN protein increases expression
/ increases phosphorylation
protein 18628248
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate results in increased expression of JUN mRNA increases expression
mRNA 8219202
17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate results in increased expression of JUN protein increases expression
protein 17148446
19969058
22561169
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate results in increased expression of JUN protein modified form increases expression
protein 17360982
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate results in increased localization of JUN protein increases localization
protein 20082219
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Tetradecanoylphorbol Acetate results in increased phosphorylation of JUN protein increases phosphorylation
protein 21354279
22561169
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Thiamylal inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15263067
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene Thiopental inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15263067
D013755 3725 JUN
AP-1
AP1
c-Jun
jun proto-oncogene W 7 inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of JUN protein] affects localization
/ decreases reaction
protein 20590612
D013755 3726 JUNB
AP-1
jun B proto-oncogene 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUNB] decreases reaction
/ increases expression
15666830
D013755 3726 JUNB
AP-1
jun B proto-oncogene benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUNB protein]] decreases reaction
/ increases expression
protein 17148446
D013755 3726 JUNB
AP-1
jun B proto-oncogene Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [FOSL1 protein binds to JUNB protein]] affects binding
/ decreases reaction
/ increases reaction
protein 17148446
D013755 3726 JUNB
AP-1
jun B proto-oncogene Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUNB protein] decreases reaction
/ increases expression
protein 17148446
D013755 3726 JUNB
AP-1
jun B proto-oncogene Tetradecanoylphorbol Acetate promotes the reaction [FOSL1 protein binds to JUNB protein] affects binding
/ increases reaction
protein 17148446
D013755 3726 JUNB
AP-1
jun B proto-oncogene Tetradecanoylphorbol Acetate results in increased expression of JUNB increases expression
15666830
D013755 3726 JUNB
AP-1
jun B proto-oncogene Tetradecanoylphorbol Acetate results in increased expression of JUNB mRNA increases expression
mRNA 8631129
D013755 3726 JUNB
AP-1
jun B proto-oncogene Tetradecanoylphorbol Acetate results in increased expression of JUNB protein increases expression
protein 17148446
D013755 3727 JUND
AP-1
jun D proto-oncogene Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUND protein] decreases reaction
/ increases expression
protein 17148446
D013755 3727 JUND
AP-1
jun D proto-oncogene Tetradecanoylphorbol Acetate promotes the reaction [JUND protein binds to CYP1A2 enhancer] affects binding
/ increases reaction
protein 10620351
D013755 3727 JUND
AP-1
jun D proto-oncogene Tetradecanoylphorbol Acetate results in increased expression of JUND protein increases expression
protein 17148446
D013755 3752 KCND3
KCND3L
KCND3S
KSHIVB
KV4.3
SCA19
SCA22
potassium voltage-gated channel, Shal-related subfamily, member 3 Tetradecanoylphorbol Acetate results in decreased activity of KCND3 protein alternative form decreases activity
protein 11709419
D013755 10112 KIF20A
MKLP2
RAB6KIFL
kinesin family member 20A [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of KIF20A mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 9585 KIF20B
CT90
KRMP1
MPHOSPH1
MPP-1
MPP1
kinesin family member 20B Tetradecanoylphorbol Acetate results in increased expression of KIF20B mRNA increases expression
mRNA 19031421
D013755 9493 KIF23
CHO1
KNSL5
MKLP-1
MKLP1
kinesin family member 23 Tetradecanoylphorbol Acetate results in increased expression of KIF23 mRNA increases expression
mRNA 19031421
D013755 11004 KIF2C
KNSL6
MCAK
kinesin family member 2C Tetradecanoylphorbol Acetate results in increased expression of KIF2C mRNA increases expression
mRNA 19031421
D013755 11278 KLF12
AP-2rep
AP2REP
Kruppel-like factor 12 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of KLF12 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 9314 KLF4
EZF
GKLF
Kruppel-like factor 4 (gut) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of KLF4 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 9314 KLF4
EZF
GKLF
Kruppel-like factor 4 (gut) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of KLF4 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 1316 KLF6
BCD1
CBA1
COPEB
CPBP
GBF
PAC1
ST12
ZF9
Kruppel-like factor 6 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of KLF6 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 1316 KLF6
BCD1
CBA1
COPEB
CPBP
GBF
PAC1
ST12
ZF9
Kruppel-like factor 6 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of KLF6 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 3845 KRAS
C-K-RAS
CFC2
K-RAS2A
K-RAS2B
K-RAS4A
K-RAS4B
KI-RAS
KRAS1
KRAS2
NS
NS3
RASK2
Kirsten rat sarcoma viral oncogene homolog Methohexital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 15263067
D013755 3845 KRAS
C-K-RAS
CFC2
K-RAS2A
K-RAS2B
K-RAS4A
K-RAS4B
KI-RAS
KRAS1
KRAS2
NS
NS3
RASK2
Kirsten rat sarcoma viral oncogene homolog Pentobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 15263067
D013755 3845 KRAS
C-K-RAS
CFC2
K-RAS2A
K-RAS2B
K-RAS4A
K-RAS4B
KI-RAS
KRAS1
KRAS2
NS
NS3
RASK2
Kirsten rat sarcoma viral oncogene homolog Secobarbital inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 15263067
D013755 3845 KRAS
C-K-RAS
CFC2
K-RAS2A
K-RAS2B
K-RAS4A
K-RAS4B
KI-RAS
KRAS1
KRAS2
NS
NS3
RASK2
Kirsten rat sarcoma viral oncogene homolog Thiamylal inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of KRAS protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 15263067
D013755 3912 LAMB1
CLM
LIS5
laminin, beta 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LAMB1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3936 LCP1
CP64
L-PLASTIN
LC64P
LPL
PLS2
lymphocyte cytosolic protein 1 (L-plastin) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of LCP1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 3936 LCP1
CP64
L-PLASTIN
LC64P
LPL
PLS2
lymphocyte cytosolic protein 1 (L-plastin) KT 5926 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of LCP1 protein] decreases reaction
/ increases phosphorylation
protein 14769871
D013755 3936 LCP1
CP64
L-PLASTIN
LC64P
LPL
PLS2
lymphocyte cytosolic protein 1 (L-plastin) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of LCP1 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 3936 LCP1
CP64
L-PLASTIN
LC64P
LPL
PLS2
lymphocyte cytosolic protein 1 (L-plastin) Tetradecanoylphorbol Acetate results in increased phosphorylation of LCP1 protein increases phosphorylation
protein 14769871
D013755 3976 LIF
CDF
DIA
HILDA
MLPLI
leukemia inhibitory factor [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LIF mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4005 LMO2
RBTN2
RBTNL1
RHOM2
TTG2
LIM domain only 2 (rhombotin-like 1) Tetradecanoylphorbol Acetate results in increased expression of LMO2 mRNA increases expression
mRNA 7544155
D013755 4008 LMO7
FBX20
FBXO20
LOMP
LIM domain 7 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LMO7 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4023 LPL
HDLCQ11
LIPD
lipoprotein lipase (EC:3.1.1.34) Tetradecanoylphorbol Acetate results in increased expression of LPL protein increases expression
protein 18435438
D013755 4035 LRP1
A2MR
APOER
APR
CD91
IGFBP3R
LRP
LRP1A
TGFBR5
low density lipoprotein receptor-related protein 1 Tetradecanoylphorbol Acetate results in increased expression of LRP1 mRNA increases expression
mRNA 15910848
D013755 4035 LRP1
A2MR
APOER
APR
CD91
IGFBP3R
LRP
LRP1A
TGFBR5
low density lipoprotein receptor-related protein 1 Tetradecanoylphorbol Acetate results in increased expression of LRP1 protein increases expression
protein 15910848
D013755 4035 LRP1
A2MR
APOER
APR
CD91
IGFBP3R
LRP
LRP1A
TGFBR5
low density lipoprotein receptor-related protein 1 very low density lipoprotein triglyceride promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of LRP1 mRNA] increases expression
/ increases reaction
mRNA 15910848
D013755 8425 LTBP4
ARCL1C
LTBP-4
LTBP4L
LTBP4S
latent transforming growth factor beta binding protein 4 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LTBP4 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 8425 LTBP4
ARCL1C
LTBP-4
LTBP4L
LTBP4S
latent transforming growth factor beta binding protein 4 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LTBP4 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 8425 LTBP4
ARCL1C
LTBP-4
LTBP4L
LTBP4S
latent transforming growth factor beta binding protein 4 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LTBP4 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 8379 MAD1L1
MAD1
PIG9
TP53I9
TXBP181
MAD1 mitotic arrest deficient-like 1 (yeast) Tetradecanoylphorbol Acetate results in increased expression of MAD1L1 mRNA increases expression
mRNA 19031421
D013755 4085 MAD2L1
HSMAD2
MAD2
MAD2 mitotic arrest deficient-like 1 (yeast) Tetradecanoylphorbol Acetate results in increased expression of MAD2L1 mRNA increases expression
mRNA 19031421
D013755 81631 MAP1LC3B
ATG8F
LC3B
MAP1A/1BLC3
MAP1LC3B-a
microtubule-associated protein 1 light chain 3 beta 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] decreases reaction
/ increases expression
protein 20479004
D013755 81631 MAP1LC3B
ATG8F
LC3B
MAP1A/1BLC3
MAP1LC3B-a
microtubule-associated protein 1 light chain 3 beta E2F4 protein promotes the reaction [PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]] increases expression
/ increases reaction
protein 20479004
D013755 81631 MAP1LC3B
ATG8F
LC3B
MAP1A/1BLC3
MAP1LC3B-a
microtubule-associated protein 1 light chain 3 beta E2F4 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] increases expression
/ increases reaction
protein 20479004
D013755 81631 MAP1LC3B
ATG8F
LC3B
MAP1A/1BLC3
MAP1LC3B-a
microtubule-associated protein 1 light chain 3 beta EGR1 protein promotes the reaction [PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]] increases expression
/ increases reaction
protein 20479004
D013755 81631 MAP1LC3B
ATG8F
LC3B
MAP1A/1BLC3
MAP1LC3B-a
microtubule-associated protein 1 light chain 3 beta EGR1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] increases expression
/ increases reaction
protein 20479004
D013755 81631 MAP1LC3B
ATG8F
LC3B
MAP1A/1BLC3
MAP1LC3B-a
microtubule-associated protein 1 light chain 3 beta juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] decreases reaction
/ increases expression
protein 20479004
D013755 81631 MAP1LC3B
ATG8F
LC3B
MAP1A/1BLC3
MAP1LC3B-a
microtubule-associated protein 1 light chain 3 beta PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] increases expression
/ increases reaction
protein 20479004
D013755 81631 MAP1LC3B
ATG8F
LC3B
MAP1A/1BLC3
MAP1LC3B-a
microtubule-associated protein 1 light chain 3 beta Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein increases expression
protein 20479004
D013755 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Reactive Oxygen Species] decreases activity
/ decreases reaction
/ increases abundance
protein 16945329
D013755 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] decreases activity
/ decreases reaction
/ increases expression
protein 16945329
D013755 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) MAP2K1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] affects reaction
/ increases expression
protein 16945329
D013755 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K1 protein] increases phosphorylation
/ increases reaction
protein 20479004
D013755 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAP2K1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 11861786
D013755 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K1 protein increases phosphorylation
protein 20479004
D013755 5605 MAP2K2
CFC4
MAPKK2
MEK2
MKK2
PRKMK2
mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K2 protein] increases phosphorylation
/ increases reaction
protein 20479004
D013755 5605 MAP2K2
CFC4
MAPKK2
MEK2
MKK2
PRKMK2
mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of MAP2K2 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 5605 MAP2K2
CFC4
MAPKK2
MEK2
MKK2
PRKMK2
mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of MAP2K2 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 5605 MAP2K2
CFC4
MAPKK2
MEK2
MKK2
PRKMK2
mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAP2K2 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 11861786
D013755 5605 MAP2K2
CFC4
MAPKK2
MEK2
MKK2
PRKMK2
mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K2 protein increases phosphorylation
protein 20479004
D013755 9020 MAP3K14
FTDCR1B
HS
HSNIK
NIK
mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25) Tetradecanoylphorbol Acetate results in increased expression of MAP3K14 mRNA increases expression
mRNA 10910055
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14610070
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 19416633
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
protein 9545260
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16091123
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 12781867
18628248
19945525
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
protein 11728381
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 20599481
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 22245252
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 15978937
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK1 protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 14610070
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of MAPK1 protein]] affects cotreatment
/ decreases reaction
/ increases phosphorylation
/ increases reaction
protein 15477007
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Bee Venoms promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 19969058
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) bisindolylmaleimide I inhibits the reaction [[arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14610070
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 18628248
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 12761878
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 20152819
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 15978937
19804834
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAPK1 protein] decreases reaction
/ increases expression
protein 19375915
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 20188714
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 20152819
21354279
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) MAPK1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] increases expression
/ increases reaction
protein 17767925
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 20082219
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] increases phosphorylation
/ increases reaction
protein 20479004
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 21354279
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] affects cotreatment
/ increases activity
/ increases phosphorylation
/ increases reaction
protein 18423386
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 19447859
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of MAPK1 protein] affects cotreatment
/ increases phosphorylation
/ increases reaction
protein 15477007
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 18628248
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] affects reaction
/ increases phosphorylation
protein 19804834
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 19416633
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 18647594
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [resveratrol results in decreased activity of MAPK1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases activity
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 18628248
20599481
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein affects cotreatment
/ increases phosphorylation
protein 19416633
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 18423386
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of MAPK1 protein affects cotreatment
/ increases phosphorylation
protein 15477007
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) [Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased phosphorylation of MAPK1 protein affects cotreatment
/ increases phosphorylation
protein 12115659
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
protein 17309078
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 11861786
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK1 protein] affects localization
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 15542774
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate promotes the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 14610070
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate promotes the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK1 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 14610070
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] increases phosphorylation
/ increases reaction
protein 16251475
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased activity of MAPK1 protein increases activity
protein 9545260
11728381
17309078
17767925
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased expression of MAPK1 increases expression
15666830
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased expression of MAPK1 protein increases expression
protein 19375915
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of MAPK1 protein increases activity
/ increases localization
protein 21375462
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein increases activity
/ increases phosphorylation
protein 12761878
14610070
14739659
16091123
19969058
20082219
21107699
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein increases phosphorylation
protein 9728050
12781867
15728660
15978937
16838270
18628248
18647594
19447859
19804834
19945525
20152819
20188714
20479004
20590612
20599481
21295103
21354279
22245252
22353212
22561169
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) U 0126 inhibits the reaction [[arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK1 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14610070
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 5594 MAPK1
ERK
ERK2
ERT1
MAPK2
P42MAPK
PRKM1
PRKM2
p38
p40
p41
p41mapk
mitogen-activated protein kinase 1 (EC:2.7.11.24) wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] decreases reaction
/ increases phosphorylation
protein 21295103
D013755 1432 MAPK14
CSBP
CSBP1
CSBP2
CSPB1
EXIP
Mxi2
PRKM14
PRKM15
RK
SAPK2A
p38
p38ALPHA
mitogen-activated protein kinase 14 (EC:2.7.11.24) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]] decreases reaction
/ increases activity
/ increases phosphorylation
/ increases reaction
protein 14610070
D013755 1432 MAPK14
CSBP
CSBP1
CSBP2
CSPB1
EXIP
Mxi2
PRKM14
PRKM15
RK
SAPK2A
p38
p38ALPHA
mitogen-activated protein kinase 14 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein] decreases reaction
/ increases activity
protein 17309078
D013755 1432 MAPK14
CSBP
CSBP1
CSBP2
CSPB1
EXIP
Mxi2
PRKM14
PRKM15
RK
SAPK2A
p38
p38ALPHA
mitogen-activated protein kinase 14 (EC:2.7.11.24) Tetradecanoylphorbol Acetate promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 14610070
D013755 1432 MAPK14
CSBP
CSBP1
CSBP2
CSPB1
EXIP
Mxi2
PRKM14
PRKM15
RK
SAPK2A
p38
p38ALPHA
mitogen-activated protein kinase 14 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased activity of MAPK14 protein increases activity
protein 12781867
15949478
17309078
D013755 1432 MAPK14
CSBP
CSBP1
CSBP2
CSPB1
EXIP
Mxi2
PRKM14
PRKM15
RK
SAPK2A
p38
p38ALPHA
mitogen-activated protein kinase 14 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK14 protein increases phosphorylation
protein 16838270
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14610070
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 19416633
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
protein 9545260
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 16091123
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 12781867
18628248
19945525
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
protein 11728381
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 20599481
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 22245252
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 15978937
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK3 protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 14610070
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of MAPK3 protein]] affects cotreatment
/ decreases reaction
/ increases phosphorylation
/ increases reaction
protein 15477007
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Bee Venoms promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 19969058
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) bisindolylmaleimide I inhibits the reaction [[arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14610070
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 18628248
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 12761878
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 20152819
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 15978937
19804834
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAPK3 protein] decreases reaction
/ increases expression
protein 19375915
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 20188714
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 20152819
21354279
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) MAPK3 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] increases expression
/ increases reaction
protein 17767925
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 20082219
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] increases phosphorylation
/ increases reaction
protein 20479004
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 21354279
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK3 protein] affects cotreatment
/ increases activity
/ increases phosphorylation
/ increases reaction
protein 18423386
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 19447859
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of MAPK3 protein] affects cotreatment
/ increases phosphorylation
/ increases reaction
protein 15477007
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 18628248
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] affects reaction
/ increases phosphorylation
protein 19804834
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 19416633
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 18647594
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [resveratrol results in decreased activity of MAPK1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases activity
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [resveratrol results in decreased activity of MAPK3 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases activity
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14739659
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 18628248
20599481
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein affects cotreatment
/ increases phosphorylation
protein 19416633
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK3 protein affects cotreatment
/ increases activity
/ increases phosphorylation
protein 18423386
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of MAPK3 protein affects cotreatment
/ increases phosphorylation
protein 15477007
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) [Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased phosphorylation of MAPK3 protein affects cotreatment
/ increases phosphorylation
protein 12115659
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
protein 17309078
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein] decreases reaction
/ increases activity
/ increases phosphorylation
protein 11861786
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of MAPK3 protein] affects localization
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 15542774
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate promotes the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 14610070
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate promotes the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK3 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 14610070
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate promotes the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein] increases phosphorylation
/ increases reaction
protein 16251475
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased activity of MAPK3 protein increases activity
protein 9545260
11728381
17309078
17767925
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased expression of MAPK3 increases expression
15666830
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased expression of MAPK3 protein increases expression
protein 19375915
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of MAPK3 protein increases activity
/ increases localization
protein 21375462
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein increases activity
/ increases phosphorylation
protein 12761878
14610070
14739659
16091123
19969058
20082219
21107699
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein increases phosphorylation
protein 12781867
15728660
15978937
16838270
18628248
18647594
19447859
19804834
19945525
20152819
20188714
20479004
20590612
20599481
21295103
21354279
22245252
22353212
22561169
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) U 0126 inhibits the reaction [[arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK3 protein] affects cotreatment
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 14610070
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 5595 MAPK3
ERK-1
ERK1
ERT2
HS44KDAP
HUMKER1A
P44ERK1
P44MAPK
PRKM3
p44-ERK1
p44-MAPK
mitogen-activated protein kinase 3 (EC:2.7.11.24) wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] decreases reaction
/ increases phosphorylation
protein 21295103
D013755 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein]] decreases reaction
/ increases activity
/ increases phosphorylation
/ increases reaction
protein 14610070
D013755 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK8 protein] decreases reaction
/ increases phosphorylation
protein 19447859
D013755 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK8 protein] decreases reaction
/ increases phosphorylation
protein 20599481
D013755 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) Tetradecanoylphorbol Acetate promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein] increases activity
/ increases phosphorylation
/ increases reaction
protein 14610070
D013755 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK8 protein increases phosphorylation
protein 16838270
19447859
20599481
21354279
22353212
D013755 5601 MAPK9
JNK-55
JNK2
JNK2A
JNK2ALPHA
JNK2B
JNK2BETA
PRKM9
SAPK
SAPK1a
p54a
p54aSAPK
mitogen-activated protein kinase 9 (EC:2.7.11.24) Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] increases phosphorylation
/ increases reaction
protein 22561169
D013755 5601 MAPK9
JNK-55
JNK2
JNK2A
JNK2ALPHA
JNK2B
JNK2BETA
PRKM9
SAPK
SAPK1a
p54a
p54aSAPK
mitogen-activated protein kinase 9 (EC:2.7.11.24) pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] decreases reaction
/ increases phosphorylation
protein 19447859
D013755 5601 MAPK9
JNK-55
JNK2
JNK2A
JNK2ALPHA
JNK2B
JNK2BETA
PRKM9
SAPK
SAPK1a
p54a
p54aSAPK
mitogen-activated protein kinase 9 (EC:2.7.11.24) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] decreases reaction
/ increases phosphorylation
protein 20599481
D013755 5601 MAPK9
JNK-55
JNK2
JNK2A
JNK2ALPHA
JNK2B
JNK2BETA
PRKM9
SAPK
SAPK1a
p54a
p54aSAPK
mitogen-activated protein kinase 9 (EC:2.7.11.24) Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein increases phosphorylation
protein 16838270
19447859
20599481
21354279
22353212
22561169
D013755 9261 MAPKAPK2
MAPKAP-K2
MK-2
MK2
mitogen-activated protein kinase-activated protein kinase 2 (EC:2.7.11.1) Tetradecanoylphorbol Acetate results in increased activity of MAPKAPK2 protein increases activity
protein 9545260
D013755 4153 MBL2
COLEC1
HSMBPC
MBL
MBL2D
MBP
MBP-C
MBP1
MBPD
mannose-binding lectin (protein C) 2, soluble [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of MBL2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4223 MEOX2
GAX
MOX2
mesenchyme homeobox 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of MEOX2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 10461 MERTK
MER
RP38
c-mer
c-mer proto-oncogene tyrosine kinase (EC:2.7.10.1) Tetradecanoylphorbol Acetate results in increased cleavage of MERTK protein increases cleavage
protein 17047157
D013755 4255 MGMT
O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects cotreatment
/ decreases response to substance
protein 12663516
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with SB 203580] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MKNK1 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 12781867
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MKNK1 protein] decreases reaction
/ increases activity
protein 9545260
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MKNK1 protein] decreases reaction
/ increases phosphorylation
protein 12781867
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MKNK1 protein]] decreases reaction
/ increases activity
/ increases reaction
protein 9545260
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MKNK1 protein] decreases reaction
/ increases activity
protein 9545260
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) SB 203580 promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MKNK1 protein]] decreases reaction
/ increases activity
/ increases reaction
protein 9545260
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) Tetradecanoylphorbol Acetate results in increased activity of MKNK1 protein increases activity
protein 9545260
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) Tetradecanoylphorbol Acetate results in increased phosphorylation of MKNK1 protein increases phosphorylation
protein 12781867
D013755 8569 MKNK1
MNK1
MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MKNK1 protein] decreases reaction
/ increases phosphorylation
protein 12781867
D013755 4311 MME
CALLA
CD10
NEP
SFE
membrane metallo-endopeptidase (EC:3.4.24.11) Tetradecanoylphorbol Acetate results in decreased expression of MME protein decreases expression
protein 16997790
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 mRNA] increases expression
/ increases reaction
mRNA 20858459
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 mRNA] decreases reaction
/ increases expression
mRNA 20858459
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 mRNA] decreases reaction
/ increases expression
mRNA 20004183
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) Tetradecanoylphorbol Acetate results in increased expression of MMP1 mRNA increases expression
mRNA 16176868
20004183
20858459
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) Tetradecanoylphorbol Acetate results in increased expression of MMP1 protein increases expression
protein 20004183
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) Tretinoin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 mRNA] decreases reaction
/ increases expression
mRNA 16176868
D013755 4312 MMP1
CLG
CLGN
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP13 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP13 mRNA] decreases reaction
/ increases expression
mRNA 19656660
D013755 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP13 mRNA] decreases reaction
/ increases expression
mRNA 20004183
D013755 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP13 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP13 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) Tetradecanoylphorbol Acetate results in increased expression of MMP13 mRNA increases expression
mRNA 19656660
20004183
D013755 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) Tetradecanoylphorbol Acetate results in increased expression of MMP13 protein increases expression
protein 20004183
D013755 4322 MMP13
CLG3
MANDP1
matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP13 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4323 MMP14
MMP-14
MMP-X1
MT-MMP
MT-MMP_1
MT1-MMP
MT1MMP
MTMMP1
WNCHRS
matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP14 mRNA] decreases reaction
/ increases expression
mRNA 20599481
D013755 4323 MMP14
MMP-14
MMP-X1
MT-MMP
MT-MMP_1
MT1-MMP
MT1MMP
MTMMP1
WNCHRS
matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP14 mRNA] decreases reaction
/ increases expression
mRNA 20152819
D013755 4323 MMP14
MMP-14
MMP-X1
MT-MMP
MT-MMP_1
MT1-MMP
MT1MMP
MTMMP1
WNCHRS
matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP14 protein] decreases reaction
/ increases expression
protein 20152819
D013755 4323 MMP14
MMP-14
MMP-X1
MT-MMP
MT-MMP_1
MT1-MMP
MT1MMP
MTMMP1
WNCHRS
matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP14 mRNA] decreases reaction
/ increases expression
mRNA 21354279
D013755 4323 MMP14
MMP-14
MMP-X1
MT-MMP
MT-MMP_1
MT1-MMP
MT1MMP
MTMMP1
WNCHRS
matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP14 protein] decreases reaction
/ increases expression
protein 21354279
D013755 4323 MMP14
MMP-14
MMP-X1
MT-MMP
MT-MMP_1
MT1-MMP
MT1MMP
MTMMP1
WNCHRS
matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) Tetradecanoylphorbol Acetate results in increased expression of MMP14 mRNA increases expression
mRNA 20152819
20599481
21354279
D013755 4323 MMP14
MMP-14
MMP-X1
MT-MMP
MT-MMP_1
MT1-MMP
MT1MMP
MTMMP1
WNCHRS
matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) Tetradecanoylphorbol Acetate results in increased expression of MMP14 protein increases expression
protein 20152819
21354279
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] decreases reaction
/ increases activity
protein 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 protein] decreases reaction
/ increases expression
protein 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] decreases reaction
/ increases activity
protein 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP2 protein] decreases reaction
/ increases secretion
protein 15962302
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] decreases reaction
/ increases activity
protein 20152819
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 20152819
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP2 protein] decreases reaction
/ increases activity
/ increases expression
protein 19375915
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 protein] decreases reaction
/ increases expression
protein 17498959
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP2 protein] decreases reaction
/ increases activity
/ increases expression
protein 19375915
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 19375915
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 17498959
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 protein] decreases reaction
/ increases expression
protein 17498959
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 protein] decreases reaction
/ increases expression
protein 20590612
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) oxophenylarsine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 protein] decreases reaction
/ increases expression
protein 10569804
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] decreases reaction
/ increases activity
protein 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] decreases reaction
/ increases activity
protein 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein increases activity
protein 20152819
20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP2 protein increases activity
/ increases expression
protein 19375915
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA increases expression
mRNA 17498959
18155510
19375915
20152819
20590612
20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Tetradecanoylphorbol Acetate results in increased expression of MMP2 protein increases expression
protein 10569804
17498959
20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Tetradecanoylphorbol Acetate results in increased secretion of MMP2 protein increases secretion
protein 15962302
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 18155510
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein] decreases reaction
/ increases activity
protein 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] decreases reaction
/ increases expression
mRNA 20599481
D013755 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) Vanadates inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 protein] decreases reaction
/ increases expression
protein 10569804
D013755 118856 MMP21
MMP-21
matrix metallopeptidase 21 Tetradecanoylphorbol Acetate results in increased expression of MMP21 mRNA increases expression
mRNA 16984259
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 mRNA] increases expression
/ increases reaction
mRNA 20858459
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 mRNA] decreases reaction
/ increases expression
mRNA 20858459
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 mRNA] decreases reaction
/ increases expression
mRNA 20004183
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) Tetradecanoylphorbol Acetate results in increased expression of MMP3 mRNA increases expression
mRNA 16176868
20004183
20858459
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) Tetradecanoylphorbol Acetate results in increased expression of MMP3 protein increases expression
protein 20004183
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) Tretinoin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 mRNA] decreases reaction
/ increases expression
mRNA 16176868
D013755 4314 MMP3
CHDS6
MMP-3
SL-1
STMY
STMY1
STR1
matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4317 MMP8
CLG1
HNC
MMP-8
PMNL-CL
matrix metallopeptidase 8 (neutrophil collagenase) (EC:3.4.24.34) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of MMP8 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 21454668
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 21454668
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 20590612
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 20590612
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19447859
19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 18628248
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 12745093
15728660
21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19447859
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-chloro-5-nitrobenzanilide inhibits the reaction [10-nitro-oleic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]] decreases reaction
/ increases secretion
protein 21454668
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] decreases reaction
/ increases activity
protein 17055343
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]] decreases reaction
/ increases activity
protein 17055343
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 20599481
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 20599481
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 20599481
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 3-caffeoyl-4-dihydrocaffeoylquinic acid promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 20599481
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19447859
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 20152819
21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 20152819
21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine promotes the reaction [Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]] decreases reaction
/ increases expression
/ increases reaction
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 22245252
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19447859
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases secretion
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 22634262
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 22634262
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 15962302
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) atorvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 15728660
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Bee Venoms inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 19969058
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19447859
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 12745093
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) CAMK1 mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 20590612
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 18628248
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 20152819
20599481
21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 20152819
21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Curcumin promotes the reaction [3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 20599481
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Curcumin promotes the reaction [4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Curcumin promotes the reaction [4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]] decreases reaction
/ increases expression
/ increases reaction
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 19375915
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Doxycycline inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 17498959
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]] decreases reaction
/ increases expression
mRNA 15728660
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]] decreases reaction
/ increases secretion
protein 15728660
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 19375915
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 19375915
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 17498959
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 17498959
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) glycitein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 20188714
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases secretion
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Hesperidin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 20138977
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 19969058
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein] decreases reaction
/ increases expression
/ increases secretion
protein 20082219
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 20082219
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 20590612
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 20590612
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 20590612
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]] decreases reaction
/ increases secretion
protein 15728660
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) N-2-(4-bromophenyl) ethyl caffeamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 20093109
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) oxophenylarsine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 10569804
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 17055343
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 22634262
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 22634262
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 19447859
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 19447859
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 18628248
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 18628248
22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] affects reaction
/ increases activity
protein 19804834
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 17055343
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 22523472
22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 22523472
22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 21454668
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 21454668
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases secretion
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 15728660
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Simvastatin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 15728660
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Sulfasalazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 12745093
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of MMP9 protein increases activity
/ increases expression
protein 14627504
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein increases activity
protein 17055343
19804834
20590612
20599481
22634262
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein increases activity
/ increases expression
protein 18628248
19375915
19447859
19969058
21295103
22245252
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein increases expression
/ increases secretion
protein 20082219
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA increases expression
mRNA 10569804
12745093
14627504
15728660
16574429
17498959
18155510
18628248
19205902
19375915
19447859
19804834
20082219
20138977
20152819
20590612
20599481
21354279
21454668
22523472
22595400
22634262
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein increases expression
protein 10569804
17498959
20093109
20152819
20590612
20599481
21354279
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein increases activity
/ increases secretion
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein increases secretion
protein 12745093
15728660
15962302
20188714
20590612
21354279
21454668
22523472
22595400
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 18155510
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases secretion
protein 20152819
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 12745093
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Vanadates inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] decreases reaction
/ increases expression
mRNA 10569804
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Vanadates inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein] decreases reaction
/ increases expression
protein 10569804
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein] decreases reaction
/ increases activity
protein 20590612
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) W 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 20590612
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein] decreases reaction
/ increases activity
/ increases expression
protein 21295103
D013755 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) Y 27632 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein] decreases reaction
/ increases secretion
protein 15728660
D013755 4353 MPO
myeloperoxidase (EC:1.11.2.2) carvedilol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MPO protein] decreases reaction
/ increases secretion
protein 16601795
18987595
D013755 4353 MPO
myeloperoxidase (EC:1.11.2.2) CMI 392 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MPO protein] decreases reaction
/ increases activity
protein 11529688
D013755 4353 MPO
myeloperoxidase (EC:1.11.2.2) Potassium Cyanide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MPO protein] decreases reaction
/ increases activity
protein 3030588
D013755 4353 MPO
myeloperoxidase (EC:1.11.2.2) Tetradecanoylphorbol Acetate promotes the reaction [MPO protein results in increased oxidation of 1,2-diaminobenzene] increases oxidation
/ increases reaction
protein 3030588
D013755 4353 MPO
myeloperoxidase (EC:1.11.2.2) Tetradecanoylphorbol Acetate results in increased activity of MPO protein increases activity
protein 3030588
11529688
D013755 4353 MPO
myeloperoxidase (EC:1.11.2.2) Tetradecanoylphorbol Acetate results in increased secretion of MPO protein increases secretion
protein 16601795
18987595
D013755 10232 MSLN
MPF
SMRP
mesothelin [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of MSLN mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 acetovanillone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 21315065
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 Deferoxamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 Rotenone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 tamibarotene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 16484594
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 TEMPO inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 TEMPO inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form] decreases reaction
/ increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA increases expression
mRNA 9614211
16484594
21315065
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form increases expression
mRNA 9614211
D013755 4481 MSR1
CD204
SCARA1
SR-A
SRA
phSR1
phSR2
macrophage scavenger receptor 1 Thioctic Acid inhibits the reaction [arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA]] decreases reaction
/ increases expression
mRNA 21315065
D013755 4502 MT2A
MT2
metallothionein 2A BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA] decreases reaction
/ increases expression
mRNA 20858459
D013755 4502 MT2A
MT2
metallothionein 2A [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MT2A mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 4502 MT2A
MT2
metallothionein 2A Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA increases expression
mRNA 20858459
D013755 4582 MUC1
CA_15-3
CD227
EMA
H23AG
KL-6
MAM6
MCKD1
MUC-1
MUC-1/SEC
MUC-1/X
MUC1/ZD
PEM
PEMT
PUM
mucin 1, cell surface associated [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of MUC1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of MYC mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog catechol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MYC protein] decreases reaction
/ increases expression
protein 12749906
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog Glucose affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of MYC mRNA] affects reaction
/ increases expression
mRNA 2558650
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog hydroquinone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MYC protein] decreases reaction
/ increases expression
protein 12749906
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of MYC mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of MYC mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog Tetradecanoylphorbol Acetate promotes the reaction [Mitoxantrone results in decreased expression of MYC mRNA] decreases expression
/ increases reaction
mRNA 8219202
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog Tetradecanoylphorbol Acetate results in decreased expression of MYC mRNA decreases expression
mRNA 8219202
10739673
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog Tetradecanoylphorbol Acetate results in increased expression of MYC mRNA increases expression
mRNA 2558650
D013755 4609 MYC
MRTL
MYCC
bHLHe39
c-Myc
v-myc avian myelocytomatosis viral oncogene homolog Tetradecanoylphorbol Acetate results in increased expression of MYC protein increases expression
protein 12749906
15949478
D013755 7593 MZF1
MZF-1
MZF1B
ZFP98
ZNF42
ZSCAN6
myeloid zinc finger 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of MZF1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4675 NAP1L3
MB20
NPL3
nucleosome assembly protein 1-like 3 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NAP1L3 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 24142 NAT6
FUS-2
FUS2
N-acetyltransferase 6 (GCN5-related) (EC:2.3.1.-) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NAT6 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 24142 NAT6
FUS-2
FUS2
N-acetyltransferase 6 (GCN5-related) (EC:2.3.1.-) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NAT6 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 64151 NCAPG
CAPG
CHCG
NY-MEL-3
non-SMC condensin I complex, subunit G Tetradecanoylphorbol Acetate results in increased expression of NCAPG mRNA increases expression
mRNA 19031421
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 Acrolein inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NCF1 protein] affects localization
/ decreases reaction
protein 11246141
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NCF1 protein] decreases reaction
/ increases expression
protein 11172467
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NCF1 mRNA] decreases reaction
/ increases expression
mRNA 9794432
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 ML 7 inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NCF1 protein] affects localization
/ decreases reaction
protein 7575484
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 ML 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of NCF1 protein] decreases reaction
/ increases phosphorylation
protein 7575484
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 Tetradecanoylphorbol Acetate affects the localization of NCF1 protein affects localization
protein 7575484
11246141
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 Tetradecanoylphorbol Acetate results in increased expression of NCF1 mRNA increases expression
mRNA 9794432
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 Tetradecanoylphorbol Acetate results in increased expression of NCF1 protein increases expression
protein 11172467
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 Tetradecanoylphorbol Acetate results in increased phosphorylation of NCF1 protein increases phosphorylation
protein 7575484
D013755 653361 NCF1
NCF1A
NOXO2
SH3PXD1A
p47phox
neutrophil cytosolic factor 1 troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NCF1 protein] decreases reaction
/ increases expression
protein 11172467
D013755 4688 NCF2
NCF-2
NOXA2
P67-PHOX
P67PHOX
neutrophil cytosolic factor 2 Acrolein inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NCF2 protein] affects localization
/ decreases reaction
protein 11246141
D013755 4688 NCF2
NCF-2
NOXA2
P67-PHOX
P67PHOX
neutrophil cytosolic factor 2 NCF2 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] affects reaction
/ increases expression
protein 21705328
D013755 4688 NCF2
NCF-2
NOXA2
P67-PHOX
P67PHOX
neutrophil cytosolic factor 2 Tetradecanoylphorbol Acetate affects the localization of NCF2 protein affects localization
protein 11246141
D013755 4751 NEK2
HsPK21
NEK2A
NLK1
NIMA-related kinase 2 (EC:2.7.11.1) Tetradecanoylphorbol Acetate results in increased expression of NEK2 mRNA increases expression
mRNA 19031421
D013755 4745 NELL1
IDH3GL
NRP1
NEL-like 1 (chicken) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NELL1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 4745 NELL1
IDH3GL
NRP1
NEL-like 1 (chicken) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NELL1 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 4772 NFATC1
NF-ATC
NFAT2
NFATc
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 21603612
D013755 4773 NFATC2
NFAT1
NFATP
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 NFATC2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 21603612
D013755 4775 NFATC3
NFAT4
NFATX
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 NFATC3 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 21603612
D013755 4776 NFATC4
NF-ATc4
NFAT3
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 21603612
D013755 4781 NFIB
CTF
HMGIC/NFIB
NF-I/B
NF1-B
NFI-B
NFI-RED
NFIB2
NFIB3
nuclear factor I/B [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFIB mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 1'-acetoxychavicol acetate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] decreases reaction
/ increases activity
protein 15905586
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Anethole Trithione inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 8573121
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of NFKB1 protein] increases activity
/ increases degradation
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 20858459
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 14527959
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 14527959
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 evodiamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] decreases reaction
/ increases activity
protein 15710601
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Fenretinide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] decreases reaction
/ increases activity
protein 16230421
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Gliotoxin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 14527959
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NFKB1 protein] decreases reaction
/ increases expression
protein 17498959
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 indole-3-carbinol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] decreases reaction
/ increases activity
protein 15811958
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 lonafarnib inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] decreases reaction
/ increases activity
protein 15090542
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 pregna-4,17-diene-3,16-dione inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein] decreases reaction
/ increases activity
protein 15322087
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 pyrrolidine dithiocarbamic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 14527959
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 scoparone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NFKB1 protein] affects localization
/ decreases reaction
protein 16376386
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Tetradecanoylphorbol Acetate affects the localization of NFKB1 protein affects localization
protein 16376386
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Tetradecanoylphorbol Acetate inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 9973483
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Tetradecanoylphorbol Acetate results in increased activity of NFKB1 protein increases activity
protein 17767925
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein] affects binding
/ increases activity
protein 8573121
14527959
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Tetradecanoylphorbol Acetate results in increased expression of NFKB1 protein increases expression
protein 17498959
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of NFKB1 protein increases activity
/ increases degradation
/ increases localization
/ increases phosphorylation
protein 20858459
D013755 4790 NFKB1
EBP-1
KBF1
NF-kB1
NF-kappa-B
NF-kappaB
NFKB-p105
NFKB-p50
NFkappaB
p105
p50
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 zerumbone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 16007145
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] decreases reaction
/ increases degradation
/ increases phosphorylation
protein 20155627
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of NFKBIA protein] decreases reaction
/ increases phosphorylation
protein 20584749
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in decreased degradation of NFKBIA protein affects cotreatment
/ decreases degradation
protein 16174796
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of RELA protein] increases activity
/ increases degradation
/ increases localization
/ increases reaction
protein 20858459
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] increases degradation
/ increases phosphorylation
/ increases reaction
protein 20858459
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of NFKB1 protein] increases activity
/ increases degradation
/ increases localization
/ increases phosphorylation
/ increases reaction
protein 20858459
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased degradation of NFKBIA protein] affects cotreatment
/ decreases reaction
/ increases degradation
protein 15477007
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein affects cotreatment
/ increases degradation
protein 21515303
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha capsiate analog inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased degradation of NFKBIA protein] affects cotreatment
/ decreases reaction
/ increases degradation
protein 12115659
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein] affects cotreatment
/ decreases reaction
/ increases degradation
protein 21515303
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Clenbuterol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] decreases reaction
/ increases degradation
protein 15502056
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Cycloheximide promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of NFKBIA protein] decreases expression
/ increases reaction
protein 15330761
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Cycloheximide promotes the reaction [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] increases degradation
/ increases reaction
protein 15330761
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] decreases reaction
/ increases degradation
protein 20152819
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Dobutamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] decreases reaction
/ increases degradation
protein 15502056
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in decreased expression of NFKBIA mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B protein] decreases reaction
/ increases expression
protein 10072544
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1RN protein] decreases reaction
/ increases expression
protein 10072544
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL6 protein] decreases reaction
/ increases expression
protein 10072544
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL8 protein] decreases reaction
/ increases expression
protein 10072544
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF mRNA] decreases reaction
/ increases expression
protein 10072544
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 10072544
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1B protein] decreases reaction
/ increases expression
protein 10072544
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] decreases reaction
/ increases degradation
protein 21354279
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein] affects cotreatment
/ decreases reaction
/ increases degradation
protein 19665545
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein] affects cotreatment
/ decreases reaction
/ increases degradation
protein 17588137
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein] affects cotreatment
/ decreases reaction
/ increases degradation
protein 19416633
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of NFKBIA protein] decreases reaction
/ increases phosphorylation
protein 16376386
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein affects cotreatment
/ increases degradation
protein 17588137
19416633
19665545
22322153
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased degradation of NFKBIA protein affects cotreatment
/ increases degradation
protein 15477007
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased degradation of NFKBIA protein affects cotreatment
/ increases degradation
protein 12115659
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Tetradecanoylphorbol Acetate promotes the reaction [Cycloheximide results in decreased expression of NFKBIA protein] decreases expression
/ increases reaction
protein 15330761
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Tetradecanoylphorbol Acetate promotes the reaction [Cycloheximide results in increased degradation of NFKBIA protein] increases degradation
/ increases reaction
protein 15330761
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Tetradecanoylphorbol Acetate results in decreased expression of NFKBIA protein decreases expression
protein 15330761
16174796
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein increases degradation
protein 15330761
15502056
17767925
20152819
21354279
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] which results in increased activity of and results in increased localization of RELA protein increases activity
/ increases degradation
/ increases localization
protein 17767925
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein increases degradation
/ increases phosphorylation
protein 20155627
20858459
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of NFKB1 protein increases activity
/ increases degradation
/ increases localization
/ increases phosphorylation
protein 20858459
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of RELA protein increases activity
/ increases degradation
/ increases localization
/ increases phosphorylation
protein 20858459
D013755 4792 NFKBIA
IKBA
MAD-3
NFKBI
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Tetradecanoylphorbol Acetate results in increased phosphorylation of NFKBIA protein increases phosphorylation
protein 16376386
20584749
D013755 4795 NFKBIL1
IKBL
LST1
NFKBIL
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NFKBIL1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4818 NKG7
GIG1
GMP-17
p15-TIA-1
natural killer cell group 7 sequence pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NKG7 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 4818 NKG7
GIG1
GMP-17
p15-TIA-1
natural killer cell group 7 sequence [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NKG7 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 9111 NMI
N-myc (and STAT) interactor [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NMI mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 9111 NMI
N-myc (and STAT) interactor [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NMI mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 9221 NOLC1
NOPP130
NOPP140
NS5ATP13
P130
nucleolar and coiled-body phosphoprotein 1 Tetradecanoylphorbol Acetate results in increased expression of NOLC1 mRNA increases expression
mRNA 19031421
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA] decreases reaction
/ increases expression
mRNA 20004183
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) Peptides inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA] decreases reaction
/ increases expression
mRNA 20559769
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) Plant Extracts promotes the reaction [Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 20559769
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] decreases reaction
/ increases expression
protein 20004183
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) Tamoxifen inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA] decreases reaction
/ increases expression
mRNA 20559769
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) Tetradecanoylphorbol Acetate results in increased expression of NOS2 mRNA increases expression
mRNA 20004183
20559769
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein increases expression
protein 20004183
D013755 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] decreases reaction
/ increases expression
protein 20004183
D013755 404036 Tetradecanoylphorbol Acetate results in increased activity of NOS2A protein increases activity
protein 15016631
D013755 404036 Tetradecanoylphorbol Acetate results in increased expression of NOS2A protein increases expression
protein 15016631
D013755 4854 NOTCH3
CADASIL
CASIL
IMF2
notch 3 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NOTCH3 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 4854 NOTCH3
CADASIL
CASIL
IMF2
notch 3 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NOTCH3 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 124056 NOXO1
P41NOX
P41NOXA
P41NOXB
P41NOXC
SH3PXD5
SNX28
NADPH oxidase organizer 1 NOXO1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] affects reaction
/ increases expression
protein 21705328
D013755 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4835 NQO2
DHQV
DIA6
NMOR2
QR2
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NQO2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2908 NR3C1
GCCR
GCR
GR
GRL
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) [fluticasone co-treated with Tetradecanoylphorbol Acetate] affects the localization of NR3C1 protein affects cotreatment
/ affects localization
protein 15860753
D013755 2908 NR3C1
GCCR
GCR
GR
GRL
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) salmeterol promotes the reaction [[fluticasone co-treated with Tetradecanoylphorbol Acetate] affects the localization of NR3C1 protein] affects cotreatment
/ affects localization
/ increases reaction
protein 15860753
D013755 3164 NR4A1
GFRP1
HMR
N10
NAK-1
NGFIB
NP10
NUR77
TR3
nuclear receptor subfamily 4, group A, member 1 Tetradecanoylphorbol Acetate affects the localization of NR4A1 protein affects localization
protein 12376465
D013755 3164 NR4A1
GFRP1
HMR
N10
NAK-1
NGFIB
NP10
NUR77
TR3
nuclear receptor subfamily 4, group A, member 1 Tetradecanoylphorbol Acetate results in increased expression of NR4A1 mRNA increases expression
mRNA 12376465
D013755 3164 NR4A1
GFRP1
HMR
N10
NAK-1
NGFIB
NP10
NUR77
TR3
nuclear receptor subfamily 4, group A, member 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 4929 NR4A2
HZF-3
NOT
NURR1
RNR1
TINUR
nuclear receptor subfamily 4, group A, member 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 8013 NR4A3
CHN
CSMF
MINOR
NOR1
TEC
nuclear receptor subfamily 4, group A, member 3 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NR4A3 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 8013 NR4A3
CHN
CSMF
MINOR
NOR1
TEC
nuclear receptor subfamily 4, group A, member 3 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NR4A3 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 8013 NR4A3
CHN
CSMF
MINOR
NOR1
TEC
nuclear receptor subfamily 4, group A, member 3 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A3 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 2494 NR5A2
B1F
B1F2
CPF
FTF
FTZ-F1
FTZ-F1beta
LRH-1
LRH1
hB1F-2
nuclear receptor subfamily 5, group A, member 2 alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] affects cotreatment
/ decreases reaction
/ increases expression
/ increases reaction
protein 16357189
D013755 2494 NR5A2
B1F
B1F2
CPF
FTF
FTZ-F1
FTZ-F1beta
LRH-1
LRH1
hB1F-2
nuclear receptor subfamily 5, group A, member 2 NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA] affects cotreatment
/ increases expression
/ increases reaction
protein 16357189
D013755 51203 NUSAP1
ANKT
BM037
LNP
NUSAP
PRO0310p1
Q0310
SAPL
nucleolar and spindle associated protein 1 Tetradecanoylphorbol Acetate results in increased expression of NUSAP1 mRNA increases expression
mRNA 19031421
D013755 4953 ODC1
ODC
ornithine decarboxylase 1 (EC:4.1.1.17) pyridaben inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ODC1 mRNA] decreases reaction
/ increases expression
mRNA 9834970
D013755 4953 ODC1
ODC
ornithine decarboxylase 1 (EC:4.1.1.17) Rotenone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein] decreases reaction
/ increases activity
protein 9834970
D013755 4988 OPRM1
LMOR
M-OR-1
MOP
MOR
MOR1
OPRM
opioid receptor, mu 1 Sulfasalazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of OPRM1 mRNA] decreases reaction
/ increases expression
mRNA 11901219
D013755 4988 OPRM1
LMOR
M-OR-1
MOP
MOR
MOR1
OPRM
opioid receptor, mu 1 Tetradecanoylphorbol Acetate results in increased expression of OPRM1 mRNA increases expression
mRNA 11901219
D013755 5063 PAK3
CDKN1A
MRX30
MRX47
OPHN3
PAK3beta
bPAK
hPAK3
p21 protein (Cdc42/Rac)-activated kinase 3 (EC:2.7.11.1) Tetradecanoylphorbol Acetate results in increased expression of PAK3 mRNA increases expression
mRNA 19031421
D013755 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) 3-aminobenzamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] decreases reaction
/ increases activity
protein 2120135
2126186
D013755 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) Butylated Hydroxytoluene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] decreases reaction
/ increases activity
protein 2126186
D013755 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) CAT protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] decreases reaction
/ increases activity
protein 2126186
D013755 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased cleavage of PARP1 protein affects cotreatment
/ increases cleavage
protein 17309078
D013755 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) Indomethacin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein] decreases reaction
/ increases activity
protein 2126186
D013755 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) PARP1 protein affects the susceptibility to Tetradecanoylphorbol Acetate affects response to substance
protein 16323285
D013755 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) Tetradecanoylphorbol Acetate results in increased activity of PARP1 protein increases activity
protein 2120135
2126186
D013755 10038 PARP2
ADPRT2
ADPRTL2
ADPRTL3
ARTD2
PARP-2
pADPRT-2
poly (ADP-ribose) polymerase 2 (EC:2.4.2.30) Tetradecanoylphorbol Acetate results in increased expression of PARP2 mRNA increases expression
mRNA 19031421
D013755 55872 PBK
CT84
Nori-3
SPK
TOPK
PDZ binding kinase (EC:2.7.12.2) Tetradecanoylphorbol Acetate results in increased expression of PBK mRNA increases expression
mRNA 19031421
D013755 56146 PCDHA2
PCDH-ALPHA2
protocadherin alpha 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCDHA2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 5118 PCOLCE
PCPE
PCPE-1
PCPE1
procollagen C-endopeptidase enhancer [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCOLCE mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 27250 PDCD4
H731
programmed cell death 4 (neoplastic transformation inhibitor) Tetradecanoylphorbol Acetate results in decreased expression of PDCD4 mRNA decreases expression
mRNA 21873647
D013755 5154 PDGFA
PDGF-A
PDGF1
platelet-derived growth factor alpha polypeptide Ramipril inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PDGFA mRNA] decreases reaction
/ increases expression
mRNA 10352363
D013755 5154 PDGFA
PDGF-A
PDGF1
platelet-derived growth factor alpha polypeptide Tetradecanoylphorbol Acetate results in increased expression of PDGFA mRNA increases expression
mRNA 10352363
10428506
D013755 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide Ramipril inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PDGFB mRNA] decreases reaction
/ increases expression
mRNA 10352363
D013755 5155 PDGFB
IBGC5
PDGF-2
PDGF2
SIS
SSV
c-sis
platelet-derived growth factor beta polypeptide Tetradecanoylphorbol Acetate results in increased expression of PDGFB mRNA increases expression
mRNA 10352363
10428506
D013755 5241 PGR
NR3C3
PR
progesterone receptor bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of PGR mRNA]] decreases reaction
/ increases expression
mRNA 22643241
D013755 5241 PGR
NR3C3
PR
progesterone receptor Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of PGR mRNA] decreases reaction
/ increases expression
mRNA 22643241
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) E2F4 protein promotes the reaction [PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]] increases expression
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) EGR1 protein promotes the reaction [PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]] increases expression
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of E2F4 protein] increases expression
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein] increases expression
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of ERBB2 protein] increases expression
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] increases expression
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K1 protein] increases phosphorylation
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAP2K2 protein] increases phosphorylation
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] increases phosphorylation
/ increases reaction
protein 20479004
D013755 5300 PIN1
DOD
UBL5
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) PIN1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] increases phosphorylation
/ increases reaction
protein 20479004
D013755 5320 PLA2G2A
MOM1
PLA2
PLA2B
PLA2L
PLA2S
PLAS1
sPLA2
phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) Tetradecanoylphorbol Acetate inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] decreases reaction
/ increases expression
/ increases reaction
protein 18953428
D013755 5327 PLAT
T-PA
TPA
plasminogen activator, tissue (EC:3.4.21.68) Tetradecanoylphorbol Acetate results in increased secretion of PLAT protein increases secretion
protein 3119194
D013755 5328 PLAU
ATF
BDPLT5
QPD
UPA
URK
u-PA
plasminogen activator, urokinase (EC:3.4.21.73) arsenic trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of PLAU protein] decreases reaction
/ increases secretion
protein 15962302
D013755 5328 PLAU
ATF
BDPLT5
QPD
UPA
URK
u-PA
plasminogen activator, urokinase (EC:3.4.21.73) Tetradecanoylphorbol Acetate results in increased secretion of PLAU protein increases secretion
protein 15962302
D013755 5330 PLCB2
PLC-beta-2
phospholipase C, beta 2 (EC:3.1.4.11) edelfosine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PLCB2 protein] affects localization
/ decreases reaction
protein 9295281
D013755 5330 PLCB2
PLC-beta-2
phospholipase C, beta 2 (EC:3.1.4.11) Tetradecanoylphorbol Acetate affects the localization of PLCB2 protein affects localization
protein 9295281
D013755 5338 PLD2
phospholipase D2 (EC:3.1.4.4) PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 18423386
D013755 5338 PLD2
phospholipase D2 (EC:3.1.4.4) PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK1 protein] affects cotreatment
/ increases activity
/ increases phosphorylation
/ increases reaction
protein 18423386
D013755 5338 PLD2
phospholipase D2 (EC:3.1.4.4) PLD2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of and results in increased activity of MAPK3 protein] affects cotreatment
/ increases activity
/ increases phosphorylation
/ increases reaction
protein 18423386
D013755 5347 PLK1
PLK
STPK13
polo-like kinase 1 (EC:2.7.11.21) Tetradecanoylphorbol Acetate results in increased expression of PLK1 mRNA increases expression
mRNA 19031421
D013755 8228 PNPLA4
DXS1283E
GS2
iPLA2eta
patatin-like phospholipase domain containing 4 (EC:3.1.1.3) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PNPLA4 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 8228 PNPLA4
DXS1283E
GS2
iPLA2eta
patatin-like phospholipase domain containing 4 (EC:3.1.1.3) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PNPLA4 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 5427 POLE2
DPE2
polymerase (DNA directed), epsilon 2, accessory subunit (EC:2.7.7.7) Tetradecanoylphorbol Acetate results in increased expression of POLE2 mRNA increases expression
mRNA 19031421
D013755 5451 POU2F1
OCT1
OTF1
oct-1B
POU class 2 homeobox 1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of POU2F1 protein affects cotreatment
/ increases activity
protein 16241859
D013755 5452 POU2F2
OCT2
OTF2
Oct-2
POU class 2 homeobox 2 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of POU2F2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 5452 POU2F2
OCT2
OTF2
Oct-2
POU class 2 homeobox 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of POU2F2 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 5459 POU4F3
BRN3C
DFNA15
POU class 4 homeobox 3 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of POU4F3 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 5465 PPARA
NR1C1
PPAR
PPARalpha
hPPAR
peroxisome proliferator-activated receptor alpha PPARA protein affects the reaction [Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]] affects reaction
/ decreases reaction
/ increases expression
protein 17360982
D013755 5465 PPARA
NR1C1
PPAR
PPARalpha
hPPAR
peroxisome proliferator-activated receptor alpha PPARA protein affects the reaction [fenofibric acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]] affects reaction
/ decreases reaction
/ increases expression
protein 17360982
D013755 5465 PPARA
NR1C1
PPAR
PPARalpha
hPPAR
peroxisome proliferator-activated receptor alpha PPARA protein affects the reaction [GW 9578 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]] affects reaction
/ decreases reaction
/ increases expression
protein 17360982
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] decreases activity
/ decreases reaction
/ increases expression
protein 16945329
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of troglitazone] decreases activity
/ decreases reaction
/ increases activity
protein 16945329
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] decreases reaction
/ increases expression
protein 16945329
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] decreases reaction
/ increases expression
protein 16945329
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma MAP2K1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] affects reaction
/ increases expression
protein 16945329
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] affects reaction
/ increases expression
protein 16945329
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma [Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] affects the expression of PPARG mRNA affects cotreatment
/ affects expression
mRNA 21511917
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma Tetradecanoylphorbol Acetate results in increased activity of PPARG protein increases activity
protein 15707588
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma Tetradecanoylphorbol Acetate results in increased expression of PPARG mRNA increases expression
mRNA 12044893
16945329
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma Tetradecanoylphorbol Acetate results in increased expression of PPARG protein increases expression
protein 16945329
D013755 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma [Tetradecanoylphorbol Acetate results in increased expression of PPARG] which affects the susceptibility to troglitazone affects response to substance
/ increases expression
16945329
D013755 5473 PPBP
B-TG1
Beta-TG
CTAP-III
CTAP3
CTAPIII
CXCL7
LA-PF4
LDGF
MDGF
NAP-2
PBP
SCYB7
TC1
TC2
TGB
TGB1
THBGB
THBGB1
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) Tetradecanoylphorbol Acetate results in increased expression of PPBP protein increases expression
protein 15316029
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein] decreases reaction
/ increases activity
protein 16091123
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] affects localization
/ decreases reaction
protein 20152819
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCA protein] decreases reaction
/ increases phosphorylation
protein 20152819
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) [Ethanol results in increased localization of and results in increased activity of PRKCA protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] increases abundance
/ increases activity
/ increases localization
/ increases reaction
protein 10651808
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Metformin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCA protein] decreases reaction
/ increases phosphorylation
protein 20590612
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and affects the localization of PRKCA protein] affects localization
/ decreases reaction
/ increases phosphorylation
protein 21354279
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) PRKCA protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] affects reaction
/ increases expression
protein 21705328
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased phosphorylation of and results in increased activity of PRKCA protein] decreases reaction
/ increases activity
/ increases localization
/ increases phosphorylation
protein 14739659
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] affects localization
/ decreases reaction
protein 20032081
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of and results in increased activity of PRKCA protein affects localization
/ increases activity
protein 15978937
16091123
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of PRKCA protein affects localization
protein 15976015
19447859
20032081
20152819
21705328
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in decreased expression of PRKCA protein decreases expression
protein 15330761
17171646
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in decreased phosphorylation of PRKCA protein decreases phosphorylation
protein 15380616
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased activity of and affects the localization of PRKCA protein affects localization
/ increases activity
protein 19394402
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein increases activity
protein 21705328
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein] which results in increased expression of SOD2 increases activity
/ increases expression
protein 21705328
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased localization of and results in increased phosphorylation of and results in increased activity of PRKCA protein increases activity
/ increases localization
/ increases phosphorylation
protein 14739659
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased phosphorylation of and affects the localization of PRKCA protein affects localization
/ increases phosphorylation
protein 21354279
D013755 5578 PRKCA
AAG6
PKC-alpha
PKCA
PRKACA
protein kinase C, alpha (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCA protein increases phosphorylation
protein 20152819
20590612
D013755 5579 PRKCB
PKC-beta
PKCB
PRKCB1
PRKCB2
protein kinase C, beta (EC:2.7.11.13) [Ethanol results in increased localization of and results in increased activity of PRKCB protein] promotes the reaction [Tetradecanoylphorbol Acetate results in increased abundance of Superoxides] increases abundance
/ increases activity
/ increases localization
/ increases reaction
protein 10651808
D013755 5579 PRKCB
PKC-beta
PKCB
PRKCB1
PRKCB2
protein kinase C, beta (EC:2.7.11.13) PRKCB protein affects the reaction [Tetradecanoylphorbol Acetate affects the localization of Zinc] affects localization
/ affects reaction
protein 16495082
D013755 5579 PRKCB
PKC-beta
PKCB
PRKCB1
PRKCB2
protein kinase C, beta (EC:2.7.11.13) PRKCB protein alternative form affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] affects reaction
/ increases expression
protein 21705328
D013755 5579 PRKCB
PKC-beta
PKCB
PRKCB1
PRKCB2
protein kinase C, beta (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of PRKCB protein affects localization
protein 15976015
19447859
D013755 5579 PRKCB
PKC-beta
PKCB
PRKCB1
PRKCB2
protein kinase C, beta (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of PRKCB protein alternative form affects localization
protein 21705328
D013755 5579 PRKCB
PKC-beta
PKCB
PRKCB1
PRKCB2
protein kinase C, beta (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in decreased expression of PRKCB protein modified form decreases expression
protein 15330761
D013755 5579 PRKCB
PKC-beta
PKCB
PRKCB1
PRKCB2
protein kinase C, beta (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in decreased phosphorylation of PRKCB protein decreases phosphorylation
protein 15380616
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide affects the reaction [Tetradecanoylphorbol Acetate affects the phosphorylation of PRKCD protein] affects phosphorylation
/ affects reaction
protein 15380616
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCD protein] affects localization
/ decreases reaction
protein 20599481
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) 3-caffeoyl-4-dihydrocaffeoylquinic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCD protein] decreases reaction
/ increases phosphorylation
protein 20599481
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCD protein] affects localization
/ decreases reaction
protein 22245252
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) bisindolylmaleimide I affects the reaction [Tetradecanoylphorbol Acetate affects the phosphorylation of PRKCD protein] affects phosphorylation
/ affects reaction
protein 15380616
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) PRKCD protein affects the susceptibility to [Tetradecanoylphorbol Acetate co-treated with benz(a)anthracene] affects cotreatment
/ affects response to substance
protein 22643241
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCD protein] affects localization
/ decreases reaction
protein 18628248
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) [rottlerin results in decreased activity of PRKCD protein] inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA]] decreases activity
/ decreases reaction
/ increases expression
/ increases reaction
protein 22643241
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of PRKCD protein affects localization
protein 15976015
18628248
20599481
21705328
22245252
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) Tetradecanoylphorbol Acetate affects the phosphorylation of PRKCD protein affects phosphorylation
protein 15380616
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) Tetradecanoylphorbol Acetate inhibits the reaction [Oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein] decreases reaction
/ increases activity
/ increases localization
protein 11424089
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) Tetradecanoylphorbol Acetate results in decreased expression of PRKCD protein decreases expression
protein 15949478
D013755 5580 PRKCD
MAY1
PKCD
nPKC-delta
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCD protein increases phosphorylation
protein 15707588
20599481
21354279
D013755 5581 PRKCE
PKCE
nPKC-epsilon
protein kinase C, epsilon (EC:2.7.11.13) PRKCE protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] affects reaction
/ increases expression
protein 21705328
D013755 5581 PRKCE
PKCE
nPKC-epsilon
protein kinase C, epsilon (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of PRKCE protein affects localization
protein 14975926
21705328
D013755 5581 PRKCE
PKCE
nPKC-epsilon
protein kinase C, epsilon (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased activity of and results in increased localization of PRKCE protein increases activity
/ increases localization
protein 16793902
D013755 5581 PRKCE
PKCE
nPKC-epsilon
protein kinase C, epsilon (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased activity of PRKCE protein increases activity
protein 14975926
D013755 5582 PRKCG
PKC-gamma
PKCC
PKCG
SCA14
protein kinase C, gamma (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of PRKCG protein affects localization
protein 19447859
D013755 5582 PRKCG
PKC-gamma
PKCC
PKCG
SCA14
protein kinase C, gamma (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in decreased expression of PRKCG protein decreases expression
protein 15949478
D013755 5582 PRKCG
PKC-gamma
PKCC
PKCG
SCA14
protein kinase C, gamma (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased activity of PRKCG protein increases activity
protein 15707588
D013755 5583 PRKCH
PKC-L
PKCL
PRKCL
nPKC-eta
protein kinase C, eta (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased activity of PRKCH protein increases activity
protein 16832347
D013755 5583 PRKCH
PKC-L
PKCL
PRKCL
nPKC-eta
protein kinase C, eta (EC:2.7.11.13) [Tetradecanoylphorbol Acetate results in increased activity of PRKCH protein] inhibits the reaction [Sirolimus results in decreased phosphorylation of RPS6 protein] decreases phosphorylation
/ decreases reaction
/ increases activity
protein 16832347
D013755 5584 PRKCI
DXS1179E
PKCI
nPKC-iota
protein kinase C, iota (EC:2.7.11.13) Tetradecanoylphorbol Acetate results in increased localization of PRKCI protein increases localization
protein 21295103
D013755 5584 PRKCI
DXS1179E
PKCI
nPKC-iota
protein kinase C, iota (EC:2.7.11.13) wogonin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of PRKCI protein] decreases reaction
/ increases localization
protein 21295103
D013755 5588 PRKCQ
PRKCT
nPKC-theta
protein kinase C, theta (EC:2.7.11.13) pomalidomide promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of PRKCQ protein] affects cotreatment
/ increases activity
/ increases reaction
protein 16241859
D013755 5588 PRKCQ
PRKCT
nPKC-theta
protein kinase C, theta (EC:2.7.11.13) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased activity of PRKCQ protein affects cotreatment
/ increases activity
protein 16241859
D013755 5590 PRKCZ
PKC-ZETA
PKC2
protein kinase C, zeta (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of PRKCZ protein affects localization
protein 15976015
D013755 5587 PRKD1
PKC-MU
PKCM
PKD
PRKCM
protein kinase D1 (EC:2.7.11.13) 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide affects the reaction [Tetradecanoylphorbol Acetate affects the phosphorylation of PRKD1 protein] affects phosphorylation
/ affects reaction
protein 15380616
D013755 5587 PRKD1
PKC-MU
PKCM
PKD
PRKCM
protein kinase D1 (EC:2.7.11.13) bisindolylmaleimide I affects the reaction [Tetradecanoylphorbol Acetate affects the phosphorylation of PRKD1 protein] affects phosphorylation
/ affects reaction
protein 15380616
D013755 5587 PRKD1
PKC-MU
PKCM
PKD
PRKCM
protein kinase D1 (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the localization of PRKD1 protein affects localization
protein 21705328
D013755 5587 PRKD1
PKC-MU
PKCM
PKD
PRKCM
protein kinase D1 (EC:2.7.11.13) Tetradecanoylphorbol Acetate affects the phosphorylation of PRKD1 protein affects phosphorylation
protein 15380616
D013755 5587 PRKD1
PKC-MU
PKCM
PKD
PRKCM
protein kinase D1 (EC:2.7.11.13) [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKD1 protein] which results in increased expression of ATP7B protein increases expression
/ increases phosphorylation
protein 21189263
D013755 9536 PTGES
MGST-IV
MGST1-L1
MGST1L1
MPGES
PGES
PIG12
PP102
PP1294
TP53I12
mPGES-1
prostaglandin E synthase (EC:5.3.99.3) [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of PTGES mRNA affects cotreatment
/ increases expression
mRNA 18922899
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 1,5-bis(2-bromophenyl)penta-1,4-dien-3-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 20606309
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 1,5-bis(2-bromophenyl)penta-1,4-dien-3-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 20606309
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 11278336
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 17767925
19804834
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 11278336
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 2-arachidonylglycerol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased expression of PTGS2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21511917
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2] decreases reaction
/ increases expression
20155627
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 20584749
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 3,4-dihydroxyphenylethanol inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases chemical synthesis
/ increases expression
protein 22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 20584749
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] increases expression
/ increases reaction
mRNA 20858459
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 19804834
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) BAY 11-7085 inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21807015
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) BAY 11-7085 inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21807015
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 11278336
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 11278336
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) cinnamic aldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21807015
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) cinnamic aldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21807015
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) CREBBP protein inhibits the reaction [ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]] decreases reaction
/ increases expression
mRNA 11278336
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 16870006
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 16870006
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Dexamethasone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 20858459
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 19804834
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Dithiothreitol inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]] decreases reaction
/ increases expression
protein 20584749
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Equol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 16870006
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Equol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 16870006
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21807015
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21807015
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Genistein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 16870006
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Genistein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 16870006
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 19804834
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) GW 1929 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of PTGS2 protein] decreases reaction
/ increases activity
/ increases expression
protein 20032081
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) GW 1929 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 20032081
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA affects cotreatment
/ increases expression
mRNA 18958680
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein affects cotreatment
/ increases expression
protein 18958680
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) JUN protein inhibits the reaction [ciglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]] decreases reaction
/ increases expression
mRNA 11278336
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA affects cotreatment
/ increases expression
mRNA 21807015
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein affects cotreatment
/ increases expression
protein 21807015
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) MAPK1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] increases expression
/ increases reaction
protein 17767925
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) MAPK3 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] increases expression
/ increases reaction
protein 17767925
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 19804834
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases activity
/ increases chemical synthesis
protein 9705326
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) oleuropein inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases chemical synthesis
/ increases expression
protein 22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) pyrrolidine dithiocarbamic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 17767925
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 19804834
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone] decreases chemical synthesis
/ decreases reaction
/ increases expression
protein 22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] affects reaction
/ increases expression
protein 19804834
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19416633
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 19416633
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein] decreases reaction
/ increases activity
protein 9705326
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 9705326
22523472
22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 9705326
22523472
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] decreases reaction
/ increases chemical synthesis
/ increases expression
protein 22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of PTGS2 protein] decreases reaction
/ increases activity
/ increases expression
protein 20032081
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 20032081
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 19656660
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 17767925
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA affects cotreatment
/ increases expression
mRNA 19416633
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein affects cotreatment
/ increases expression
protein 19416633
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] results in increased expression of PTGS2 mRNA affects cotreatment
/ increases expression
mRNA 21511917
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein increases activity
protein 9705326
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone increases activity
/ increases chemical synthesis
protein 9705326
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of PTGS2 protein increases activity
/ increases expression
protein 15680906
20032081
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Tetradecanoylphorbol Acetate results in increased expression of PTGS2 increases expression
20155627
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA increases expression
mRNA 9705326
10783318
11237475
11278336
15997105
16870006
17767925
19656660
19804834
20032081
20606309
20858459
22353212
22523472
22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein increases expression
protein 8621535
9705326
11278336
15843042
16417216
16870006
17767925
19804834
20584749
20606309
21375462
22523472
22595400
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of 8-epi-prostaglandin F2alpha increases chemical synthesis
/ increases expression
protein 8621535
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone increases chemical synthesis
/ increases expression
protein 8621535
17767925
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2 increases chemical synthesis
/ increases expression
protein 8621535
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] decreases reaction
/ increases expression
mRNA 11278336
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] decreases reaction
/ increases expression
protein 11278336
D013755 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PTGS2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) Atropine inhibits the reaction [oxotremorine M promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein]] affects cotreatment
/ decreases reaction
/ increases phosphorylation
/ increases reaction
protein 10537051
D013755 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) [oxophenylarsine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PTK2 protein affects cotreatment
/ decreases expression
protein 10569804
D013755 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) oxotremorine M promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein] affects cotreatment
/ increases phosphorylation
/ increases reaction
protein 10537051
D013755 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) [Tetradecanoylphorbol Acetate co-treated with oxotremorine M] results in increased phosphorylation of PTK2 protein affects cotreatment
/ increases phosphorylation
protein 10537051
D013755 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) [Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein affects cotreatment
/ increases phosphorylation
protein 10537051
D013755 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) Tetradecanoylphorbol Acetate results in increased phosphorylation of PTK2 protein increases phosphorylation
protein 10537051
D013755 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) [Vanadates co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PTK2 protein affects cotreatment
/ decreases expression
protein 10569804
D013755 5747 PTK2
FADK
FAK
FAK1
FRNK
PPP1R71
p125FAK
pp125FAK
protein tyrosine kinase 2 (EC:2.7.10.2) [wortmannin co-treated with Tetradecanoylphorbol Acetate] inhibits the reaction [oxotremorine M results in increased phosphorylation of PTK2 protein] affects cotreatment
/ decreases reaction
/ increases phosphorylation
protein 10537051
D013755 5799 PTPRN2
IA-2beta
IAR
ICAAR
PTPRP
R-PTP-N2
protein tyrosine phosphatase, receptor type, N polypeptide 2 (EC:3.1.3.48) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PTPRN2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 9232 PTTG1
EAP1
HPTTG
PTTG
TUTR1
pituitary tumor-transforming 1 Tetradecanoylphorbol Acetate results in increased expression of PTTG1 mRNA increases expression
mRNA 19031421
D013755 5806 PTX3
TNFAIP5
TSG-14
pentraxin 3, long [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PTX3 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 5879 RAC1
Rac-1
TC-25
p21-Rac1
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) RAC1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] affects reaction
/ increases expression
protein 21705328
D013755 5879 RAC1
Rac-1
TC-25
p21-Rac1
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of RAC1 mRNA affects cotreatment
/ increases expression
mRNA 18922899
D013755 5879 RAC1
Rac-1
TC-25
p21-Rac1
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of RAC1 protein affects cotreatment
/ increases expression
protein 18922899
D013755 5879 RAC1
Rac-1
TC-25
p21-Rac1
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) Tetradecanoylphorbol Acetate results in increased expression of RAC1 mRNA increases expression
mRNA 18922899
D013755 5879 RAC1
Rac-1
TC-25
p21-Rac1
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) Tetradecanoylphorbol Acetate results in increased expression of RAC1 protein increases expression
protein 18922899
D013755 10635 RAD51AP1
PIR51
RAD51 associated protein 1 Tetradecanoylphorbol Acetate results in increased expression of RAD51AP1 mRNA increases expression
mRNA 19031421
D013755 5889 RAD51C
BROVCA3
FANCO
R51H3
RAD51L2
RAD51 paralog C Tetradecanoylphorbol Acetate results in increased expression of RAD51C mRNA increases expression
mRNA 19031421
D013755 8438 RAD54L
HR54
RAD54A
hHR54
hRAD54
RAD54-like (S. cerevisiae) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RAD54L mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 5914 RARA
NR1B1
RAR
retinoic acid receptor, alpha [Tetradecanoylphorbol Acetate co-treated with salvin] results in increased expression of RARA protein affects cotreatment
/ increases expression
protein 11504768
D013755 5918 RARRES1
LXNL
TIG1
retinoic acid receptor responder (tazarotene induced) 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RARRES1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RB1 protein] increases phosphorylation
/ increases reaction
protein 12421932
D013755 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 IL2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RB1 protein] increases phosphorylation
/ increases reaction
protein 12421932
D013755 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RB1 protein]] decreases reaction
/ increases phosphorylation
/ increases reaction
protein 12421932
D013755 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 Tetradecanoylphorbol Acetate results in decreased phosphorylation of RB1 protein decreases phosphorylation
protein 15978937
D013755 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 Tetradecanoylphorbol Acetate results in increased expression of RB1 protein modified form increases expression
protein 9348195
D013755 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 Tetradecanoylphorbol Acetate results in increased phosphorylation of RB1 protein increases phosphorylation
protein 8927716
12421932
D013755 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RB1 protein] increases phosphorylation
/ increases reaction
protein 12421932
D013755 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RB1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 5932 RBBP8
COM1
CTIP
JWDS
RIM
SAE2
SCKL2
retinoblastoma binding protein 8 Tetradecanoylphorbol Acetate results in increased expression of RBBP8 mRNA increases expression
mRNA 19031421
D013755 9978 RBX1
BA554C12.1
RNF75
ROC1
ring-box 1, E3 ubiquitin protein ligase Tetradecanoylphorbol Acetate results in increased expression of RBX1 mRNA increases expression
mRNA 19031421
D013755 5966 REL
C-Rel
v-rel avian reticuloendotheliosis viral oncogene homolog [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of REL mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 5966 REL
C-Rel
v-rel avian reticuloendotheliosis viral oncogene homolog pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of REL mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 5966 REL
C-Rel
v-rel avian reticuloendotheliosis viral oncogene homolog scoparone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of REL protein] affects localization
/ decreases reaction
protein 16376386
D013755 5966 REL
C-Rel
v-rel avian reticuloendotheliosis viral oncogene homolog Tetradecanoylphorbol Acetate affects the localization of REL protein affects localization
protein 16376386
D013755 5966 REL
C-Rel
v-rel avian reticuloendotheliosis viral oncogene homolog [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of REL mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A 1'-acetoxychavicol acetate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 15905586
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of RELA protein] affects localization
/ decreases reaction
protein 20155627
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A 3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases localization
protein 22595400
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Anethole Trithione inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 8573121
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Apigenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases expression
protein 22634262
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of and results in increased localization of RELA protein affects cotreatment
/ decreases activity
/ increases localization
protein 16174796
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of RELA protein] increases activity
/ increases degradation
/ increases localization
/ increases reaction
protein 20858459
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Bee Venoms inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RELA protein] decreases reaction
/ increases expression
protein 19969058
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 14527959
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 14527959
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein affects cotreatment
/ affects localization
protein 21515303
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein] affects cotreatment
/ affects localization
/ decreases reaction
protein 21515303
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A dihydroartemisinin inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of and results in increased phosphorylation of RELA protein] affects localization
/ decreases reaction
/ increases phosphorylation
protein 20152819
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A evodiamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 15710601
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Fenretinide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 16230421
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein] affects cotreatment
/ affects localization
/ decreases reaction
/ increases activity
protein 18958421
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Gliotoxin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 14527959
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Glucosamine analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RELA protein] decreases reaction
/ increases expression
protein 19375915
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Glucosamine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of RELA protein] decreases reaction
/ increases expression
protein 17498959
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of RELA protein] affects localization
/ decreases reaction
protein 20152819
21354279
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A hydroquinone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and affects the localization of RELA protein] affects localization
/ decreases reaction
/ increases expression
protein 16928326
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A indole-3-carbinol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 15811958
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A lonafarnib inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 15090542
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Melitten inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of RELA protein] decreases reaction
/ increases localization
protein 20082219
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein] affects cotreatment
/ affects localization
/ decreases reaction
/ increases activity
protein 18958421
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases localization
protein 22595400
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A piperine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of RELA protein] affects localization
/ decreases reaction
protein 21354279
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A piperine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RELA protein] decreases reaction
/ increases phosphorylation
protein 21354279
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein] affects cotreatment
/ affects localization
/ decreases reaction
protein 19665545
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Plant Extracts inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases expression
protein 22634262
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A pregna-4,17-diene-3,16-dione inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 15322087
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A pyrrolidine dithiocarbamic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 14527959
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A pyrrolidine dithiocarbamic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 17767925
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein] affects cotreatment
/ affects localization
/ decreases reaction
/ increases activity
protein 18958421
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein] affects cotreatment
/ affects localization
/ decreases reaction
protein 17588137
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases localization
protein 22595400
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein] affects cotreatment
/ affects localization
/ decreases reaction
protein 19416633
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of RELA protein] decreases reaction
/ increases activity
/ increases localization
protein 22595400
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A scoparone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of RELA protein] affects localization
/ decreases reaction
protein 16376386
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A scoparone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] decreases reaction
/ increases activity
protein 16376386
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate affects the localization of and results in increased phosphorylation of RELA protein affects localization
/ increases phosphorylation
protein 20152819
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate affects the localization of RELA protein affects localization
protein 16376386
20155627
20590612
21354279
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein affects cotreatment
/ affects localization
/ increases activity
protein 18958421
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein affects cotreatment
/ affects localization
protein 17588137
19416633
19665545
22322153
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate inhibits the reaction [A 771726 results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 9973483
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein] affects binding
/ increases activity
protein 8573121
14527959
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate results in increased activity of RELA protein increases activity
protein 16174796
16376386
17767925
19284563
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] which results in increased activity of and results in increased localization of RELA protein increases activity
/ increases degradation
/ increases localization
protein 17767925
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate results in increased expression of and affects the localization of RELA protein affects localization
/ increases expression
protein 16928326
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of RELA protein increases activity
/ increases expression
protein 22634262
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate results in increased expression of RELA protein increases expression
protein 17498959
19375915
19969058
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate results in increased localization of and results in increased activity of RELA protein increases activity
/ increases localization
protein 22595400
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate results in increased localization of RELA protein increases localization
protein 20082219
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of RELA protein increases activity
/ increases degradation
/ increases localization
/ increases phosphorylation
protein 20858459
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A Tetradecanoylphorbol Acetate results in increased phosphorylation of RELA protein increases phosphorylation
protein 21354279
21375462
D013755 5970 RELA
NFKB3
p65
v-rel avian reticuloendotheliosis viral oncogene homolog A zerumbone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [NFKB1 protein binds to RELA protein]] affects binding
/ decreases reaction
/ increases activity
protein 16007145
D013755 5984 RFC4
A1
RFC37
replication factor C (activator 1) 4, 37kDa Tetradecanoylphorbol Acetate results in increased expression of RFC4 mRNA increases expression
mRNA 19031421
D013755 5985 RFC5
RFC36
replication factor C (activator 1) 5, 36.5kDa Tetradecanoylphorbol Acetate results in increased expression of RFC5 mRNA increases expression
mRNA 19031421
D013755 28984 RGCC
C13orf15
RGC-32
RGC32
bA157L14.2
regulator of cell cycle [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RGCC mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 8786 RGS11
RS11
regulator of G-protein signaling 11 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RGS11 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6003 RGS13
regulator of G-protein signaling 13 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of RGS13 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 391 RHOG
ARHG
ras homolog family member G pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of RHOG mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 391 RHOG
ARHG
ras homolog family member G [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of RHOG mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 8635 RNASET2
RNASE6PL
bA514O12.3
ribonuclease T2 (EC:3.1.27.1) pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of RNASET2 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 8635 RNASET2
RNASE6PL
bA514O12.3
ribonuclease T2 (EC:3.1.27.1) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of RNASET2 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 6194 RPS6
S6
ribosomal protein S6 [Tetradecanoylphorbol Acetate results in increased activity of PRKCH protein] inhibits the reaction [Sirolimus results in decreased phosphorylation of RPS6 protein] decreases phosphorylation
/ decreases reaction
/ increases activity
protein 16832347
D013755 6256 RXRA
NR2B1
retinoid X receptor, alpha benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased degradation of RXRA protein] decreases degradation
/ decreases reaction
protein 12970875
D013755 6256 RXRA
NR2B1
retinoid X receptor, alpha Tetradecanoylphorbol Acetate results in decreased degradation of RXRA protein decreases degradation
protein 12970875
D013755 6256 RXRA
NR2B1
retinoid X receptor, alpha Tetradecanoylphorbol Acetate results in decreased localization of RXRA protein decreases localization
protein 12970875
D013755 6279 S100A8
60B8AG
CAGA
CFAG
CGLA
CP-10
L1Ag
MA387
MIF
MRP8
NIF
P8
S100 calcium binding protein A8 Tetradecanoylphorbol Acetate results in increased expression of S100A8 mRNA increases expression
mRNA 1733233
D013755 6280 S100A9
60B8AG
CAGB
CFAG
CGLB
L1AG
LIAG
MAC387
MIF
MRP14
NIF
P14
S100 calcium binding protein A9 Tetradecanoylphorbol Acetate results in increased expression of S100A9 mRNA increases expression
mRNA 1733233
D013755 6286 S100P
MIG9
S100 calcium binding protein P [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of S100P mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 9092 SART1
Ara1
HOMS1
SART1259
SNRNP110
Snu66
squamous cell carcinoma antigen recognized by T cells pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of SART1 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 9092 SART1
Ara1
HOMS1
SART1259
SNRNP110
Snu66
squamous cell carcinoma antigen recognized by T cells [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of SART1 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 6382 SDC1
CD138
SDC
SYND1
syndecan
syndecan 1 GW280264X inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of SDC1 protein] decreases reaction
/ increases secretion
protein 19875451
D013755 6382 SDC1
CD138
SDC
SYND1
syndecan
syndecan 1 N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of SDC1 protein] decreases reaction
/ increases secretion
protein 19875451
D013755 6382 SDC1
CD138
SDC
SYND1
syndecan
syndecan 1 Tetradecanoylphorbol Acetate affects the localization of and results in increased cleavage of and results in increased secretion of SDC1 protein affects localization
/ increases cleavage
/ increases secretion
protein 19875451
D013755 6382 SDC1
CD138
SDC
SYND1
syndecan
syndecan 1 Tetradecanoylphorbol Acetate results in decreased expression of SDC1 protein alternative form decreases expression
protein 19875451
D013755 6385 SDC4
SYND4
syndecan 4 GW280264X inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of SDC4 protein] decreases reaction
/ increases secretion
protein 19875451
D013755 6385 SDC4
SYND4
syndecan 4 N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of SDC4 protein] decreases reaction
/ increases secretion
protein 19875451
D013755 6385 SDC4
SYND4
syndecan 4 Tetradecanoylphorbol Acetate affects the localization of and results in increased cleavage of and results in increased secretion of SDC4 protein affects localization
/ increases cleavage
/ increases secretion
protein 19875451
D013755 6385 SDC4
SYND4
syndecan 4 Tetradecanoylphorbol Acetate results in decreased expression of SDC4 protein alternative form decreases expression
protein 19875451
D013755 6401 SELE
CD62E
ELAM
ELAM1
ESEL
LECAM2
selectin E adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SELE protein] decreases reaction
/ increases expression
protein 8780174
D013755 6401 SELE
CD62E
ELAM
ELAM1
ESEL
LECAM2
selectin E [Colforsin co-treated with Rolipram] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SELE protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 8780174
D013755 6401 SELE
CD62E
ELAM
ELAM1
ESEL
LECAM2
selectin E Tetradecanoylphorbol Acetate results in increased expression of SELE protein increases expression
protein 8780174
D013755 5055 SERPINB2
HsT1201
PAI
PAI-2
PAI2
PLANH2
serpin peptidase inhibitor, clade B (ovalbumin), member 2 Tetradecanoylphorbol Acetate results in increased expression of SERPINB2 mRNA increases expression
mRNA 8631129
D013755 5055 SERPINB2
HsT1201
PAI
PAI-2
PAI2
PLANH2
serpin peptidase inhibitor, clade B (ovalbumin), member 2 Tetradecanoylphorbol Acetate results in increased expression of SERPINB2 protein increases expression
protein 8631129
D013755 5272 SERPINB9
CAP-3
CAP3
PI-9
PI9
serpin peptidase inhibitor, clade B (ovalbumin), member 9 Tetradecanoylphorbol Acetate results in increased expression of SERPINB9 mRNA increases expression
mRNA 12177049
D013755 5272 SERPINB9
CAP-3
CAP3
PI-9
PI9
serpin peptidase inhibitor, clade B (ovalbumin), member 9 Tetradecanoylphorbol Acetate results in increased expression of SERPINB9 protein increases expression
protein 12177049
D013755 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SERPINE1 mRNA affects cotreatment
/ increases expression
mRNA 18958680
D013755 10262 SF3B4
AFD1
Hsh49
SAP49
SF3b49
splicing factor 3b, subunit 4, 49kDa pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of SF3B4 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 10262 SF3B4
AFD1
Hsh49
SAP49
SF3b49
splicing factor 3b, subunit 4, 49kDa [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of SF3B4 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 22941 SHANK2
AUTS17
CORTBP1
CTTNBP1
ProSAP1
SHANK
SPANK-3
SH3 and multiple ankyrin repeat domains 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SHANK2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6464 SHC1
SHC
SHCA
SHC (Src homology 2 domain containing) transforming protein 1 Tetradecanoylphorbol Acetate results in increased expression of SHC1 mRNA increases expression
mRNA 19031421
D013755 7979 SHFM1
DSS1
ECD
SEM1
SHFD1
SHSF1
Shfdg1
split hand/foot malformation (ectrodactyly) type 1 [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of SHFM1 mRNA affects cotreatment
/ increases expression
mRNA 18922899
D013755 7979 SHFM1
DSS1
ECD
SEM1
SHFD1
SHSF1
Shfdg1
split hand/foot malformation (ectrodactyly) type 1 Tetradecanoylphorbol Acetate results in increased expression of SHFM1 mRNA increases expression
mRNA 18922899
D013755 946 SIGLEC6
CD327
CD33L
CD33L1
CD33L2
CDW327
OBBP1
sialic acid binding Ig-like lectin 6 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SIGLEC6 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6503 SLA
SLA1
SLAP
Src-like-adaptor [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SLA mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 6503 SLA
SLA1
SLAP
Src-like-adaptor pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SLA mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 6503 SLA
SLA1
SLAP
Src-like-adaptor [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SLA mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 6520 SLC3A2
4F2
4F2HC
4T2HC
CD98
CD98HC
MDU1
NACAE
solute carrier family 3 (amino acid transporter heavy chain), member 2 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SLC3A2 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 6520 SLC3A2
4F2
4F2HC
4T2HC
CD98
CD98HC
MDU1
NACAE
solute carrier family 3 (amino acid transporter heavy chain), member 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SLC3A2 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 8884 SLC5A6
SMVT
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 Tetradecanoylphorbol Acetate promotes the reaction [SLC5A6 protein results in increased transport of Biotin] increases reaction
/ increases transport
protein 15561972
D013755 6531 SLC6A3
DAT
DAT1
PKDYS
solute carrier family 6 (neurotransmitter transporter), member 3 Tetradecanoylphorbol Acetate results in increased localization of [SLC6A3 protein co-treated with EEA1 protein] affects cotreatment
/ increases localization
protein 22683840
D013755 23657 SLC7A11
CCBR1
xCT
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 Tetradecanoylphorbol Acetate results in increased expression of SLC7A11 mRNA increases expression
mRNA 17200146
D013755 10051 SMC4
CAP-C
CAPC
SMC-4
SMC4L1
hCAP-C
structural maintenance of chromosomes 4 Tetradecanoylphorbol Acetate results in increased expression of SMC4 mRNA increases expression
mRNA 19031421
D013755 8835 SOCS2
CIS2
Cish2
SOCS-2
SSI-2
SSI2
STATI2
suppressor of cytokine signaling 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SOCS2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6647 SOD1
ALS
ALS1
IPOA
SOD
hSod1
homodimer
superoxide dismutase 1, soluble (EC:1.15.1.1) Tetradecanoylphorbol Acetate promotes the reaction [Glucose deficiency results in decreased expression of and results in increased degradation of SOD1 protein] decreases expression
/ increases degradation
/ increases reaction
protein 17309078
D013755 6647 SOD1
ALS
ALS1
IPOA
SOD
hSod1
homodimer
superoxide dismutase 1, soluble (EC:1.15.1.1) Tetradecanoylphorbol Acetate results in increased expression of SOD1 protein increases expression
protein 20831825
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] decreases reaction
/ increases expression
protein 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of SOD2 protein] decreases reaction
/ increases activity
protein 12161520
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 12161520
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 15330761
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] decreases reaction
/ increases expression
protein 15330761
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] decreases reaction
/ increases expression
protein 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) CYBA protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] affects reaction
/ increases expression
protein 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Cycloheximide promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] increases expression
/ increases reaction
mRNA 15330761
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) FOXO3 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2] affects reaction
/ increases expression
21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] decreases reaction
/ increases expression
protein 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOD2 mRNA affects cotreatment
/ decreases expression
mRNA 18958680
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) NCF2 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] affects reaction
/ increases expression
protein 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) NOXO1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] affects reaction
/ increases expression
protein 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) PRKCA protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] affects reaction
/ increases expression
mRNA 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) PRKCB protein alternative form affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] affects reaction
/ increases expression
mRNA 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) PRKCE protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] affects reaction
/ increases expression
mRNA 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) RAC1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] affects reaction
/ increases expression
protein 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein] decreases reaction
/ increases expression
protein 21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) SN50 peptide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of SOD2 protein] decreases reaction
/ increases activity
protein 12161520
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) SN50 peptide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 12161520
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCR1 mRNA] increases expression
/ increases reaction
protein 21045076
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1A mRNA] increases expression
/ increases reaction
protein 21045076
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1R1 mRNA] increases expression
/ increases reaction
protein 21045076
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) SOD2 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1R2 mRNA] increases expression
/ increases reaction
protein 21045076
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) SOD2 protein results in decreased susceptibility to [Tetradecanoylphorbol Acetate co-treated with Ionomycin] affects cotreatment
/ decreases response to substance
protein 22429591
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Tetradecanoylphorbol Acetate promotes the reaction [Cycloheximide results in increased expression of SOD2 mRNA] increases expression
/ increases reaction
mRNA 15330761
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Tetradecanoylphorbol Acetate promotes the reaction [[SP1 protein binds to SOD2 promoter] which results in increased expression of SOD2 mRNA] affects binding
/ increases expression
/ increases reaction
mRNA / promoter 10669635
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) [Tetradecanoylphorbol Acetate results in increased abundance of Reactive Oxygen Species] which results in increased abundance of SOD2 increases abundance
21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of SOD2 protein increases activity
/ increases expression
protein 17309078
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) [Tetradecanoylphorbol Acetate results in increased activity of PRKCA protein] which results in increased expression of SOD2 increases activity
/ increases expression
21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Tetradecanoylphorbol Acetate results in increased activity of SOD2 protein increases activity
protein 12161520
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA increases expression
mRNA 10669635
12161520
15330761
17309078
21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) Tetradecanoylphorbol Acetate results in increased expression of SOD2 protein increases expression
protein 15330761
20831825
21705328
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) [Tetradecanoylphorbol Acetate results in increased expression of TNF] which results in increased expression of SOD2 increases expression
10769695
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of SOD2 protein] decreases reaction
/ increases activity
/ increases expression
protein 17309078
D013755 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 17309078
D013755 6667 SP1
Sp1 transcription factor Tetradecanoylphorbol Acetate promotes the reaction [SP1 protein binds to CDKN1A promoter] affects binding
/ increases reaction
protein 15978937
D013755 6667 SP1
Sp1 transcription factor Tetradecanoylphorbol Acetate promotes the reaction [[SP1 protein binds to SOD2 promoter] which results in increased expression of SOD2 mRNA] affects binding
/ increases expression
/ increases reaction
protein 10669635
D013755 6667 SP1
Sp1 transcription factor Tetradecanoylphorbol Acetate results in increased activity of SP1 protein increases activity
protein 15978937
D013755 10615 SPAG5
DEEPEST
MAP126
hMAP126
sperm associated antigen 5 Tetradecanoylphorbol Acetate results in increased expression of SPAG5 mRNA increases expression
mRNA 19031421
D013755 6688 SPI1
OF
PU.1
SFPI1
SPI-1
SPI-A
spleen focus forming virus (SFFV) proviral integration oncogene Tetradecanoylphorbol Acetate results in increased activity of SPI1 protein increases activity
protein 18418899
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA] decreases reaction
/ increases expression
mRNA 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 protein] decreases reaction
/ increases expression
protein 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 fenofibric acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA] decreases reaction
/ increases expression
mRNA 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 [FOS protein co-treated with JUN protein] inhibits the reaction [pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 protein]] affects cotreatment
/ decreases reaction
/ increases expression
protein 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 GW 9578 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA] decreases reaction
/ increases expression
mRNA 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter]] affects binding
/ decreases reaction
/ increases reaction
promoter 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA] decreases reaction
/ increases expression
mRNA 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 pirinixic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 protein] decreases reaction
/ increases expression
protein 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 PPARA protein affects the reaction [Bezafibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]] affects reaction
/ decreases reaction
/ increases expression
mRNA 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 PPARA protein affects the reaction [fenofibric acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]] affects reaction
/ decreases reaction
/ increases expression
mRNA 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 PPARA protein affects the reaction [GW 9578 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA]] affects reaction
/ decreases reaction
/ increases expression
mRNA 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 Tetradecanoylphorbol Acetate promotes the reaction [[FOS protein binds to JUN protein modified form] which binds to SPP1 promoter] affects binding
/ increases reaction
promoter 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA increases expression
mRNA 11426586
17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 Tetradecanoylphorbol Acetate results in increased expression of SPP1 protein increases expression
protein 17360982
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA] decreases reaction
/ increases expression
mRNA 11426586
D013755 6696 SPP1
BNSP
BSPI
ETA-1
OPN
secreted phosphoprotein 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SPP1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6698 SPRR1A
SPRK
small proline-rich protein 1A Tetradecanoylphorbol Acetate results in increased expression of SPRR1A mRNA increases expression
mRNA 11485391
D013755 6699 SPRR1B
CORNIFIN
GADD33
SPRR1
small proline-rich protein 1B Tetradecanoylphorbol Acetate results in increased expression of SPRR1B mRNA increases expression
mRNA 11485391
D013755 6700 SPRR2A
small proline-rich protein 2A [Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of SPRR2A mRNA affects cotreatment
/ increases expression
mRNA 18922899
D013755 6734 SRPR
DP
Sralpha
signal recognition particle receptor (docking protein) [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SRPR mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 6734 SRPR
DP
Sralpha
signal recognition particle receptor (docking protein) [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SRPR mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 10492 SYNCRIP
GRY-RBP
GRYRBP
HNRNPQ
HNRPQ1
NSAP1
PP68
hnRNP-Q
synaptotagmin binding, cytoplasmic RNA interacting protein Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein] affects localization
/ decreases reaction
protein 19331829
D013755 10492 SYNCRIP
GRY-RBP
GRYRBP
HNRNPQ
HNRPQ1
NSAP1
PP68
hnRNP-Q
synaptotagmin binding, cytoplasmic RNA interacting protein Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein affects localization
protein 19331829
D013755 8148 TAF15
Npl3
RBP56
TAF2N
TAFII68
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TAF15 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6876 TAGLN
SM22
SMCC
TAGLN1
WS3-10
transgelin Tetradecanoylphorbol Acetate results in decreased expression of TAGLN mRNA decreases expression
mRNA 15380616
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 protein]] decreases reaction
/ increases expression
/ increases reaction
protein 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 protein]] decreases reaction
/ increases expression
/ increases reaction
protein 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 fulvestrant inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
mRNA 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 [rottlerin results in decreased activity of PRKCD protein] inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA]] decreases activity
/ decreases reaction
/ increases expression
/ increases reaction
mRNA 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 mRNA] increases expression
/ increases reaction
mRNA 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 Tetradecanoylphorbol Acetate promotes the reaction [benz(a)anthracene results in increased expression of TFF1 protein] increases expression
/ increases reaction
protein 22643241
D013755 7031 TFF1
BCEI
D21S21
HP1.A
HPS2
pNR-2
pS2
trefoil factor 1 Tetradecanoylphorbol Acetate results in increased expression of TFF1 mRNA increases expression
mRNA 22643241
D013755 7037 TFRC
CD71
T9
TFR
TFR1
TR
TRFR
p90
transferrin receptor catechol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TFRC protein] decreases reaction
/ increases expression
protein 12749906
D013755 7037 TFRC
CD71
T9
TFR
TFR1
TR
TRFR
p90
transferrin receptor hydroquinone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TFRC protein] decreases reaction
/ increases expression
protein 12749906
D013755 7037 TFRC
CD71
T9
TFR
TFR1
TR
TRFR
p90
transferrin receptor Tetradecanoylphorbol Acetate results in increased expression of TFRC protein increases expression
protein 12749906
D013755 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TGFB1 mRNA affects cotreatment
/ increases expression
mRNA 18434080
D013755 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 TGFB1 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HGF protein] decreases reaction
/ increases expression
15802798
D013755 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 TGFB1 protein promotes the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] decreases reaction
/ increases expression
/ increases reaction
protein 11728381
D013755 7040 TGFB1
CED
DPD1
LAP
TGFB
TGFbeta
transforming growth factor, beta 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TGFB1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 7042 TGFB2
LDS4
TGF-beta2
transforming growth factor, beta 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TGFB2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 7051 TGM1
ARCI1
ICR2
KTG
LI
LI1
TGASE
TGK
transglutaminase 1 (EC:2.3.2.13) Tetradecanoylphorbol Acetate results in increased expression of TGM1 mRNA increases expression
mRNA 11485391
D013755 7066 THPO
MGDF
MKCSF
ML
MPLLG
THCYT1
TPO
thrombopoietin [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of THPO mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 10440 TIMM17A
TIM17
TIM17A
translocase of inner mitochondrial membrane 17 homolog A (yeast) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TIMM17A mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 7076 TIMP1
CLGI
EPA
EPO
HCI
TIMP
TIMP metallopeptidase inhibitor 1 Quercetin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of TIMP1 mRNA] increases expression
/ increases reaction
mRNA 11414687
D013755 7076 TIMP1
CLGI
EPA
EPO
HCI
TIMP
TIMP metallopeptidase inhibitor 1 Tetradecanoylphorbol Acetate results in increased expression of TIMP1 mRNA increases expression
mRNA 11414687
18155510
20599481
D013755 7076 TIMP1
CLGI
EPA
EPO
HCI
TIMP
TIMP metallopeptidase inhibitor 1 troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TIMP1 mRNA] decreases reaction
/ increases expression
mRNA 18155510
D013755 7077 TIMP2
CSC-21K
DDC8
TIMP metallopeptidase inhibitor 2 Tetradecanoylphorbol Acetate results in increased expression of TIMP2 protein increases expression
protein 19969058
D013755 10333 TLR6
CD286
toll-like receptor 6 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TLR6 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 3371 TNC
150-225
DFNA56
GMEM
GP
HXB
JI
TN
TN-C
tenascin C [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TNC mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor 1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF mRNA] decreases reaction
/ increases expression
mRNA 16091123
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor 1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 16091123
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor alpha-Tocopherol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein] decreases reaction
/ increases secretion
protein 19135038
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor beta Carotene affects the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein] affects reaction
/ increases secretion
protein 19135038
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor butein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 20696233
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA affects cotreatment
/ increases expression
mRNA 21515303
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein affects cotreatment
/ increases secretion
protein 21515303
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor chromic acid inhibits the reaction [[Glucose co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 11726202
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor chromic chloride inhibits the reaction [[Hydrogen Peroxide co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 11726202
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 21515303
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21515303
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor cinnamic aldehyde inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21807015
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Cycloheximide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 12812920
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Cycloheximide inhibits the reaction [Zinc deficiency promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]] decreases reaction
/ increases expression
/ increases reaction
protein 12812920
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 12812920
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Dactinomycin inhibits the reaction [Zinc deficiency promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]] decreases reaction
/ increases expression
/ increases reaction
protein 12812920
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Doxycycline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 16134060
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21807015
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 18958421
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Glucose co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein affects cotreatment
/ increases secretion
protein 11726202
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Hydrogen Peroxide co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein affects cotreatment
/ increases secretion
protein 11726202
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor hydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 10890505
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein affects cotreatment
/ increases secretion
protein 17685462
21075198
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Ionomycin inhibits the reaction [[N-(4-hydroxyphenyl)arachidonylamide co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17196940
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF protein affects cotreatment
/ increases expression
protein 17051331
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein affects cotreatment
/ increases secretion
protein 21807015
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor mancozeb inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein] decreases reaction
/ increases secretion
protein 16112155
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor naringenin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein] decreases reaction
/ increases secretion
protein 19135038
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF mRNA] decreases reaction
/ increases expression
mRNA 10072544
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 10072544
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19118619
19665545
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of and results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 19118619
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 19665545
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor prolinedithiocarbamate inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 21515303
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Quercetin affects the reaction [beta Carotene affects the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein]] affects reaction
/ increases secretion
protein 19135038
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 17588137
18958421
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17588137
18958421
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein] decreases reaction
/ increases secretion
protein 19135038
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
/ increases secretion
protein 19416633
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 19416633
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 16154495
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of TNF protein] decreases reaction
/ increases expression
/ increases secretion
protein 19416633
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 18958421
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 18958421
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF mRNA] decreases reaction
/ increases expression
mRNA 16091123
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor sodium bichromate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 17685462
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 17051331
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 1371491
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 16134060
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 16134060
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein affects cotreatment
/ increases expression
/ increases secretion
protein 19416633
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA affects cotreatment
/ increases expression
mRNA 16134060
17588137
18958421
19118619
19416633
19665545
22322153
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein affects cotreatment
/ increases expression
protein 1371491
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of and results in increased expression of TNF protein affects cotreatment
/ increases expression
/ increases secretion
protein 19118619
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein affects cotreatment
/ increases secretion
protein 16134060
17588137
18958421
19665545
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF mRNA affects cotreatment
/ increases expression
mRNA 18434080
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein affects cotreatment
/ increases expression
protein 10890505
15358692
16154495
17572062
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of TNF protein increases expression
/ increases secretion
protein 19416633
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Tetradecanoylphorbol Acetate results in increased expression of TNF increases expression
10769695
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Tetradecanoylphorbol Acetate results in increased expression of TNF mRNA increases expression
mRNA 14573775
16091123
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Tetradecanoylphorbol Acetate results in increased expression of TNF protein increases expression
protein 9628260
12812920
16091123
20696233
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor [Tetradecanoylphorbol Acetate results in increased expression of TNF] which results in increased expression of SOD2 increases expression
10769695
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Tetradecanoylphorbol Acetate results in increased secretion of TNF protein increases secretion
protein 19135038
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor TNF affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA] affects reaction
/ increases expression
14573775
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor TNF protein affects the susceptibility to Tetradecanoylphorbol Acetate affects response to substance
protein 10769695
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Triclosan inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with TNF protein] results in increased expression of IL1B protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 9584910
D013755 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor Zinc deficiency promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein] increases expression
/ increases reaction
protein 12812920
D013755 7128 TNFAIP3
A20
OTUD7C
TNFA1P2
tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) Tetradecanoylphorbol Acetate results in decreased expression of TNFAIP3 mRNA decreases expression
mRNA 21873647
D013755 7128 TNFAIP3
A20
OTUD7C
TNFA1P2
tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) Tetradecanoylphorbol Acetate results in increased activity of TNFAIP3 protein increases activity
protein 15451058
D013755 7128 TNFAIP3
A20
OTUD7C
TNFA1P2
tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) Tetradecanoylphorbol Acetate results in increased expression of TNFAIP3 mRNA increases expression
mRNA 15451058
21873647
D013755 7128 TNFAIP3
A20
OTUD7C
TNFA1P2
tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) Zinc deficiency inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of TNFAIP3 protein] decreases reaction
/ increases activity
protein 15451058
D013755 7128 TNFAIP3
A20
OTUD7C
TNFA1P2
tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) Zinc deficiency inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFAIP3 mRNA] decreases reaction
/ increases expression
mRNA 15451058
D013755 7132 TNFRSF1A
CD120a
FPF
MS5
TBP1
TNF-R
TNF-R-I
TNF-R55
TNFAR
TNFR1
TNFR1-d2
TNFR55
TNFR60
p55
p55-R
p60
tumor necrosis factor receptor superfamily, member 1A 1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1A protein] decreases reaction
/ increases expression
protein 9870925
D013755 7132 TNFRSF1A
CD120a
FPF
MS5
TBP1
TNF-R
TNF-R-I
TNF-R55
TNFAR
TNFR1
TNFR1-d2
TNFR55
TNFR60
p55
p55-R
p60
tumor necrosis factor receptor superfamily, member 1A calphostin C inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1A protein] decreases reaction
/ increases expression
protein 9870925
D013755 7132 TNFRSF1A
CD120a
FPF
MS5
TBP1
TNF-R
TNF-R-I
TNF-R55
TNFAR
TNFR1
TNFR1-d2
TNFR55
TNFR60
p55
p55-R
p60
tumor necrosis factor receptor superfamily, member 1A Dimethyl Sulfoxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1A protein] decreases reaction
/ increases expression
protein 9870925
D013755 7132 TNFRSF1A
CD120a
FPF
MS5
TBP1
TNF-R
TNF-R-I
TNF-R55
TNFAR
TNFR1
TNFR1-d2
TNFR55
TNFR60
p55
p55-R
p60
tumor necrosis factor receptor superfamily, member 1A KB R8301 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1A protein] decreases reaction
/ increases expression
protein 9870925
D013755 7132 TNFRSF1A
CD120a
FPF
MS5
TBP1
TNF-R
TNF-R-I
TNF-R55
TNFAR
TNFR1
TNFR1-d2
TNFR55
TNFR60
p55
p55-R
p60
tumor necrosis factor receptor superfamily, member 1A Tetradecanoylphorbol Acetate results in decreased expression of TNFRSF1A protein decreases expression
protein 11882518
D013755 7132 TNFRSF1A
CD120a
FPF
MS5
TBP1
TNF-R
TNF-R-I
TNF-R55
TNFAR
TNFR1
TNFR1-d2
TNFR55
TNFR60
p55
p55-R
p60
tumor necrosis factor receptor superfamily, member 1A Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1A protein increases expression
protein 9870925
D013755 7133 TNFRSF1B
CD120b
TBPII
TNF-R-II
TNF-R75
TNFBR
TNFR1B
TNFR2
TNFR80
p75
p75TNFR
tumor necrosis factor receptor superfamily, member 1B [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 7133 TNFRSF1B
CD120b
TBPII
TNF-R-II
TNF-R75
TNFBR
TNFR1B
TNFR2
TNFR80
p75
p75TNFR
tumor necrosis factor receptor superfamily, member 1B NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1B protein] decreases reaction
/ increases expression
protein 10072544
D013755 7133 TNFRSF1B
CD120b
TBPII
TNF-R-II
TNF-R75
TNFBR
TNFR1B
TNFR2
TNFR80
p75
p75TNFR
tumor necrosis factor receptor superfamily, member 1B [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 7133 TNFRSF1B
CD120b
TBPII
TNF-R-II
TNF-R75
TNFBR
TNFR1B
TNFR2
TNFR80
p75
p75TNFR
tumor necrosis factor receptor superfamily, member 1B Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1B protein increases expression
protein 10072544
D013755 3604 TNFRSF9
4-1BB
CD137
CDw137
ILA
tumor necrosis factor receptor superfamily, member 9 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TNFRSF9 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 8743 TNFSF10
APO2L
Apo-2L
CD253
TL2
TRAIL
tumor necrosis factor (ligand) superfamily, member 10 Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ decreases reaction
/ increases expression
protein 21603612
D013755 8743 TNFSF10
APO2L
Apo-2L
CD253
TL2
TRAIL
tumor necrosis factor (ligand) superfamily, member 10 NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 21603612
D013755 8743 TNFSF10
APO2L
Apo-2L
CD253
TL2
TRAIL
tumor necrosis factor (ligand) superfamily, member 10 NFATC2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 21603612
D013755 8743 TNFSF10
APO2L
Apo-2L
CD253
TL2
TRAIL
tumor necrosis factor (ligand) superfamily, member 10 NFATC3 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 21603612
D013755 8743 TNFSF10
APO2L
Apo-2L
CD253
TL2
TRAIL
tumor necrosis factor (ligand) superfamily, member 10 NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] affects cotreatment
/ increases expression
/ increases reaction
protein 21603612
D013755 8743 TNFSF10
APO2L
Apo-2L
CD253
TL2
TRAIL
tumor necrosis factor (ligand) superfamily, member 10 [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein affects cotreatment
/ increases expression
protein 21603612
D013755 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 Tetradecanoylphorbol Acetate inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and affects the localization of TP53 protein] affects localization
/ decreases reaction
/ increases activity
/ increases phosphorylation
protein 15542774
D013755 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 Tetradecanoylphorbol Acetate results in decreased expression of TP53 protein decreases expression
protein 10910098
D013755 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 Tetradecanoylphorbol Acetate results in increased phosphorylation of TP53 protein increases phosphorylation
protein 8076368
8927716
D013755 7163 TPD52
D52
N8L
PC-1
PrLZ
hD52
tumor protein D52 Tetradecanoylphorbol Acetate results in decreased expression of TPD52 mRNA decreases expression
mRNA 21873647
D013755 7163 TPD52
D52
N8L
PC-1
PrLZ
hD52
tumor protein D52 Tetradecanoylphorbol Acetate results in increased expression of TPD52 mRNA increases expression
mRNA 21873647
D013755 22974 TPX2
C20orf1
C20orf2
DIL-2
DIL2
FLS353
GD:C20orf1
HCA519
HCTP4
REPP86
p100
TPX2, microtubule-associated Tetradecanoylphorbol Acetate results in increased expression of TPX2 mRNA increases expression
mRNA 19031421
D013755 7185 TRAF1
EBI6
MGC:10353
TNF receptor-associated factor 1 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 7185 TRAF1
EBI6
MGC:10353
TNF receptor-associated factor 1 bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA]] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 7185 TRAF1
EBI6
MGC:10353
TNF receptor-associated factor 1 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 7185 TRAF1
EBI6
MGC:10353
TNF receptor-associated factor 1 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 6967 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TRGC2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 29953 TRHDE
PAP-II
PGPEP2
TRH-DE
thyrotropin-releasing hormone degrading enzyme (EC:3.4.19.6) [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TRHDE mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 28951 TRIB2
C5FW
GS3955
TRB2
tribbles pseudokinase 2 pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TRIB2 mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 28951 TRIB2
C5FW
GS3955
TRB2
tribbles pseudokinase 2 [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TRIB2 mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 Tetradecanoylphorbol Acetate inhibits the reaction [Capsaicin results in increased activity of TRPV1 protein] decreases reaction
/ increases activity
protein 17913835
D013755 7296 TXNRD1
GRIM-12
TR
TR1
TRXR1
TXNR
thioredoxin reductase 1 (EC:1.8.1.9) Tetradecanoylphorbol Acetate results in increased expression of TXNRD1 mRNA increases expression
mRNA 12949356
D013755 1890 TYMP
ECGF
ECGF1
MEDPS1
MNGIE
MTDPS1
PDECGF
TP
hPD-ECGF
thymidine phosphorylase (EC:2.4.2.4) Aspirin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA] decreases reaction
/ increases expression
mRNA 14573775
D013755 1890 TYMP
ECGF
ECGF1
MEDPS1
MNGIE
MTDPS1
PDECGF
TP
hPD-ECGF
thymidine phosphorylase (EC:2.4.2.4) Tetradecanoylphorbol Acetate results in increased activity of TYMP protein increases activity
protein 14573775
D013755 1890 TYMP
ECGF
ECGF1
MEDPS1
MNGIE
MTDPS1
PDECGF
TP
hPD-ECGF
thymidine phosphorylase (EC:2.4.2.4) Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA increases expression
mRNA 14573775
D013755 1890 TYMP
ECGF
ECGF1
MEDPS1
MNGIE
MTDPS1
PDECGF
TP
hPD-ECGF
thymidine phosphorylase (EC:2.4.2.4) TNF affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA] affects reaction
/ increases expression
mRNA 14573775
D013755 7298 TYMS
HST422
TMS
TS
thymidylate synthetase (EC:2.1.1.45) Tetradecanoylphorbol Acetate results in increased expression of TYMS mRNA increases expression
mRNA 19031421
D013755 7305 TYROBP
DAP12
KARAP
PLOSL
TYRO protein tyrosine kinase binding protein [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 7305 TYROBP
DAP12
KARAP
PLOSL
TYRO protein tyrosine kinase binding protein pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA] affects cotreatment
/ decreases expression
/ decreases reaction
mRNA 15477007
D013755 7305 TYROBP
DAP12
KARAP
PLOSL
TYRO protein tyrosine kinase binding protein [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA affects cotreatment
/ decreases expression
mRNA 15477007
D013755 29128 UHRF1
ICBP90
Np95
RNF106
hNP95
hUHRF1
ubiquitin-like with PHD and ring finger domains 1 (EC:6.3.2.19) Tetradecanoylphorbol Acetate results in decreased expression of UHRF1 mRNA decreases expression
mRNA 15964557
D013755 29128 UHRF1
ICBP90
Np95
RNF106
hNP95
hUHRF1
ubiquitin-like with PHD and ring finger domains 1 (EC:6.3.2.19) Tetradecanoylphorbol Acetate results in decreased expression of UHRF1 protein decreases expression
protein 15964557
D013755 7412 VCAM1
CD106
INCAM-100
vascular cell adhesion molecule 1 3,4-dihydroxyphenylethanol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VCAM1 protein] decreases reaction
/ increases expression
protein 12615669
D013755 7412 VCAM1
CD106
INCAM-100
vascular cell adhesion molecule 1 Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VCAM1 protein] decreases reaction
/ increases expression
protein 12615669
D013755 7412 VCAM1
CD106
INCAM-100
vascular cell adhesion molecule 1 oleuropein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VCAM1 protein] decreases reaction
/ increases expression
protein 12615669
D013755 7412 VCAM1
CD106
INCAM-100
vascular cell adhesion molecule 1 resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VCAM1 protein] decreases reaction
/ increases expression
protein 12615669
D013755 7421 VDR
NR1I1
vitamin D (1,25- dihydroxyvitamin D3) receptor Tetradecanoylphorbol Acetate promotes the reaction [salvin results in increased expression of VDR protein] increases expression
/ increases reaction
protein 11504768
D013755 7421 VDR
NR1I1
vitamin D (1,25- dihydroxyvitamin D3) receptor Tetradecanoylphorbol Acetate results in increased expression of VDR mRNA increases expression
mRNA 20006981
D013755 7421 VDR
NR1I1
vitamin D (1,25- dihydroxyvitamin D3) receptor Tetradecanoylphorbol Acetate results in increased expression of VDR protein increases expression
protein 9348195
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A Acetylcysteine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Hydrogen Peroxide] results in increased secretion of VEGFA protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 19910455
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A Acetylcysteine inhibits the reaction [[Tretinoin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of VEGFA protein] affects cotreatment
/ decreases reaction
/ increases secretion
protein 19910455
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A [Tetradecanoylphorbol Acetate co-treated with Hydrogen Peroxide] results in increased secretion of VEGFA protein affects cotreatment
/ increases secretion
protein 19910455
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A Tetradecanoylphorbol Acetate inhibits the reaction [VEGFA protein results in increased expression of ACE protein] decreases reaction
/ increases expression
protein 11158990
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A Tetradecanoylphorbol Acetate results in increased expression of VEGFA mRNA increases expression
mRNA 19910455
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A [Tretinoin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of VEGFA mRNA affects cotreatment
/ increases expression
mRNA 19910455
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A [Tretinoin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of VEGFA protein affects cotreatment
/ increases expression
protein 19910455
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A [Tretinoin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of VEGFA protein modified form affects cotreatment
/ increases secretion
protein 19910455
D013755 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of VEGFA mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 7431 VIM
CTRCT30
vimentin [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of VIM mRNA] affects cotreatment
/ decreases reaction
/ increases expression
mRNA 15477007
D013755 7431 VIM
CTRCT30
vimentin [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of VIM mRNA affects cotreatment
/ increases expression
mRNA 15477007
D013755 7434 VIPR2
C16DUPq36.3
DUP7q36.3
PACAP-R-3
PACAP-R3
VIP-R-2
VPAC2
VPAC2R
VPCAP2R
vasoactive intestinal peptide receptor 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of VIPR2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 6935 ZEB1
AREB6
BZP
DELTAEF1
FECD6
NIL2A
PPCD3
TCF8
ZFHEP
ZFHX1A
zinc finger E-box binding homeobox 1 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ZEB1 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 9839 ZEB2
HSPC082
SIP-1
SIP1
SMADIP1
ZFHX1B
zinc finger E-box binding homeobox 2 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ZEB2 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 9310 ZNF235
ANF270
HZF6
ZFP93
ZNF270
zinc finger protein 235 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ZNF235 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 113835 ZNF257
BMZF-4
BMZF4
zinc finger protein 257 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ZNF257 mRNA affects cotreatment
/ affects expression
mRNA 16979875
D013755 11130 ZWINT
HZwint-1
KNTC2AP
ZWINT1
ZW10 interacting kinetochore protein Tetradecanoylphorbol Acetate results in increased expression of ZWINT mRNA increases expression
mRNA 19031421

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (57)

OMIM preferred title UniProt
#300438 17-beta-hydroxysteroid dehydrogenase x deficiency Q99714
#202300 Adrenocortical carcinoma, hereditary; adcc P04637
#608584 Asthma-related traits, susceptibility to, 2 Q6W5P4
#614740 Basal cell carcinoma, susceptibility to, 7; bcc7 P04637
#210900 Bloom syndrome; blm P54132
#115200 Cardiomyopathy, dilated, 1a; cmd1a P02545
#212112 Cardiomyopathy, dilated, with hypergonadotropic hypogonadism P02545
#118300 Charcot-marie-tooth disease and deafness Q01453
#605588 Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 P02545
#118220 Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a Q01453
#609535 Drug metabolism, poor, cyp2c19-related P33261
#608902 Drug metabolism, poor, cyp2d6-related P10635
#181350 Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 P02545
#133239 Esophageal cancer P04637
#600274 Frontotemporal dementia; ftd P10636
#139393 Guillain-barre syndrome, familial; gbs Q01453
#605130 Hairy elbows, short stature, facial dysmorphism, and developmental delay Q03164
#610140 Heart-hand syndrome, slovenian type P02545
#176670 Hutchinson-gilford progeria syndrome; hgps P02545
#145000 Hyperparathyroidism 1; hrpt1 O00255
#603373 Hyperthyroidism, familial gestational P16473
#609152 Hyperthyroidism, nonautoimmune P16473
#145900 Hypertrophic neuropathy of dejerine-sottas Q01453
#275200 Hypothyroidism, congenital, nongoitrous, 1; chng1 P16473
#151623 Li-fraumeni syndrome 1; lfs1 P04637
#151660 Lipodystrophy, familial partial, type 2; fpld2 P02545
#613688 Long qt syndrome 2; lqt2 Q12809
#211980 Lung cancer P04637
#248370 Mandibuloacral dysplasia with type a lipodystrophy; mada P02545
#300705 Mental retardation, x-linked 17; mrx17 Q99714
#300220 Mental retardation, x-linked, syndromic 10; mrxs10 Q99714
#131100 Multiple endocrine neoplasia, type i; men1 O00255
#613205 Muscular dystrophy, congenital, lmna-related P02545
#159001 Muscular dystrophy, limb-girdle, type 1b; lgmd1b P02545
#162500 Neuropathy, hereditary, with liability to pressure palsies; hnpp Q01453
#257220 Niemann-pick disease, type c1; npc1 O15118
#260500 Papilloma of choroid plexus; cpp P04637
#260540 Parkinson-dementia syndrome P10636
#172700 Pick disease of brain P10636
#601399 Platelet disorder, familial, with associated myeloid malignancy Q01196
#275210 Restrictive dermopathy, lethal P02545
#604906 Schizophrenia 9; sczd9 P49798
#181500 Schizophrenia; sczd P49798
#609620 Short qt syndrome 1; sqt1 Q12809
#253300 Spinal muscular atrophy, type i; sma1 Q16637
#253550 Spinal muscular atrophy, type ii; sma2 Q16637
#253400 Spinal muscular atrophy, type iii; sma3 Q16637
#271150 Spinal muscular atrophy, type iv; sma4 Q16637
#605361 Spinocerebellar ataxia 14; sca14 P05129
#183090 Spinocerebellar ataxia 2; sca2 Q99700
#607250 Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 Q9NUW8
#275355 Squamous cell carcinoma, head and neck; hnscc P04637
#601367 Stroke, ischemic P24723
#601104 Supranuclear palsy, progressive, 1; psnp1 P10636
#152700 Systemic lupus erythematosus; sle O95267
#187950 Thrombocythemia 1; thcyt1 P40225
#278750 Xeroderma pigmentosum, variant type; xpv Q9Y253

KEGG DISEASE (76)

KEGG disease name UniProt
H00033 Adrenal carcinoma O00255 (related)
P04637 (related)
H00034 Carcinoid O00255 (related)
H00045 Malignant islet cell carcinoma O00255 (related)
H00246 Primary hyperparathyroidism O00255 (related)
H01102 Pituitary adenomas O00255 (related)
H00136 Niemann-Pick disease type C (NPC) O15118 (related)
H00264 Charcot-Marie-Tooth disease (CMT) P02545 (related)
Q01453 (related)
H00294 Dilated cardiomyopathy (DCM) P02545 (related)
H00420 Familial partial lipodystrophy (FPL) P02545 (related)
H00563 Emery-Dreifuss muscular dystrophy P02545 (related)
H00590 Congenital muscular dystrophies (CMD/MDC) P02545 (related)
H00593 Limb-girdle muscular dystrophy (LGMD) P02545 (related)
H00601 Hutchinson-Gilford progeria syndrome P02545 (related)
H00663 Restrictive dermopathy P02545 (related)
H00665 Mandibuloacral dysplasia P02545 (related)
H01216 Left ventricular noncompaction (LVNC) P02545 (related)
H00004 Chronic myeloid leukemia (CML) P04637 (related)
Q01196 (related)
H00005 Chronic lymphocytic leukemia (CLL) P04637 (related)
H00006 Hairy-cell leukemia P04637 (related)
H00008 Burkitt lymphoma P04637 (related)
H00009 Adult T-cell leukemia P04637 (related)
H00010 Multiple myeloma P04637 (related)
H00013 Small cell lung cancer P04637 (related)
H00014 Non-small cell lung cancer P04637 (related)
H00015 Malignant pleural mesothelioma P04637 (related)
H00016 Oral cancer P04637 (related)
P04637 (marker)
H00017 Esophageal cancer P04637 (related)
P04637 (marker)
H00018 Gastric cancer P04637 (related)
H00019 Pancreatic cancer P04637 (related)
P04637 (marker)
H00020 Colorectal cancer P04637 (related)
P04637 (marker)
H00022 Bladder cancer P04637 (related)
H00025 Penile cancer P04637 (related)
P04637 (marker)
H00026 Endometrial Cancer P04637 (related)
H00027 Ovarian cancer P04637 (related)
H00028 Choriocarcinoma P04637 (related)
H00029 Vulvar cancer P04637 (related)
H00031 Breast cancer P04637 (related)
H00032 Thyroid cancer P04637 (related)
H00036 Osteosarcoma P04637 (related)
P08684 (marker)
H00038 Malignant melanoma P04637 (related)
H00039 Basal cell carcinoma P04637 (related)
H00040 Squamous cell carcinoma P04637 (related)
H00041 Kaposi's sarcoma P04637 (related)
H00042 Glioma P04637 (related)
P04637 (marker)
H00044 Cancer of the anal canal P04637 (related)
H00046 Cholangiocarcinoma P04637 (related)
H00047 Gallbladder cancer P04637 (related)
H00048 Hepatocellular carcinoma P04637 (related)
H00055 Laryngeal cancer P04637 (related)
P04637 (marker)
H00881 Li-Fraumeni syndrome P04637 (related)
H01007 Choroid plexus papilloma P04637 (related)
H00021 Renal cell carcinoma P04637 (marker)
H00063 Spinocerebellar ataxia (SCA) P05129 (related)
Q99700 (related)
Q9NUW8 (related)
H00058 Amyotrophic lateral sclerosis (ALS) P10636 (related)
H00077 Progressive supranuclear palsy (PSP) P10636 (related)
H00078 Frontotemporal lobar degeneration (FTLD) P10636 (related)
H01205 Coumarin resistance P11712 (related)
H00250 Congenital nongoitrous hypothyroidism (CHNG) P16473 (related)
H01269 Congenital hyperthyroidism P16473 (related)
H01171 Poor drug metabolism (PM) P33261 (related)
H00227 Congenital amegakaryocytic thrombocytopenia (CAMT) P40225 (marker)
H00094 DNA repair defects P54132 (related)
H00296 Defects in RecQ helicases P54132 (related)
H00001 Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) Q01196 (related)
Q01196 (marker)
Q03164 (related)
Q03164 (marker)
H00003 Acute myeloid leukemia (AML) Q01196 (related)
Q01196 (marker)
Q13951 (marker)
H00978 Thrombocytopenia (THC) Q01196 (related)
H01296 Hereditary neuropathy with liability to pressure palsies (HNPP) Q01453 (related)
H00002 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) Q03164 (related)
H00408 Type I diabetes mellitus Q04759 (related)
H00720 Long QT syndrome Q12809 (related)
H00725 Short QT syndrome Q12809 (related)
H00455 Spinal muscular atrophy (SMA) Q16637 (related)
Q16637 (related)
H00480 Non-syndromic X-linked mental retardation Q99714 (related)
H00658 Syndromic X-linked mental retardation Q99714 (related)
H00925 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency Q99714 (related)
H00403 Disorders of nucleotide excision repair Q9Y253 (related)

Diseases related to CTD interactions

23 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D001932 D013755 Brain Neoplasms marker/mechanism
6732984
D002277 D013755 Carcinoma marker/mechanism
17060372
D006528 D013755 Carcinoma, Hepatocellular marker/mechanism
15138027
19447859
D002294 D013755 Carcinoma, Squamous Cell marker/mechanism
18922899
20852150
D002471 D013755 Cell Transformation, Neoplastic marker/mechanism
6732984
9703276
11808923
18245498
20172950
20584749
D017453 D013755 Dermatitis, Irritant marker/mechanism
11851881
D004487 D013755 Edema marker/mechanism
7812673
8113982
8190018
8273558
9599246
9811170
11698051
15177302
16716910
19161993
20709134
22036979
22981962
D006930 D013755 Hyperalgesia marker/mechanism
15626726
19646975
D006965 D013755 Hyperplasia marker/mechanism
1923905
3677084
7586191
19161993
20172950
20852150
22359662
22981962
D007249 D013755 Inflammation marker/mechanism
7562506
7812673
8273558
11698051
15177302
18262176
20172950
20423157
21235518
22036979
D017254 D013755 Leukemic Infiltration marker/mechanism
22981962
D008113 D013755 Liver Neoplasms marker/mechanism
14514661
D008175 D013755 Lung Neoplasms marker/mechanism
11807781
14514661
D008325 D013755 Mammary Neoplasms, Experimental marker/mechanism
8985016
D009336 D013755 Necrosis therapeutic
17323976
D009361 D013755 Neoplasm Invasiveness marker/mechanism
15962302
19447859
20188714
22634262
D009362 D013755 Neoplasm Metastasis marker/mechanism
19447859
D009374 D013755 Neoplasms, Experimental marker/mechanism
20043298
20691676
D010190 D013755 Pancreatic Neoplasms therapeutic
15976015
D010212 D013755 Papilloma marker/mechanism
2548529
3115617
7513819
8330346
9846968
11507057
12065085
17060372
18404319
18922899
20172950
20660715
20852150
22842666
D012868 D013755 Skin Abnormalities marker/mechanism
20172950
D012878 D013755 Skin Neoplasms marker/mechanism
1923905
3098411
7586191
7871547
8330346
8597533
8985016
9714339
9766437
10381133
11241758
11243714
11507057
11807781
12065085
12504893
12543062
14997284
15063134
17060372
18201729
18404319
19161993
20043298
20660715
20691676
21159610
21533367
21597743
22359662
22842666
D020301 D013755 Vasospasm, Intracranial therapeutic
17105827